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ABSTRACT
Metastatic disease represents the greatest cause of morbidity and mortality in most 
cancer patients. The process of metastasis appears complex and multifaceted and 
has still to be comprehensively understood. To investigate the metastatic 
phenotype, a murine model system was employed: the CMT model. The basis of 
this model is a pair of related epithelial cell lines which were both derived from the 
same spontaneous tumour in a C57B/T animal, but which exhibit markedly 
differing metastatic potentials. The CMT 167/C6 subline exhibits a high metastatic 
potential as measured in the spontaneous metastasis assay in syngeneic, 
immunocompetent C57B/T animals and the subline CMT 170/E9 exhibits low 
metastatic potential. Examination and characterization of these two cell lines 
revealed remarkably few differences between the cell lines. Decreased protein 
expressions of the cell adhesion molecules E-cadherin and NCAM were detected 
in CMT 167/C6 cells in comparison with CMT 170/E9 cells. Neither cell line 
secreted collagenases as assayed by zymography, nor did either cell line exhibit 
gap-junctional communication. Expression of the putative metastasis-associated 
gene mts-1 was not detected by Northern analysis in either cell line and expression 
of alternatively-spliced isoforms of CD44, which have been implicated in another 
metastasis model system, was not found. Examination of gene amplification by 
in-gel renaturation, which allows for the detection of reiterated DNA sequences 
without specific analysis of a particular gene, revealed no differences between the 
two cell lines which may be correlated with their differing metastatic phenotypes. 
The evidence presented suggests that metastasis as displayed in this model may 
result from a number of subtle alterations within the cell which may not be an 
"all-or-nothing" effect. This is supported from preliminary evidence of 2-D gel 
electrophoresis which detected few differences between the cell lines with 
apparently no resolved protein identified to be specifically expressed in either cell 
line; the preliminary identification of differences were quantitative in nature.
Additionally, analysis of transcription factors in the CMT model revealed only 
subtle quantitative differences in EMSA experiments; qualitative differences were 
not observed. In this model, the most distinct differences found between the cell 
lines which may be significant to the differing metastatic phenotypes, were 
alterations in cell adhesion. The implications of these results and further 
experiments to examine this are discussed.
ACKNOWLEDGEMENTS
Firstly, sincere thanks go to my family for their support and confidence in me 
through all these years. A big thank you goes out to all the many people who have 
had the patience to put up with my various instances of apparent madness, 
experimental crises and momentary lapses of drawing on anything (or anyone) that 
stayed still long enough in the lab! Appreciation is also extended to those who 
were willing to feign interest at my latest ideas - trust me, there is reason behind 
my madness....somewhere. Thanks also to those who knew how to make me laugh 
when I needed it most (the Kelvin Way will never be the same again!) and of late, 
may thanks to those who have provided me with a place to stay - tour dates to be 
announced! I'll always have great memories of R3 (the work hard, play hard 
group), the research club and Mexican parties!
Also, thanks to Lynn McGarry for 2-D gel analysis work and Iain Foulkes for 
assistance with dye transfer and immunofluorescence experiments. Last, but not 
least, I would like to thank my supervisors Dr. George Bimie and Mr. Ian Pickford 
for all that they have done for me.
CONTENTS
ABSTRACT i
ACKNOWLEDGEMENTS iii
CONTENTS iv
UST OF FIGURES viii
UST OF TABLES xi
ABBREVIATIONS xii
INTRODUCTION
CHAPTER I CANCER METASTASIS 1
1.1 Overview 1
1.2 THE METASTATIC PROCESS 3
1.2.1 The Extracellular Matrix 5
1.2.2 Cell Adhesion 6
1.2.2.1 Cadherins 6
1.2.2.2 Integrins 8
1.2.2.3 Selectins 12
1.2.2.4 Immunoglobulin Superfamily 13
1.2.2.4.1 NCAM 14
1.2.2.4.2 CEA 15
1.2.2.4.3 M UC18 16
1.2.2.4.4 DCC 17
1.2.2.5 Other Cell Adhesion-Related Molecules: CD44 18
1.2.2.6 Connexons 20
1.2.3 Extracellular Matrix Degradative Enzymes 20
1.2.3.1 Matrix Metalloproteases 21
1.2.3.2 Serine Proteases 25
1.2.4 Tumour Cell Motility 26
1.2.4.1 Autocrine Motility Factor 27
1.2.4.2 Scatter Factor/Hepatocyte Growth Factor 28
1.2.4.3 Migration Stimulating Factor 29
1.2.5 Organ-Specific Metastasis 30
1.2.6 A ngio genesis 31
1.2.7 Metastases ofMetastases 32
1.2.8 Conclusion 32
CHAPTER H GENETIC ALTERATIONS ASSOCIATED WITH TUMOUR 
PROGRESSION
H.l Multistep Model Of Colon Carcinogenesis 34
H.2 Gene Amplification 36
H.3 Putative Metastasis Genes 38
H.3.1 Nm23 39
iv
TL.3.2 Mts-1 41
H.3.3 CD44 42
n.3.4 Cell Adhesion 43
n.3.5 Conclusion 45
CHAPTER HI MODEL SYSTEMS FOR THE STUDY OF METASTASIS
HI.1 Introduction 47
111.2 In Vivo Model Systems 47
111.3 In Vitro Model Systems 50
HI.3.1 Confrontation Assay 51
ni.3.2 Collagen Gels / Matrigels 51
HI.3.3 Invasion Of Tissue Fragments 51
HI.3.4 Summary 53
m.3.5 CMT Model 54
MATERIALS AND METHODS 
CHAPTER IV MATERIALS
IV. 1 Antiserum 57
IV.2 Cell lines, Media and Tissue Culture Supplies 57
IV.3 Chemicals 59
IV.4 Columns 61
TV.5 Enzymes and Inhibitors 61
IV.6 Kits 62
IV.7 Markers 62
IV.8 Membranes, Paper, TLC Plates and X-Ray Film 63
IV.9 Water 63
CHAPTER V METHODS
V.l CELL CULTURE 64
V.1.1 Cell Maintenance 64
V. 1.2 Mycoplasma Testing Of Cell Lines 64
V.I.3 Treatment O f Culture Surfaces 65
V.1.4 Cell Storage 66
V. 1.5 Soft Agar Assays 66
V .l.6 M IT Assay 67
V.2 SPONTANEOUS METASTASIS ASSAY 67
V.3 DNA METHODOLOGIES 69
V.3.1 Genomic DNA Extraction & Purification 69
V.3.2 Spectrophotometric Quantitation Of DNA 69
V.3.3 Restriction Enzyme Digestion Of DNA 70
v
V.3.4 Agarose Gel Electrophoresis 70
V.3.5 Southern Transfer & Hybridization 71
V.3.6 Plasmid DNA Minipreparations 72
V.3.7 Large Scale Plasmid DNA Preparations 73
V.3.8 Purification Of DNA Fragments From Agarose Gels 74
V.3.9 Preparation & Quantitation Of Oligonucleotides 74
V.3.10 Chain-Termination Sequencing 75
V.4 RNA METHODOLOGIES 75
V.4.1 RNA Extraction, Purification & Quantitation 15
V.4.2 RNA Electrophoresis 76
V.4.3 Northern Transfer & Hybridization 76
V.4.4 cDNA Synthesis & Polymerase Chain Reaction (RT-PCR) 77
V.5 RADIOISOTOPIC LABELLING METHODOLOGIES 78
V.5.1 Random Priming 78
V.5.2 Replacement Synthesis 18
V.5.3 Klenow Labelling Of Double-Stranded Blunt Ends 79
V.5.4 End Labelling Of Oligonucleotides 80
V.6 PROTEIN METHODOLOGIES 80
V.6.1 Whole Cell Protein Extraction 80
V.6.2 Nuclear Protein Extraction 80
V.6.3 Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis
(SDS-PAGE) 81
V.6.4 Western Transfer & Blotting 83
V.6.5 SDS-Substrate Gel Analysis Of Proteinases - Zymography 85
V.6.6 Immunocytochemistry 86
V.6.7 Immunofluorescence 87
V.6.8 Phosphoamino Acid Analysis Of Whole Cell Lysates 88
V.6.9 2-D Gel Analysis 90
V.7 OTHER TECHNIQUES 91
V.7.1 In-Gel Renaturation Analysis Of Gene Amplification 91
V.7.2 Electrophoretic Mobility Shift A nalysis (EMSA) 93
V.7.3 Dye Transfer Of Gap-Junctional Communication 94
RESULTS
CHAPTER VI BIOLOGICAL CHARACTERIZATION 95
VI.l In Vivo Confirmation Of Metastatic Phenotypes
Of The CMT Model 95
VI.2 In Vitro Characteristics Of The CMT Model 99
VI.2.1 Anchorage-Independent Growth 100
VI.2.2 In Vitro Growth Curves Of The CMT Cell Lines 102
VI.2.3 Morphology Of CMT Cell Lines Plated Onto Matrix Components 102
VI.2.4 P53 Status 105
VI.2.5 Gap-Junctional Communication 107
VI.2.6 Matrix Metalloprotease Expression 109
VI.3 Cell Adhesion Analysis 111
vi
VI.3.1 Cadherins 112
VI.3.2 NCAM 117
VL3.3 Integrins 121
VI.4 Two-Dimensional Gel Analysis Of Total Cellular Proteins 121
VL5 Phosphoamino Acid Analysis Of Total Cellular Proteins 125
CHAPTER VH MOLECULAR GENETICS ANALYSIS 128
VII. 1 Putative Metastasis-Associated Genes 128
VII.1.1 CD44 128
VII. 1.2 Mts-1 133
VII.2 Gene Amplification 138
VII.2.1 In-Gel Renaturation 138
VII.2.2 N-myc 147
CHAPTER VHI TRANSCRIPTION FACTORS IN THE CMT MODEL 150
\ I U A N F kB 152
VIH.2 PE A3 and AP-1 154
Vin.3 Erg 157
VIH.4 C/EBP 160
DISCUSSION
CHAPTER IX GENERAL DISCUSSION 162
IX.l Biological Characterization Of The CMT Model 163
IX.2 Molecular Genetics Analyses Of The CMT Model 167
IX .2.1 CD44 Expression 168
IX.2.2 Mts-1 Expression 169
IX.2.3 Gene Amplification 170
IX.3 DNA Binding Activites Of Transcription Factors In The CMT Model 174 
IX.4 Conclusions 111
IX.5 Future Prospects 178
REFERENCES 179
vii
Figure 1. Diagrammatic Representation Of The Metastatic Process 4
Figure 2. Multistep Model Of Colon Carcinogenesis 35
Figure 3. Schematic Illustration Of The Derivation Of The CMT Cell Lines 55
Figure 4. Comparison Of CMT 167/C6 And CMT 170/E9 Primary
Tumours In Different Mouse Strains 97
Figure 5. Comparison Of Metastatic Potentials Of CMT 167IC6 And
CMT 170IE9 Cell Lines In Different Mouse Strains 98
Figure 6. Soft Agar Assays For Anchorage-Independent Growth 101
Figure 7. Growth Curves Of CMT Cell Lines In Vitro 103
Figure 8. Morphology Of CMT Cell Lines Plated Onto Matrix
Components In Vitro 104
Figure 9. p53 Immunocytochemical Analysis Of CMT 167/C6 And
CMT 170/E9 Cell Lines 106
Figure 10. Gap-Junction Intercellular Coupling (GJIC) Of
CMT Cell Lines 108
Figure 11. Zymography Of Gelatinase Activity In Conditioned Media
Activated With APMA 110
Figure 12. ECL Western Analysis Of E-Cadherin Expression 113
Figure 13. Immunofluoresence Analysis Of E-Cadherin Expression 114
Figure 14. ECL Western Analysis Of N-Cadherin Expression 115
Figure 15. ECL Western Analysis Of P-Cadherin Expression 116
Figure 16. ECL Western Analysis OfNCAM Expression 119
Figure 17. Immunofluorescence Analysis of NCAM Expression 120
Figure 18. 2-D Gel Analysis Of Total Cellular Proteins 123
Figure 19. Phosphoamino Acid Analysis Of Total Cellular Protein 126
Figure 20. Schematic Diagram Of CD44, Alternative Splice Sites
And Primer Positions 130
Figure 21. Southern Hybridization OfCD44 RT-PCR Products 132
Figure 22. Map Of Mts-1 Plasmid, p271 And Gel Purified Mts-1 Insert 134
Figure 23. Northern Analysis Of Mts-1 And Actin mRNA Expressions 135
Figure 24. Southern Analysis Of Mts-1 137
Figure 25. Diagrammatic Representation Of The In-Gel Renaturation
Procedure 139
Figure 26. In-Gel Renaturation Sensitivity Experiment (1) 142
Figure 27. In-Gel Renaturation Sensitivity Experiment (2) 143
Figure 28. Example Of An In-Gel Renaturation Experiment
Comparing Both CMT Cell Lines And Normal Syngeneic DNA 144
Figure 29. Hindlll In-Gel Renaturation Experiment Comparing Both
CMT Cell Lines And Normal Syngeneic DNA 146
Figure 30. Southern Analysis OfN-Myc In Both CMT Cell Lines And
Compared With Normal Syngeneic DNA 148
Figure 31. EMSA Demonstrating The Presence OfNFxB Oligonucleotide 
Binding Activity In Nuclear Protein Extracts From Both 
CMT Cell Lines 153
ix
Figure 32. EMSA Demonstrating The Presence OfPEA3 Oligonucleotide 
Binding Activity In Nuclear Extracts From Both 
CMT Cell Lines 156
Figure 33. EMSA Demonstrating The Presence OfAP-1 Oligonucleotide 
Binding Activity In Nuclear Protein Extracts From Both 
CMT Cell Lines 158
Figure 34. EMSA Demonstrating The Presence O f Erg Oligonucleotide 
Binding Activity In Nuclear Extracts From Both 
CMT Cell Lines 159
Figure 35. EMSA Demonstrating The Presence O f CiEBP Oligonucleotide 
Binding Activity In Nuclear Extracts From Both 
CMT Cell Lines 161
Figure 36. Schematic Illustration Of Inverted Repeat DNA Analysis 172
x
List o f Tables
Table 1 Estimated isoelectric points and molecular weights o f proteins 
identified in 2-D gel analysis
Table 2 Oligonucleotide sequences ofPCR primers and probes for  
CD44 analysis
Table 3 Oligonucleotides for electrophoretic mobility shift assays 
(EMSAs)
Abbreviations
+'ve positive
-’ve negative
2-D 2-dimensional
72T4C1 72kD type IV collagenase
92T4C1 92kD type IV collagenase
AMF autocrine motility factor
ampT ampicillin resistance gene
AMV avian myeloblastosis virus
APC adenomatous polyposis coli
APMA 4-aminophenvlmercuric acetate
Ax Absorbance (x=wavelength)
bp base pair(s)
BSA bovine serum albumin
CAM chorioallantoic membrane
cDNA complementary deoxyribonucleic acid
CEA carcinoembryonic antigen
C02 carbon dioxide
cpm counts per minute
Da dalton(s)
DCC deleted in colorectal cancer
DEPC diethylpyrocarbonate
dH20  distilled water
DMBA 9,10-dimethyl-1,2-benzathracene
DMEM Dulbecco's modified Eagle's medium
DMSO dimethylsulphoxide
DNA deoxyribonucleic acid
dNTP 3'deoxyribonucleoside 5'triphosphate
dsDNA double-stranded deoxyribonucleic acid
DTT dithiothreitol
ECL enhanced chemiluminescence
ECM extracellular matrix
EDTA ethylenediaminetetra-acetic acid, disodium salt
EMSA electrophoretic mobility shift assay
FAK focal adhesion kinase
FAP familial adenomatous polyposis coli
g gram(s)
GJIC gap-junctional intercellular communication
HC1 hydrochloric acid
HGF hepatocyte growth factor
HRP horse radish peroxidase
i.p. intraperitoneal
i.v. intraveneous
kb kilobase(s)
kD kilo dalton(s)
LPS lipopolysaccharide
p micro
M molar
MCMF mast cell-derived motility factor
min(s) minute (s)
MMP matrix metalloprotease
MOPS 4-morpholinepropanesulphonic acid
mRNA messenger ribonucleic acid
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide
MW molecular weight
NCAM neural cell adhesion molecule
NGF nerve growth factor
oligo oligonucleotide
PA plasminogen activator
PAI plasminogen activator inhibitor
PBS phosphate buffered saline
PCR polymerase chain reaction
Pi isoelectrc point
PMSF phenylmethylsulphonyl fluoride
PNK polynucleotide kinase
RNA ribonucleic acid
rpm revolutions per minute
RT reverse transcription
s.c. subcutaneous
SCLC small cell lung carcinoma
SDS sodium dodecyl sulphate
SDS-PAGE sodium dodecyl sulphate-polyacrylamide gel electrophoresis
SF scatter factor
ssDNA single-stranded deoxyribonucleic acid
TCA trichloroacetic acid
TEMED tetramethylenediamine
TIMP tissue inhibitor of matrix metalloprotease
tPA tissue-type plasminogen activator
uPA urokinase-type plasminogen activator
UV ultra violet
v/v volume for volume
w/v weight for volume
Amino acid one letter and three letter code used in this thesis is the same as that 
described by Sambrook et al., 1989.
Throughout this thesis genes/alleles are indicated by italics, whilst proteins are 
non-italicised.
INTRODUCTION
CHAPTER I METASTASIS
1.1 Overview
There is increasing evidence that a malignant cancer predominantly arises 
through an accumulation of genetic events (Bishop, 1991; Fearon & Vogelstein, 
1990). Notably, genes associated with carcinogenesis have been essentially 
categorized as being either oncogenes or tumour suppressor genes. Oncogenes, 
whether the cellular proto-oncogenes or the viral counterparts, can generally be 
defined as genes whose products are tightly associated with cell proliferation. 
Conversely, tumour suppressor genes encode for proteins that function to confer 
responsiveness to growth-inhibiting signals.
Inappropriate activation of oncogenes can occur through different genetic 
mechanisms such as point mutations, as commonly found in the ras genes (Bos 
eta l., 1987; Bos, 1989), or chromosomal translocations (Solomon, Borrow & 
Goddard, 1991) which, for example, occurs in Burkitt's lymphoma whereby a 
translocation occurs between the c-myc gene on chromosome 8 to one of the 
immunoglobulin loci on chromosomes 2, 14 or 22 (reviewed by Croce, 1991). 
Classical oncogene activation promotes cell proliferation by abrogating the 
requirement for exogenous mitogenic stimulation: for example, constitutive 
expression of an active Ras protein which is conformationally held in the GTP- 
bound state, displaces the requirement of upstream signalling from the interaction 
of specific growth factors with the appropriate receptor since the active Ras 
constantly transduces mitogenic signals downstream. In conjunction, inactivation 
of the normal function of tumour suppressor proteins is necessary for tumours to 
escape the regulatory controls inhibiting cell proliferation. This loss of function 
can occur through different mechanisms including: mutation of both alleles 
resulting in the expression of a non-functional protein or a protein with aberrant 
function; loss of one allele with, and possibly in some cases without, mutation of
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the remaining allele. Mutation such as insertion and small deletions can inactivate 
the encoded protein, as has been described of the retinoblastoma (RB) gene 
(Horowitz etal.y 1987; Hogg et al., 1993) and the tumour suppressor gene TP53 
(Baker et al., 1989; Chen et al., 1990), or through larger deletions, as discovered of 
the gene DCC (deleted in colorectal carcinoma) (Fearon et al., 1990). In addition, 
gain-of-function mutations can occur which convert the tumour suppressor gene 
encoded protein, for example p53, into a dominant negative form which is capable 
of suppressing the normal activity of the wild type protein (Gannon et al., 1990).
However, the greatest life-threatening aspect to the patient with cancer is the 
progression of a hyperproliferative lesion to a malignant tumour. It is this which 
remains the least understood process of carcinogenesis, even though invasive 
tumours and metastatic disease represent the major causes of morbidity and 
mortality in most cancer patients. Even though primary tumours of different 
origins can be successfully resected by surgeons, patient survival is still 
determined largely on malignancy of the cancer and presence of metastatic disease. 
It is therefore critically important and clinically relevant to understand how a 
tumour disseminates resulting in secondary tumours distant to the primary site, in 
order to determine therapeutic strategies aimed at relief, regression and prevention 
of metastatic disease for the patient.
While there is relatively little evidence of the underlying genetic mechanisms 
involved in metastasis, it is becoming more apparent that it will be the result of 
several events integrated together (Fidler & Randinsky, 1990). Alterations in the 
cell which may contribute to the metastatic phenotype, will be addressed later in 
this text (see chapter II).
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1.2 THE METASTATIC PROCESS
The initial neoplasm is a number of cells, probably arising from a single cell, 
which has escaped the normal controls of cell growth, division and death, resulting 
in a growth which is outwith normal regulation and presenting as a cancer. 
However, unrestrained growth alone does not impart the malignant phenotype; 
further aberrations within the cell must occur in order for the hyperproliferative 
cell to progress further towards malignancy.
A brief and reductionist view of the metastatic process involves the metastatic cell 
invading into surrounding normal stroma, degrading the extracellular matrix 
(ECM) in order to facilitate migration of the tumour cell through normal tissue, the 
gain of access to the circulation, whether haematogenous or lymphatic, survival 
during circulation until another suitable organ environment is encountered where 
extravasation occurs, continued survival and proliferation of the tumour cell in the 
foreign microenvironment with stimulation of angiogenesis (see Figure 1). From 
this point, the metastatic cascade may repeat, forming metastases of metastases. 
Throughout this whole process, the malignant cell requires to survive or escape 
immunological attack.
With such a particularly complex process as metastasis, which most tumorigenic 
cells shed from the primary tumour fail to complete (Fidler, 1970; Glaves, 1983; 
Weiss, 1986), research has tended to be focused on particular aspects of the 
metastatic process. This in turn, has led to the combining of research from different 
disciplines, such as molecular biology, protein chemistry, biochemistry, 
immunology and cell biology. Each scientific approach provides further insights 
into metastasis and is essential for them to be viewed together in order to gain a 
stronger and more coherent understanding of metastasis.
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Figure 1
Figure 1. Diagrammatic Representation Of The Metastatic Process
For a tumour cell to successfully produce a metastatic deposit at a site distant to 
the primary tumour, it has been proposed that the cell requires to complete a series 
of sequential steps as illustrated. Alterations in a variety of cellular properties 
including:- decreased cell-cell adhesion, increased cell-matrix adhesion, increased 
matrix metalloprotease (MMP) expression and / or decreased tissue inhibitors of 
matrix metalloprotease (TIMP) expression, are proposed to enhance the metastatic 
potential of a tumorigenic cell.
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1.2.1 The Extracellular Matrix
Invasive cells are characterized by their ability to penetrate surrounding normal 
tissue stroma through the extracellular matrix (ECM) and traverse the basement 
membrane. The ECM is recognised to be an important component in normal 
cellular processes such as the regulation of development and control of 
differentiation (reviewed by Adams & Watt, 1993; Mooney et al., 1992). In 
addition to the complex array of glycoproteins, proteoglycans, collagens and 
glycosaminoglycans which constitute the major components of the ECM, many 
growth factors are also found to be integrated within the ECM structure (Ruoslahti 
& Yamaguchi, 1991; Benezra et al., 1993; Masumoto & Yamamoto, 1993). In 
order to facilitate the active migration of invasive cells within this "exoskeleton" of 
the ECM, three sequential and integrated events have been hypothesized (Liotta, 
1986). Initially, cell adhesion is required to the underlying substratum, perhaps 
through the integrins, to facilitate the necessary tractional forces generated through 
locomotion with the continuous formation of new adhesions at the invading face of 
the cell and loss of adhesion at the trailing edge of the cell; secretion of enzymes 
capable of degrading the ECM, for example the collagenases, in the immediate 
vicinity of the invading cell front, one possible consequence of which may be the 
release and activation of factors present in the ECM (Masumoto & Yamamoto,
1993); finally, the response of the cell to motility factors such as autocrine motility 
factor or scatter factor, which promote cell locomotion, their actions being 
mediated either in an autocrine or paracrine fashion. The processes here are not 
unique to invading tumour cells, but instead are associated with normal cellular 
processes such as development, inflammation, wound healing and angiogenesis, 
however in normal physiological situations these processes are under highly 
stringent controlling mechanisms. It is these controls that are circumvented or
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aberrantly manipulated in malignancy leading to the devastating effects of 
metastatic disease.
1.2.2 Cell Adhesion
Cell adhesion, both cell-cell and cell-matrix interactions, are mediated by an 
amalgamation of cell adhesion molecules, many of which are specific for cell 
types and their interactive ligands. As a consequence of the large numbers of cell 
adhesion molecules, classifications have been derived, primarily based upon 
structural similarities.
1.2.2.1 Cadherins
This superfamily of transmembrane cell surface molecules mediate 
Ca2+-dependent homophilic cell-cell interactions which are normally 
developmentally regulated controlling cell polarity and tissue morphology 
(Takeichi, 1991). Of the cadherins, E-cadherin (uvomorulin) has probably been 
the most extensively studied and is found commonly on epithelial cells. Through 
structural similarities of the different cadherins, each could be predicted to be 
functioning in a similar manner for each particular cell type on which they are 
expressed, for example, N-cadherin on neural cells (Ozawa & Kemler, 1992), P- 
cadherin of placental cells (Nose et a l, 1987) and M-cadherin of muscle cells 
(Donalies et a l, 1991), although they may not necessarily be functionally 
interchangeable between cell types (Levine et a l, 1994).
The cadherins are synthesized as precursor polypeptides which undergo 
post-translational modifications. Without the correct proteolytic cleavage of a 12 
amino acid precursor segment from E-cadherin, the resulting expressed molecule 
is rendered non-functional in its adhesive properties (Ozawa & Kemler, 1990). 
Additionally, three cytosolic proteins termed catenins a , (3 and y of molecular
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weight sizes 102, 88 and 80kD respectively, are implicated to covalently associate 
with a specific 72 amino acid region in the cytoplasmic domain of cadherins, 
stabilizing their association to the cytoskeleton and mediating the cadherins' 
adhesive properties (Ozawa, Baribault & Kemler, 1989; Ozawa, Ringwald & 
Kemler, 1990; Gumbiner & McCrea, 1993). [3-catenin has been demonstrated to 
I associate with the E-cadherin precursor immediately after synthesis of this 
precursor molecule (Ozawa & Kemler, 1992). Following a lag period of 
-10 minutes, a-catenin appears to associate with this complex (Ozawa & Kemler, 
1992), which may correlate to the post-translational modifications of precursor 
E-cadherin, including endoproteolytic cleavage (Ozawa & Kemler, 1990). At 
present, it is not known whether a-catenin interacts directly or indirectly through 
(3-cat<enin with E-cadherin. y-catenin appears to weakly associate on the periphery 
of this complex. Deletion of the COOH-terminal portion of the intracellular 
domain of E-cadherin, or single amino acid substitutions in one of the 
Ca2+-binding domains, abolishes the receptor's function in cell-cell adhesion even 
though the extracellular components remain intact and can be detected on the cell 
surface (Nagafuchi & Takeichi, 1988; Ozawa, Engel & Kemler, 1990). This 
emphasizes the importance of intracellular interactions with the cytoplasmic 
domain of E-cadherin in addition to specific receptor recognition on the cell 
surface for cell-cell adhesive function. However, although the catenins obviously 
play an important role in cadherin function (Hirano et al., 1992), other as yet 
unkmown mechanisms are implicated which anchor cadherin-catenin complexes to 
cytojskeletal structures since it is known that detergent-insoluble cadherin 
complexes are found at stable cell-cell contacts (McNeill et al., 1993) and yet 
cadhierin-catenin complexes can be found in both detergent-soluble and -insoluble 
extractions (Ozawa et al., 1989). Detergent insolubility is regarded as being 
indkcative of proteins complexed to cytoskeletal components. The phosphorylation 
statuis of cadherins and catenins may influence adhesive function since v-Src
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v-Src tyrosine phosphorylation of these proteins have been demonstrated to 
disrupt and inactivate E- and N-cadherin mediated adhesion (Hamaguchi et al., 
1993; Matsuyoshi et al 1992; Brehens et al., 1993).
Evidence to support the involvement of cadherin mediated cell adhesion in 
invasion and therefore the overall process of metastasis has arisen from in vitro 
studies using cell lines to transfect with either E-cadherin, rendering the cells 
non-invasive in collagen matrix gel assays and in chick embryo heart fragment 
invasion assays (Vleminckx et al., 1991); or transfection with anti-sense 
E-cadherin into E-cadherin expressing cells rendering them invasive as assayed 
by the same methods (Vleminckx et al., 1991). Indeed, treatment of cells with 
neutralizing antibodies to E-cadherin also allows the invasive phenotype to arise 
(Vleminckx et al., 1991). Studies of tumours from patients presenting with 
breast, gastric or head and neck squamous cell cancers indicate that loss or 
reduction of E-cadherin expression correlates with cellular dedifferentiation of 
the tumour (Oka et al., 1993; Meyer et al., 1993; Schipper et al., 1991). Cellular 
dedifferentiation of tumours is often associated with increased malignancy.
I.2.2.2 Integrins
The integrin receptors are a family of transmembrane glycoproteins which are 
non-covalently associated a(3 heterodimers. Currently there are at least 14 known 
a  subunits and 8 known (3 subunits (Hynes, 1992), of size ranges 120-180kD and 
90-110kD respectively. Several of the a  subunits can associate with different 
|3 subunits, furthermore, in mammals, several subunits have alternatively spliced 
cytoplasmic domains (Hynes, 1992). It appears that individual integrins are 
capable of binding more than one ligand and equally, particular ligands can be 
recognized by different integrins. Significantly, the majority of interactions 
mediated by integrins are cell-matrix.
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The first integrin recognition site to be defined was the Arg-Gly-Asp (RGD) 
sequence (Pierschbacher & Ruoslahti, 1984a; Pierschbacher & Ruoslahti, 1984b) 
which is present in fibronectin, vitronectin and thrombospondin, for example. It 
has been demonstrated that experimental metastasis can be inhibited using 
synthetic peptides encompassing this RGD sequence (Humphries et al., 1986). 
Poly(RGD) peptides have also been shown to reduce the number of lung metastatic 
colonies formed in a spontaneous assay (Dsaiki et a l, 1989). Both assay systems 
employed murine B16 melanoma cell lines. The decrease in number of lung 
colonies formed was observed when poly(RGD) peptides were co-injected with the 
B16 melanoma cells, as well as when the tumour cells were preincubated with 
RGD before injection. The inference from these results was that peptides which 
can mimic the natural ligands for integrins, can inhibit the formation of lung 
metastases by interfering with normal cell adhesion processes. By occupying the 
integrin receptor sites, the cells are prevented from further cell attachment to other 
components of the ECM or basement membranes and thus cannot invade.
Both a  and [3 subunits of integrins are transmembrane glycoproteins. The active 
integrin receptor is of high affinity, whereas the inactive state has low affinity. The 
cytoplasmic domains of each are believed to interact with cytoskeletal proteins 
such as talin (Horwitz et al., 1986) and a-actinin (Otey et a l, 1990) and potentially 
mediate specific signalling pathways within the cell. The affinity and specificity of 
the integrin receptor can be modulated by the cytoplasmic domains as 
demonstrated by O'Toole and colleagues (O'Toole et a l, 1991). Truncation of the 
cytoplasmic domain of a jj^  of the integrin resulted in a receptor which
was constitutively active. Moreover, substitution of the deleted a jj^  cytoplasmic 
domain with a$ cytoplasmic domain did not reverse the activated state of the 
receptor. These results and results from other similar experiments (O'Toole et a l,
1994) substantiate the belief that the specificity of the cytoplasmic domain can
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nfluence the ligand affinity of the extracellular domain, thus maintaining control 
)ver the receptor status, either active or inactive. This type of signalling is 
’ecognised as the inside-out signalling of integrins.
Outside-in signalling by integrins is also thought to occur. Ligand occupancy of 
integrin receptors leading to clustering of these receptors at focal adhesions has 
been proposed to activate signal transduction into the cell, causing an increase in 
protein tyrosine phosphorylation of a number of proteins ranging between 
115-130kD in size (Komberg et al., 1991). Precisely how this is effected is not yet 
understood since the integrins themselves, with short cytoplasmic domains, are not 
tyrosine kinases, however some preliminary evidence is now emerging. Similar 
sized proteins have also been identified to be tyrosine phosphorylated in NIH 3T3 
cells after adhesion and spreading on fibronectin or via anti-integrin antibodies 
(Guan et al., 1991). One of these proteins has now been identified and is itself a 
tyrosine kinase and is therefore implicated in being directly involved in the 
tyrosine phosphorylation of the other proteins upon signalling through the 
integrins. Due to its size and cellular localization, it has been termed ppl25FAK 
(focal adhesion kinase) (Schaller etal, 1992).
ppl25FAK was first identified as a tyrosine phosphorylated protein substrate of 
chick embryo fibroblasts transformed with oncogene-encoded tyrosine kinases 
v-src, v-yes and v-crk (Kanner et al., 1990). It has been since characterized to be a 
tyrosine kinase localized at focal adhesions (Schaller et al., 1992). The 
phosphorylation of ppl25FAK appears to correlate with its tyrosine kinase activity 
(Guan & Shalloway, 1992) and it has been shown that v-src transformed chick 
embryo cells exhibit enhanced tyrosine phosphorylation content of ppl25FAK over 
untransformed cells (Schaller et al., 1992) and in addition, NIH 3T3 cells plated on 
fibronectin exhibit enhanced phosphotyrosine content over cells plated on 
poly-L-lysine (i.e., no integrin-mediated adhesion) (Guan & Shalloway, 1992).
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Indeed, Guan and Shalloway propose that signalling via the integrins to regulate 
attachment to the ECM with possible consequent involvement in the control of 
cellular proliferation is in part regulated by ppl25FAK and its substrates. 
Transformation by oncogenes such as v-src overrides the requirement of 
attachment to the ECM leading to anchorage-independent growth by 
constitutively activating ppl25FAK or by phosphorylating its substrates (Guan & 
Shalloway, 1992). As yet, these substrates have still to be conclusively identified. 
Platelets also exhibit ppl25FAK activation upon <^ xibP3 stimulation,
although only if platelet aggregation is allowed to occur (Lipfert et al., 1992). If 
aggregation is inhibited or actin polymerization is prevented using cytochalasin D, 
then tyrosine phosphorylation of ppl25FAK is abrogated (Lipfert et al., 1992). 
Also, platelets from patients with Glanzmann's thrombasthenia, which are deficient 
in the integrin do not display the tyrosine phosphorylation of ppl25FAK
upon stimulation with fibrinogen, thus demonstrating the integrin dependence of 
activation in platelets (Lipfert et al., 1992). However recent evidence indicates that 
prior to platelet aggregation and ppl25FAK tyrosine phosphorylation, fibrinogen 
binding to ocjjxft initiates the tyrosine phosphorylation of other proteins of sizes 
50-68kD and 140kD (Huang etal., 1993), therefore ppl25FAK activation is not an 
immediate event upon integrin binding and may depend on integrin 
oligomerization and actin reorganization and polymerization. Interestingly, the 
neuropeptides bombesin, vasopressin and endothelin also stimulate the rapid 
tyrosine phosphorylation of ppl25FAK in Swiss 3T3 cells at concentrations which 
closely parallel those required for mitogenic stimulation (Zachary, 1992). It 
appears that ppl25FAK activity is relevant to many cell types and may represent a 
point of convergence in many different signalling pathways.
Another intracellular event triggered via integrins is cytoplasmic alkalinization. 
Intracellular pH of bovine capillary endothelial cells can be elevated in vitro,
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through the binding of different ligands (for example, fibronectin) with the 
endothelial cell surface expressed integrins or through specific anti-integrin 
antibodies resulting in the activation of the Na-H antiporter (Schwartz et al., 1991). 
This cytoplasmic alkalinization can be inhibited with hexamethylene amiloride 
(HMA), a specific inhibitor of the Na-H antiporter (Schwartz et al., 1991). 
Furthermore, fibronectin binding to on T cells induces the AP-1 transcription 
factor necessary for IL-2 transcription (Jamaica et al., 1991); crosslinking of 
integrins on monocytes induces immediate-early gene expression which correlates 
with initiation of an inflammatory response (Yurochko et al., 1992); and 
fibronectin stimulation of rabbit synovial fibroblasts induces the expression of two 
matrix metalloproteinase enzymes, collagenase and stromelysin (Werb et al.,
1989). Clearly, ligand binding to integrins can result in further downstream events 
within the cell, therefore outside-in signalling can also function via integrins.
I.2.2.3 Selectins
There are three known selectins; P, L and E. These adhesion molecules recognise 
specific carbohydrate structures on glycoproteins and have been implicated in a 
direct involvement in the process of leukocyte trafficking (reviewed in Lasky,
1992). The initial step required for the arrest and extravasation of circulating 
leukocytes at sites of inflammation is their transient interaction with the activated 
endothelium of blood vessels in the vicinity of the inflammatory response. This 
transient interaction, recognised as leukocyte rolling, accommodates the slowing of 
the leukocytes in circulation thus providing the opportunity for the (32 integrins 
expressed on the leukocytes to become activated and mediate their subsequent 
arrest and extravasation. It has only recently become evident that the transient 
interactions of the leukocytes with activated endothelial cells is determined 
significantly through endothelial expression of P-selectin (Mayadas et al., 1993). 
Mice deficient in P-selectin, engineered through genetic manipulation, have
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provided conclusive evidence that P-selectin has a critical role in leukocyte 
recruitment since, in these animals, leukocyte rolling is not evident as measured by 
intravital microscopy. Additionally, during an experimentally induced 
inflammatory reaction in mice, neutrophil recruitment to the inflamed peritoneal 
cavity has a lag phase of four hours before neutrophil numbers are attained to less 
than a two-fold difference of normal controls (Mayadas et al., 1993). It may be 
postulated that during early responses to inflammation, recruitment is dependent 
on P-selectin, possibly in conjunction with L-selectin (Watson et al., 1991) since 
these adhesion proteins are either expressed within minutes of stimulation or are 
constitutively expressed. Later leukocyte recruitment may be regulated through 
E-selectin which is maximally expressed on the cell surface 4-6 hours after 
stimulation with inflammatory cytokines (Beviacqua, 1987).
An important criterion for dissemination of the primary tumour is extravasation 
into secondary organs. It may be therefore anticipated that haematogenous spread 
of tumour cells could similarly undergo a process resembling that of leukocyte 
recruitment. This may be an area deserving of further investigation in relation to 
metastasis since the prevention of tumour cells gaining access to secondary sites 
could have profound implications in the treatment of cancer patients.
I.2.2.4 Immunoglobulin Superfamily
This superfamily consists of genes whose encoded proteins share structural 
similarities with the immunoglobulins. The polypeptide backbone of these proteins 
contain one or more domains which are formed from two anti-parallel (3-pleated 
sheets and are often stabilized through interconnecting disulphide bridges. Many 
proteins identified as members of this superfamily are involved in the regulation of 
the immune system, for example, the major histocompatability complex antigens 
(MHC class I and class II), Thyl and the T cell receptor. Expression of other
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#members of this family is not restricted to the immune system, for example, the 
neural cell adhesion molecules (NCAMs) are expressed in the nervous system 
(Walsh & Docherty, 1992), and carcinoembryonic antigen (CEA), MUC 18 and 
DCC (deleted in colorectal cancer) have all been proposed to be cell adhesion 
molecules, although their roles are yet to be clearly defined.
I.2.2.4.1 NCAM
Neural cell adhesion molecule (NCAM) possesses five immunoglobulin (Ig) 
domains and two type HI fibronectin repeats. Through alternative splicing of the 
single gene encoding 26 exons (Colwell et al., 1992), NCAM can exist in several 
isoforms (Reyes, Small & Akeson, 1991). The major classes are:-
(i) transmembrane, of M.W.s 140kD and 180kD, the larger containing an extended 
cytoplasmic tail which may be constitutively anchored to the cytoskeleton and 
consequently be restricted in membrane mobility; (ii) glycophosphatidylinositol 
(GPI)-linked isoforms, M.W. 120-125kD and (iii) soluble isoforms of -HOkD.
In addition to alternative splicing, NCAM varies in polysialic acid content, an 
important carbohydrate moiety which can influence NCAM function (Docherty, 
Cohen & Walsh, 1990).
NCAM mediates Ca2+-independent homophilic cell-cell interactions and can also 
promote neurite outgrowth. This latter property is restricted to particular NCAM 
isoforms with only the smaller transmembrane forms containing polysialic acid 
being capable of fully inducing neurite outgrowth (Docherty et al., 1992a). In early 
development, these isoforms predominate as would be expected for the maturation 
of the central nervous system (CNS). In the adult, polysialic acid content in 
NCAM decreases and a greater proportion of NCAM isoforms contain 
alternatively spliced VASE (variable alternative splice exon) in the fourth Ig 
repeat, which is known to downregulate neurite growth-promoting activity, but
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increase adhesiveness (Docherty et al., 1992b). This would provide a mechanism 
by which the adult CNS maintains stable cell-cell interactions but preventing 
continued neurite development.
To further support NCAMs association with development is the transcriptional 
regulation of NCAM which can be potentially regulated, at least in part, by the 
developmental and morphoregulatory associated mouse homeobox gene, hox-2.5 
(Jones et al., 1992). Hox-2.5 is the homologue to the human hox-2E, which are 
recently revised under the new nomenclature as hox-B9 (Scott, 1992).
NCAM-stimulated neurite outgrowth appears not to be mediated by adhesion 
perse, since the effect of NCAMs can be mimicked by the activation of L- and 
N-type neuronal Ca2+ channels resulting in Ca2+ influx (Docherty et al., 1991). 
This effect can be abrogated using Ca2+ antagonists and is reported to be pertussis 
toxin sensitive.
In malignancy, the majority of human small cell lung carcinomas (SCLC) and 
around one fifth of non-SCLCs express NCAM. These NCAM-positive patients 
have a poorer prognosis than those who are NCAM negative (Moolenaar et al., 
1992; Kibbelaar et al, 1991). However, the biological consequences of this 
expression in cancers are not understood, but nevertheless, is a useful diagnostic 
marker (Aletsee-Ufrecht et al., 1990).
I.2.2.4.2 CEA
Carcinoembryonic antigen, identified as a member of the immunoglobulin 
superfamily (Paxton et al., 1987), is a highly glycosylated cell surface protein of 
M.W. 180kD, implicated in Ca2+-independent intercellular adhesion (Benchimol 
etal., 1989). Expression is normally detected during embryogenesis and only low 
levels detected in normal adult tissues. However, overexpression of CEA is
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frequently observed in tumours of epithelial origin, including breast, lung and 
colorectal cancers (reviewed by Shuster et al., 1980) and correlation has been 
found between high serum levels of CEA and metastatic disease of SCLC 
(Chevinsky, 1991). As such, CEA is widely used as a clinical marker, although due 
to the high glycosylation status of CEA, antibodies used in these assays tend to 
have high cross-reactivity, therefore lowering the specificity and accuracy of these 
assays. Preliminary experiments present evidence to suggest that expression of 
functional CEA can prevent terminal differentiation and allow for continued cell 
proliferation (Eidelman et al., 1993). This study incorporated the use of a rat L6 
myoblast cell line which can be induced to differentiate under the appropriate 
conditions. Stable transfection of this cell line with CEA prevented terminal 
differentiation and abrogated myogenin up-regulation, creatine phosphokinase 
up-regulation and (3-actin down-regulation which are all associated with the 
normal program of myoblast differentiation (Eidelman et al., 1993). In addition, 
transfected cells retained their capacity to proliferate, therefore expression of CEA 
in tumour cells could be postulated to disrupt normal cell regulation allowing for 
inappropriate cell growth and obstruct normal differentiation processes.
I.2.2.4.3 MUC18
MUC18 antigen is a membrane glycoprotein of 113kDa size with sequence 
similarity to NCAM (Lehmann et al., 1989). Direct correlation has been 
demonstrated with tumour progression of human melanoma; increased expression 
is associated with advanced primary tumours which have high metastatic 
probabilities and metastases (Lehmann et al., 1989). Studies of human melanoma 
cell lines with known metastatic abilities in nude mice (using both spontaneous 
and experimental assays) also correlate MUC18 expression of both mRNA and the 
glycoprotein with metastatic potential, to statistical significance (Luca etal.,
1993).
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1.2 2A A D C C
Allelic deletions involving chromosome 18q have been shown to occur in more 
than 70% of colorectal cancers (Vogelstein et al., 1988). Within this region, the 
candidate tumour suppressor gene DCC (deleted in colorectal carcinoma) was 
identified (Fearon et al., 1990). Contrasting with the above described members of 
the immunoglobulin superfamily, DCC is frequently lost or reduced in its 
expression in the latter stages of colorectal carcinogenesis (Fearon et al., 1990). 
These alterations in expression of DCC have also been described in breast cancer 
(Thompson et al., 1993), prostatic carcinomas (Gao et al., 1993), and in a small 
study of leukaemias (Porfiri et al., 1993).
Insight into DCC function is presently tentative, however through its sequence 
similarity to NCAM, it was first designated as a putative cell adhesion molecule. 
Transfection of anti-sense DCC constructs into Rat-1 cells, which express low 
levels of DCC, resulted in a stable cell line which exhibited increased growth rates, 
anchorage-independence and tumorigenicity in nude mice (Narayanan et al.,
1992). Exposure of the parental Rat-1 fibroblasts to DCC anti-sense 
oligonucleotides caused their detachment from the substratum, an effect which can 
be overcome through plating the cells onto laminin, fibronectin, collagen type IV 
and poly-D-lysine (Narayanan etal., 1992).
In a further study, rat pheochromocytoma (PCI2) cells, when stimulated to 
differentiate with nerve growth factor (NGF), exhibit increased DCC expression 
which is maximal at 72-96 hours. In DCC anti-sense transfected PC 12 cells, 
morphological differentiation is prevented when this construct is induced and the 
cells continue to proliferate in the presence of NGF (Lawlor & Narayanan, 1992). 
Also reported by these authors is the inhibition of interleukin-6 (IL-6) and basic 
growth factor (bFGF) induced neuronal differentiation in these anti-sense
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transfected cells, thus it would seem that the expression of DCC is of fundamental 
importance in the establishment of neurite extensions. Indeed, differentiated PCI2 
cells will retract neurite outgrowths upon exposure to anti-sense oligonucleotides 
(Lawlor & Narayanan, 1992). In a further study from Pierceall et al. (1994), 
neurite outgrowth could be stimulated in PCI2 cells when co-cultured with 
NIH 3T3 cells transfected with DCC expressing constructs. This neurite 
stimulation appeared to be dependent on cell-to-cell contact since conditioned 
media from the transfected NIH 3T3 cells did not induce neurite outgrowth. In 
addition, transfection with a truncated DCC construct which lacked the majority of 
the cytoplasmic domain also failed to stimulate neurite outgrowth (Pierceall et al.,
1994), which suggests that the cytoplasmic domain is of critical importance, 
perhaps through the stabilization of cell-to-cell contacts. As already noted, cell 
interactions with the extracellular matrix have critical roles in maintenance of cell 
behaviour and this appears to be the situation with DCC as a cell adhesion 
molecule involved in the maintenance of morphological differentiation of PCI2 
cells.
I.2.2.5 Other Cell Adhesion-Related Molecules: CD44
CD44 comprises a large family of cell surface glycoproteins implicated in cell 
adhesion and known to function in a variety of processes including lymphocyte 
homing and trafficking, T cell activation and metastatic spread (Arch et al., 1992; 
Haegel etal., 1993; Gunthert etal., 1991).
Multiplicity of CD44 variants arise predominantly through alternative splicing in 
addition to differential glycosylation and alternative poly A+ sites (Screaton et al., 
1992; Camp, Kraus & Pure 1991; Gunthert et al., 1991). Alternative splicing 
appears to occur in at least two main regions of the CD44 molecule; either 
proximal to the membrane in the extracellular domains or within the cytoplasmic
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tail (Screaton et al., 1992). In studies to date, it would appear that there are at least 
ten alternatively spliced exons of the single CD44 gene in the extracellular domain 
and these exons are conserved between mouse, rat and human (Screaton et al., 
1993). The apparent ability for alternative splicing to occur in numerous 
permutations of these exons gives rise to enormous possibilities of different 
isoforms to exist and for these to contribute to numerous functions. The biological 
consequences of variant CD44 expressions remain to be elucidated, however 
tissue-specific expression patterns are becoming apparent (Kennel et al., 1993; 
Wirth et al., 1993; MacKay et al., 1994) and possible alterations in associated 
function are presently the focus of much attention. It is already known that the 
standard form of CD44 (devoid of variant exons) which has widespread 
expression, and particularly associated with lymphocytes, possesses the ability to 
bind hyaluronic acid (Aruffo et al., 1990; Stamenokovic et al., 1991). When exons 
v8-vl0 are alternatively spliced into CD44, this molecule, which is predominantly 
expressed on normal epithelial cells, cannot bind hyaluronic acid (Stamenokovic 
et al., 1991).
Recent interest in CD44 has intensified after the identification of a CD44 isoform 
containing variant exons v4-v7 within the extracellular domain which was 
discovered to be expressed on a metastatic rat pancreatic carcinoma cell line and 
not the corresponding tumorigenic, but non-metastatic cell line (Gunthert et al.,
1991). Furthermore, overexpression of this variant CD44 in the non-metastatic cell 
line conferred the metastatic phenotype, as measured by a spontaneous assay 
(Gunthert et al., 1991; Rudy et al., 1993). The question of how this variant 
molecule can confer metastatic properties is still unanswered, and may only give 
this significant effect when in conjunction with other properties already present in 
these particular cell lines. However, the finding that alterations of variant CD44 
expression may be associated with the progression of certain tumours, and the
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evidence of a "metastatic-associated / enhancing" CD44 variants could have 
profound implications in human cancers for clinical diagnosis and treatment 
(Matsumura & Tarin, 1992; Wielenga et al., 1993; Matsumurae/tf/., 1994).
1.2.2.6 Connexins
These are a class of molecules implicated in cell-cell communication through the 
formation of intercellular gap junctions, with integrated involvement in cell 
adhesion. Gap junctions facilitate the transfer of small molecules and ions thus 
mediating signalling between adjacent cells. Such physical transfer of molecules 
directly between cells can be elegantly demonstrated in vitro by microinjection of 
fluorescent dyes into a single cell. The ability to communicate through these gap 
junctions is reflected in the number of cells which fluoresce as a result of dye 
transfer through adjacent cells.
The identity of the subunit components of connexons remains the target of* 
controversy, however evidence lends to the argument that gap junctions consist of 
ductins rather than the more popularly believed connexins (Finbow & Pitts, 1993). 
Either way, gap junctions are of critical importance in intercellular communication 
and contribute to cellular adhesion.
It has been considered that highly metastatic cells could avoid inhibitory signals 
from adjacent cells, thus aiding their malignant phenotype, by reducing or 
completely abolishing their ability for gap-junctional communication. Preliminary 
data has indicated that reduction and / or loss of junctional communication may, in 
some instances, be correlated with the metastatic phenotype (Hamada et al., 1991)
1.2.3 Extracellular Matrix Degradative Enzymes
The presence of proteinases capable of degrading components of the extracellular 
matrix is a characteristic feature of invasive carcinomas. However, this is not a
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unique phenomenon of malignant cells: proteolysis of tissue barriers is also seen in 
the normal situations of trophoblast implantation, embryo morphogenesis, 
angiogenesis and bacterial and parasitic invasion, for example.
Various matrix degrading enzymes have been implicated in tumour invasion and 
metastasis. These include the matrix metalloproteinases (MMPs), members of 
which include the collagenases and stromelysin enzymes; serine proteases which 
include the plasmin/plasminogen activator system; cysteine and aspartic proteases 
termed cathepsins; and the glycosidases which include heparanase and 
hyaluronidase (Nakajima & Chop, 1991). Of these, the most thoroughly studied are 
the matrix metalloproteinases and the plasminogen activator/plasmin system, 
which are given further discussion below.
1.2.3.1 Matrix Metalloproteinases
Particular attention has focused on the matrix metalloproteinase (MMP) family. 
Currently, there are eight known members:- interstitial collagenase (MMP-1), 
neutrophil collagenase, stromelysins-1,-2 and -3 (MMP-3, MMP-10 respectively, 
with no MMP nomenclature for st-3 since it has only been characterized at the 
mRNA level with no native protein isolated to date), matrilysin, and 72kDa and 
92kDa type IV collagenases (72T4C1 and 92T4C1 respectively, also termed 
MMP-2 or gelatinase A and MMP-9 or gelatinase B). Each member of this family 
have in common a signal peptide segment, propeptide domain and a catalytic 
domain containing the zinc-binding region. In all except the smallest member, 
matrilysin, each also possesses a carboxyl-terminal domain which shares sequence 
homology with haemopexin and vitronectin. This carboxyl-terminal domain 
appears to determine the binding specificity of tissue inhibitor of 
metalloproteinases (TIMPs), with each TIMP carboxyl-terminal binding 
specifically to only one of the gelatinases at its carboxyl-terminal. The
21
amino-terminal of the TIMPs appear to be capable of interacting with the open and 
active sites of all the metalloproteinases and cause inhibition of enzymatic activity.
Regulation of these enzymes occurs both at the level of gene expression, with 
induction through growth factors and cytokines, and post-translational control 
exerted at three levels: (1) each enzyme is synthesized and secreted as a zymogen 
which requires to undergo proteolytic cleavage of an 80-84 residue amino-terminal 
domain to generate a conformationally altered and active enzyme {in vitro 
activation can be attained with organomercurial treatment of the latent enzymes);
(2) once activated, the metalloproteinases can be subjected to inactivation by 
specific inhibitors, e.g., TIMP-1 or TIMP-2, and possibly the recently identified 
TIMP-3 (Leco et al., 1994), at a stoichiometry of 1:1; (3) autodegradation. 
However, to further complicate this, both latent gelatinases can be secreted already 
in complex with their respective TIMP (Wilhelm et al., 1989; Stetler-Stevenson 
Krutzsch & Liotta, 1989). This complex is thought to function by stabilizing the 
enzyme through inhibitory binding of the amino-terminal domains and prevent its 
autodegradation Kleiner et al., 1993). It could be postulated that stabilization is 
indeed the primary function of TIMPs and activation of the enzyme results from 
the (transient?) interaction of a third factor which partially displaces TIMP thus 
providing opportunity for enzyme activation and also maintaining localized 
enzymatic activity. Interestingly, 72T4C1 has been discovered to be activated in a 
plasmin-independent manner (unlike the other interstitial collagenases and 
prostromelysins) (Brown et al., 1993; Strongin et al., 1993). Initiation of enzyme 
activation can be mediated by a cell membrane-dependent mechanism as 
demonstrated with the co-incubation of purified 72T4C1 in complex with TIMP-2 
together with residual cell fractions of phorbol ester treated HT-1080 cells (Brown 
et al., 1993). Conversion of the proenzyme 72T4C1 to the active enzyme was 
monitored with a gelatin degradation assay. Similar co-incubation experiments
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with HT-1080 cell lysates or conditioned medium instead of membrane fractions 
did not display gelatinase activities. It may be postulated that interaction of 72T4C1 
/ TIMP-2 with the plasma membrane of stimulated cells is mediated through a 
specific receptor on the cell surface which binds the complex causing a 
conformational alteration which induces autoproteolytic activity thus leading to 
cleavage of the propeptide and subsequent enzymatic activation. This sequence of 
events would allow for the discrete degradation of ECM components in the 
immediate vicinity of cells which have been suitably stimulated to initiate these 
events. However, there is conflicting evidence suggesting that plasma membrane 
activation of 72T4C1 is inhibited by TIMP-2 complex formation (Strongin et al., 
1993). It is difficult to reconcile these opposing findings and it needs further 
investigation in order to clarify the situation. To speculate, it may be possible that 
during the purification procedures of 72T4C1 / TIMP-2 complexes by Brown and 
colleagues, a proportion of the complex was dissociated producing free enzyme 
and the observed plasma-dependent activation was of the non-complexed enzyme.
Since controlled degradation of the ECM is important in normal cellular processes, 
including angiogenesis and trophoblast implantation, it is not surprising that the 
inhibitors of the metalloproteinases have been associated with controlled inhibition 
of these processes (Schnaper et al., 1993; Murphy, Unsworth & Stetler-Stevenson,
1993). Further still, transfection of ras-transformed rat embryo cells (ras-4R) with 
an expression vector encoding TIMP-2 caused a suppression in these cells ability 
to form experimental metastatic lung deposits (DeClerck et al., 1992). Upon 
sub-cutaneous injection of the transfected cells, the invasive characteristics of the 
tumour were completely suppressed whereas primary tumours formed from 
non-transfected ras-4R cells were highly invasive into surrounding muscle tissue. 
Similarly, intraperitoneal injection of recombinant TIMP-1 two hours prior, upon
23
and following intravenous injection of ras-4R cells inhibited experimental 
metastatic deposit formation by 83% (Alvarez, Carmichael & DeClerck, 1990).
In situ hybridization studies for 74T4C1 and 92T4C1 mRNAs in human skin 
carcinomas detected signals at tumour / stromal interfaces (Pyke et al., 1992). The 
mRNAs were particularly abundant in normal stroma adjacent to infiltrating 
squamous and basal cell carcinomas, whereas normal skin from control patients 
did not exhibit expression. This clearly demonstrates that modulation of MMP 
expression may not only occur in the tumour cells themselves, but may involve 
surrounding normal tissue which may be recruited by the tumour cells to express 
products enabling ECM degradation thereby enhancing migratory potential of 
invasive cells. The mechanism by which this "recruitment" of normal cells occurs 
remains to be elucidated, but it is conceivable that the tumour cells may secrete a 
diffusible factor which stimulates the surrounding cells, inducing MMP 
expression. This induction appears to also occur in breast cancers with 
stromelysin-3 gene expression reported as being restricted to normal surrounding 
stromal tissues as detected by the methods of in situ-hybridization and 
immunohistochemical analyses (Basset et al., 1990; Wolf et al., 1993). However, 
analysis of metastatic deposits and comparison with the primary tumour from the 
same patient did not consistently correlate with their stromelysin-3 mRNA 
abundance (Wolf et al., 1993). But, concerning the primary tumour and its 
classification type, correlation was found between invasive and metastatic 
potential with positive expression of stromelysin-3: those tumours which rarely 
progress or progress to malignant carcinoma only over prolonged periods of time, 
such as the in situ lobular carcinomas, scoring as negative (Wolf et al., 1993). In 
this latter situation, it may be that during these later stages of progression, 
stromelysin-3 expression will also be found, although this is still to be examined.
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I.2.3.2 Serine Proteases
Most widely studied of the serine proteases is the plasminogen activator /  plasmin 
system. Both urokinase-type plasminogen activator (uPA) and tissue-type 
plasminogen activator (tPA) are capable of activating the zymogen plasminogen 
through proteolytic cleavage at arginine 560 giving rise to active plasmin which 
characteristically has broad substrate specificity (Liotta et al., 1981). In 
particular, tPA exhibits enhanced activity in the presence of fibrin; it may 
therefore serve a critical function as a fibrinolytic agent. In contrast, uPA is not 
fibrin modulated, and this would suggest that its major roles may be in activities 
such as tissue remodelling and cell migration. Notably, when uPA /  pro-uPA and 
plasminogen are cell surface bound by specific receptors concentrated at focal 
adhesions, uPA plasminogen activation is enhanced (Ossowski et al., 1991).
Post-transcriptional regulation of plasminogen activators includes the specific 
inactivation by PA inhibitors (PAIs) which mediate rapid PA internalization and 
degradation (Cubellis, Wun & Blasi, 1990). Enhanced uPA transcription 
stimulated by phorbol ester treatment is mediated in part through the cooperation 
of a PEA3/AP-1 element and an AP-1 site (Nerlov et al., 1992). Similar 
PEA3/AP-1 elements are present in the promoters of stromelysin and collagenase 
genes (Gutman & Wasylyk, 1990; Sirum-Conolly & Brinckerhoff, 1991). In 
addition to these elements, NFxB has also been demonstrated to be involved in 
uPA transcription (Hansen et al., 1992). Interestingly, xB  elements have also 
been identified in the promoter regions of some cell adhesion molecule encoding 
genes (Shu et al., 1993, Smith et al., 1993; Whelan et al., 1991). Inhibition 
experiments of NFxB mediated transcription either through the use of antisense 
NFxB constructs or phosphorothioate oligonucleotides composed of either 
single-stranded oligonucleotides specific to different NFxB subunits at their 5' 
mRNA termini and inclusive of ATG initiation sites, or as double-stranded
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oligonucleotides capable of competitively binding endogenous NFxB, have clearly 
demonstrated inhibition of cellular adhesion (Eck et al., 1993; Higgins etal.,
1993). The reduction of adhesion seen in phorbol ester-stimulated HL60 cells 
treated with competitive NFxB double stranded oligonucleotides may be due to 
reduced CDll-mediated cell adhesion in these cells (Eck et al., 1993). Reduced 
cell-matrix adhesion, soft agar colonization ability and tumorigenicity of a 
fibrosarcoma cell line (K-BALB, a ras-transfected NIH 3T3 cell line) and of a 
melanoma cell line (B16) in nude mice was observed by Higgins et al. (1993) and 
indeed these authors demonstrate with inducible antisense constructs to a subunit 
of NFxB, p65, the regression of established primary tumours in nude mice and 
extended survival times. Although not addressed in these studies, inhibition of 
NF%B would inevitably also affect the transcription of other genes including uPA. 
If synthesis of uPA was reduced, it could be proposed that the effects on cellular 
behaviour may include reduced tumorigenicity in vivo and reduced colonization 
ability in soft agar in vitro assays due to a decrease* in enzymatic ECM degradation 
which aids the expansion of tumour cell growth. Thus the reported alterations 
using antisense approaches could be a complementation of effects on expression of 
cell adhesion molecules and enzymes involved in ECM degradation.
1.2.4 Tumour Cell Motility
Active motility coupled with proteolysis is required for the tumour cell to invade 
normal stroma. These processes are also necessary in later events of metastasis 
during the extravasation of the malignant cell into a secondary site. Again, cell 
locomotion is not a unique characteristic of metastatic cells, normal cellular 
processes also involve cellular movement, such as in wound healing, 
morphogenesis, embryo implantation and the migration of immunological cells 
such as neutrophils and macrophages. However, despite many studies on such 
processes and control of these mechanisms, very little is known.
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1.2.4.1 Autocrine Motility Factor
In the past few years, a group of cytokines have been described which can 
stimulate motility in various cells. One such cytokine is autocrine motility factor 
(AMF), isolated by Liotta and co-workers from a melanoma cell line derived from 
a brain metastasis (Liotta et al., 1986). This protein is not unique to melanoma 
cells and has also been purified from human HT-1080 fibrosarcoma cells along 
with its receptor, gp78 (Watanabe etaL, 1991). AMF migrates as a single band of 
55kD in SDS-PAGE, under non-reducing conditions. In reducing conditions, it 
migrates as a single polypeptide of 64kD, suggesting that AMF has intrapeptide 
disulphide bonds (Liotta etal., 1986; Watanabe et al., 1991).
Zetter and Yano (1992) have reported the purification of a molecule termed mast 
cell motility factor (MCMF) which exhibits high amino acid similarity with AMF 
and presents identical molecular weights in SDS-PAGE as AMF. It seems highly 
probable that MCMF is the same as AMF, or indeed is closely related. Since mast 
cells normally produce many factors upon degranulation, some of which are 
considered to be important for the induction of blood vessel formation (see section
1.2.6 on angiogenesis), it may be that tumour cells can recruit such normal cells 
during the process of carcinogenesis and metastasis.
Precisely how motility is induced by AMF is not yet understood. However, studies 
have revealed that AMF stimulation of the human breast carcinoma cell line, MDA 
435, with AMF purified from MDA 435 conditioned media, resulted in 
pseudopodial protrusion of the tumour cells, leading to cell motility (Guirguis 
et al., 1987). These AMF-induced pseudopodia contain a twenty-fold increase in 
laminin and fibronectin RGD recognition receptors over the levels found in the 
plasma membrane of unstimulated cells. The concentrated presence of these
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receptors could facilitate cell-matrix adhesion necessary for traction in cell 
motility, allowing for directional movement leading to invasion by tumour cells.
I.2.4.2 Scatter Factor / Hepatocyte Growth Factor
Scatter factor (SF) is a secretory product of fibroblasts which induces epithelial 
cells to dissociate, increasing their motility and invasiveness (Stoker et al., 1987; 
Weidner et al., 1990) and as such has been proposed to be an important factor in 
invasion and metastasis. In addition, another factor reported to be a powerful 
mitogen for hepatocytes in primary cultures, known as hepatocyte growth factor 
(HGF), has recently been found to be indistinguishable from SF (Weidner et al.,
1991). This factor is synthesized as a precursor of 92kD size which undergoes 
proteolytic cleavage (Naka et al., 1992) to yield a disulphide linked a p  
heterodimer. This proteolytic cleavage has been demonstrated to be inhibited by 
serine proteases (Naka et al., 1992) and can be catalysed by both urokinase-type 
plasminogen activator (uPA) and tissue-type plasminogen activator (tPA) (Naldini 
et al., 1992; Mars, Zamegar & Michalopoulos, 1993). The a  chain contains four 
kringle domains and functional studies indicate that the first two domains are 
required for the scatter factor activity, whereas it appears that the complete mature 
form is necessary for mitogenic activity (Hartmann etal., 1992; Lokker et al.,
1992). Both forms appear to compete with identical affinity for the p l9 0 ^ et 
receptor and consequently, both equally trigger the tyrosine phosphorylation of the 
Met receptor p subunit (Naldini et al., 1991).
The different biological properties ascribed to SF/HGF, although both are almost 
certainly the same molecule (both factors have been identified as products of a 
single gene located on chromosome bands 7ql 1.2-21 (Weidner et al., 1991)), may 
be the consequence of the particular cell type stimulated and the presence of other
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cell type-specific cooperating proteins acting to modify the ligand-receptor 
interaction leading to divergent signalling pathways. However, the mechanism for 
this, at present, remains open to speculation.
It is worth noting at this point that the met gene has been reported to be amplified 
and overexpressed in some cell lines derived from human tumours (Giordano 
etal., 1989) and in some spontaneously transformed NIH 3T3 cells after in vitro 
culture (Cooper et al., 1986). Cooper and colleagues report the amplification of the 
met gene between 4- to 8-fold, with at least a 20-fold overexpression of the met 
mRNA compared to untransformed NIH 3T3 cells. In another study of human 
thyroid carcinomas, overexpression of the Met receptor correlated with advanced 
stage tumours which had locally invaded and/or had distant metastases (Di Renzo 
etal., 1992).
Another molecule has been isolated which appears to be similar in sequence to 
SF/HGF (Rubin et al., 1991) and is lung fibroblast derived. However, there are 
some distinguishing features for both: SF/HGF is synthesized as a precursor 
molecule which requires to undergo proteolytic cleavage but the lung fibroblast- 
derived factor appears to be synthesized and secreted as a single polypeptide chain 
of 87kD size (Rubin et al., 1991). Additionally, p87 appears to have some amino 
acid substitutions in comparison to SF/HGF, one of which interrupts a potential 
integrin-binding RGD sequence and another that adds a cysteine residue which 
could potentially alter disulphide bridge formations (Rubin et al., 1991).
I.2.4.3 Migration Stimulating Factor
Migration stimulating factor (MSF) is another cytokine identified for its ability to 
stimulate cell migration (Grey et al., 1989). It has been purified from foetal and 
breast cancer patient fibroblasts and appears to operate in an autocrine fashion as
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observed for AMF (Liotta et al., 1986). It does not exhibit sequence similarity to 
SF/HGF or AMF (Grey et a l, 1989).
1.2.5 Organ-Specific Metastasis
Many tumours characteristically metastasize in an apparently non-random manner 
to particular organs. The specific colonization of secondary sites cannot be 
consistently explained by the simple mechanical entrapment of circulating tumour 
cells in the first microcirculatory network encountered. For example, cutaneous 
malignant melanoma can spread to many sites including the brain, ovaries, spleen 
and thyroid; bone metastases can specifically result from breast adenocarcinomas 
and kidney clear cell carcinomas (reviewed by Rusciano & Burger, 1992).
Although organ-specificity is a recognised phenomenon of tumour metastasis, and 
has been for many years whereupon the first hypothesis of the "seed and soil" 
nature of metastasis was proposed (Paget, 1889), the questions of how and why 
this occurs remain unanswered. Indications from experiments examining the 
influence of conditioned medium from cultured organs (Nicolson & Dulski, 1986) 
and the ability of various organ-derived biomatrices (Doerr et al., 1989) to support 
tumour cell growth suggest that particular properties exist for organs which are 
preferential sites of metastasis. But evidence of what these properties are, remains 
to date inconclusive. Additionally it has been proposed by some investigators that 
progression of tumours to the metastatic state involve the transition of cells from a 
paracrine responsive state to an ultimately "acrine" state (Nicolson, 1993). This 
would suggest that tumour cells could therefore be unresponsive to inhibitory 
signals in different organ environments, however, it does not provide the 
mechanism underlying organ specificity.
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1.2.6 Angiogenesis
For a tumour cell population to proliferate in vivo beyond a volume restricted by 
oxygen and nutrient diffusion, there must be new blood vessel formation (Bouck,
1990). This applies both to the primary tumour and disseminated tumours. As 
noted before for other normal processes involved in metastasis, angiogenesis is a 
normal cellular process involved in reproduction, development and wound repair.
Angiogenesis is a cascade of events by which pre-existing, resting endothelial cells 
respond to angiogenic factors causing degradation of the endothelial basement 
membrane, migration of the cells into the stroma in the direction of the angiogenic 
stimulus and formation of a capillary sprout. This new capillary sprout expands 
and forms into a tubular structure. The continued endothelial proliferation allows 
the vascular tubules to extend and form loops which can then function as a 
capillary network (Liotta, Steeg & Stetler-Stevenson, 1991). Again, degradation of 
the extracellular matrix and cell migration are not dissimilar to the processes 
involved in invasion.
Some cells, notably malignant cells, are capable of producing several angiogenic 
factors (Folkman & Klagsbrun, 1987). These angiogenic factors in addition to 
stimulating angiogenesis, also promote the recruitment of other cell types 
(e.g. macrophages and mast cells) which can in turn produce their own angiogenic 
factors (Meininger & Zetter, 1992). Many different factors have now been ascribed 
to possess angiogenic properties, including macrophage-derived interleukin-8, IL-8 
(Koch etal., 1992) and vascular endothelial growth factor, VEGF (Plate et al., 
1992; Shweiki et al., 1992). Interestingly, one factor recently identified is scatter 
factor, SF/HGF (Grant et al., 1993), previously shown to have the ability to 
dissociate epithelial cells and to be mitogenic for hepatocytes (see section I.2.4.2). 
The normal function of SF/HGF may therefore be to promote angiogenesis under
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normal physiological circumstances such as wound healing (Miyazawa et al.,
1994) through the simultaneous recruitment of cells into the wound area (induction 
of scattering) and the stimulation of cell proliferation (as required for blood vessel 
expansion and the formation of scar tissue). Furthermore, other factors required in 
angiogenesis include the matrix degradative proteases which have been 
demonstrated to be produced by stimulated endothelial cells allowing for the 
expansion of the capillary tubule into the ECM (Kalebic, 1983).
Correlation between angiogenesis and tumour invasion can be readily visualized, 
since both processes require cell motility, degradation of the ECM and cell 
proliferation. Therefore, inhibitors of angiogenesis may also be potent inhibitors of 
tumour invasion and metastasis.
1.2.7 Metastases of Metastases
Once metastases have established at distant sites to the primary tumour, it could be 
postulated that these tumours can in turn metastasize, thus taking the metastatic 
process around in full circle. However, at this stage of the metastatic disease, long 
term patient survival must be improbable.
1.2.8 Conclusion
It seems unequivocal that the cascade of events which ultimately leads to the 
successful dissemination of a primary tumour to form metastatic deposits must 
involve a plethora of signalling events and responses, and indeed the inhibition of 
normal regulatory signals and responses. Many host-tumour cell interactions are 
required to occur, some of which have been outlined here, but the progression of 
the tumour depends on the outcome of an imbalance of normal control 
mechanisms, giving rise to inappropriate responses and the misdirecting of normal 
cellular functions. It is this imbalance of homeostasis which may fundamentally lie
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in genetic alterations. Some of these possible genetic alterations will be addressed 
in the following chapter.
33
CHAPTER II GENETIC ALTERATIONS ASSOCIATED WITH TUMOUR 
PROGRESSION
II. I Multistep Model Of Colon Carcinogenesis
Progression of a primary tumour to malignancy is frequently associated with 
alterations within the cancerous cell at the genetic level. One such alteration is 
gene amplification and this will be discussed in more detail in section II.2. An 
intensively studied human cancer, with respect to the characterization of genetic 
alterations associated with tumour progression, is colon cancer (Fearon & 
Vogelstein, 1990). The model, now widely adopted as Vogelstein's model of colon 
carcinogenesis, was initially derived from studies of numerous colorectal tumour 
samples representative of different stages of tumour progression, including benign 
polyps, adenomas and carcinomas (Fearon, Hamilton & Vogelstein, 1987; 
Vogelstein et al., 1988; Vogelstein et al., 1989; Kern et al., 1989). A number of 
genetic alterations have been associated with the progression of an adenoma to an 
invasive and metastatic carcinoma, including the mutation of TP53 (Baker et al., 
1989; Rodrigues et al., 1990; Campo et al., 1991), Ki-ras (Forrester et al., 1987; 
Bos et al., 1987), DCC (Fearon et al., 1990) and MCC (Kinzler et al., 1991; 
Ashton-Rickardt et al., 1991). Evidently, it is not the sequential mutation of 
particular genes in any given order which is of prime importance, since early 
lesions can have loss of p53 without mutation of Ki -ras and late stage carcinomas 
may not have all of the mutations implicated in colon tumour progression, rather it 
is the overall accumulation of genetic aberrations (Fearon & Vogelstein, 1990). 
The classically represented model of colorectal tumour progression (see Figure 2) 
is therefore misleading such that there is no rigid requirement for each genetic 
alteration to occur at a precisely pre-determined step in tumour progression. 
However, the model does provide a concept upon which to found further studies on 
the process of carcinogenesis. But, the progression of a non-invasive tumour to the
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Figure 2
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Figure 2. Multistep Model Of Colon Carcinogenesis
Progression of colon cancer has been viewed as a multistep event with several 
genetic alterations involved at different stages, as shown in this figure. See section
II. 1 for details.
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metastatic state is not addressed in this model and is broadly labelled as 
"other mutations". Many studies have been attempted to elucidate the metastatic 
phenotype and some genes have been identified as being putatively metastasis- 
associated. Some of these will be discussed (see section II.3).
II .2 Gene Amplification
A recurrent feature of malignant tumours is gene amplification (reviewed by 
Brison, 1993). Cytogenetically, two different structures have been identified which 
are believed to harbour amplified DNA; homogeneously staining regions (HSRs) 
integrated with the chromosomal structure (Alitalo et al., 1983) and 
extrachromosomal elements termed double minutes (DMs) (Hahn, 1993; Barker, 
1982). Most frequently, amplification has been described of the ras, myc and erbB 
proto-oncogene families (Yokota et al., 1986; Brodeur et al., 1984; Nau et al., 
1986; Mizutani et al., 1993), and of the human chromosomal locus 1 lq l3 
(Lammie & Peters, 1991). The 1 l q l 3 region spans -15 million base pairs (mb) of 
DNA and the genes found within this region are still being characterized. 
However, a strong candidate gene which is thought to contribute significantly to 
the development of some tumours is cyclin D1 (Motokura et al., 1991; Lovec 
et al., 1994; Zhang et al., 1993; Jiang et al., 1993). In addition to being amplified 
in tumours such as breast cancer (Buckley et al., 1993; Lammie et al., 1991), the 
l lq l3  locus is also translocated in some B cell lymphomas (Koduru, Offit & 
Filippa, 1989; Rabbitts et al., 1988), further substantiating the prediction of a 
proto-oncogene within this locus (Lammie & Peters, 1991).
The mechanism of gene amplification in mammalian cells remains elusive since 
there is no known example of normal mammalian cells which undergo 
programmed gene amplification (Stark et al., 1989). Several models have been 
proposed to explain the formation of both DMs and HSRs (reviewed by Stark
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et al., 1989; Hahn, 1993) but none have been proven. Events leading to gene 
amplification in the proposed models include both DNA damage and 
recombination (Hahn, 1993; Stark et al., 1989). Amplicons which contain 
amplified genes can often have duplicate DNA sequences in an inverted / 
palindromic "head-to-head" orientation (Ford & Fried, 1986; Ford etal., 1985).
Regardless of the mechanism of gene amplification, increased copy number of 
particular genes has been identified to be clinically correlated with particular 
tumours and their disease stage. A notable example is neuroblastomas, whereby 
N-myc amplification was found to be increased 3-100 fold, as detected by Southern 
analysis, in patients with advanced-stage disease, i.e., invasion and metastasis had 
occurred (Brodeur et al., 1984). More recently, a gene named MDM2 by virtue of 
its identification in DMs contained in a murine cell line 3T3DM, which was 
derived from spontaneously transformed Balb/c cells (Fakharzadeh et al., 1993), 
has been discovered to be a regulator of p53 (Oliner et al., 1993). The protein 
encoded by MDM2 inhibits p53 activation of transcription by binding and 
concealing the p53 activation domain (Oliner et al., 1993), therefore it can be 
surmised that gene amplification of MDM2 will increase MDM2 protein levels 
within the cell and result in the sequestration of p53, thus potentiating deregulated 
cell growth. Amplification of MDM2 has been associated with human sarcomas 
(Oliner et al., 1992; Cordon-Cardo et al., 1994). However, with the observation 
that amplification of MDM2 may lead to deregulated cell growth, it is not 
surprising that direct correlation of this amplification has not been reported with 
tumour progression to invasiveness and metastatic potential, but it may indeed be 
an earlier event leading to this phenotype.
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II.3 Putative Metastasis Genes
Already apparent is that the metastatic phenotype arises through a cascade of 
events, affecting numerous aspects of normal cellular behaviour including cell 
adhesion, production of matrix degrading enzymes and cellular motility, as 
detailed in Chapter I. As a consequence of the multifaceted nature of metastasis, 
’putative metastasis-suppressor genes may affect different individual aspects of 
metastasis, but the overall result is the suppression of the metastatic phenotype. 
With this regard, metastasis-suppressor genes may be multiple in number and 
divergent in function, but with only a single functional metastasis-suppressor gene 
required for metastasis to be overcome in any one tumour cell. Conversely, 
alterations of numerous metastasis-associated genes may be necessary for the 
metastatic phenotype to be manifested, since it has yet to be proven that any single 
gene is the universal metastasis-gene. However, in some systems studied, there 
may be the apparent induction of metastatic ability by mutation of a single gene or 
the modulation of gene expression, this can generally be restricted to particular cell 
types of particular origins. Thus, these cells may already possess many of the other 
requirements for metastasis and need only one further factor, or up-regulation / 
down-regulation of factors already present within the cell for full conversion to the 
metastatic phenotype. This therefore presents distinct difficulties in determining 
which, if any genes, are responsible for the metastatic phenotype.
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II.3.1 Nm23
Nm23 was identified by differential colony hybridization of related murine 
melanoma K-1735 cell lines of high and low metastatic potentials (Steeg et al., 
1988a). Reduced expression of nm23 was correlated with high metastatic potential 
and nm23 was therefore proposed to be a candidate metastasis suppressor gene. 
Early reports indicated that in some rodent systems and in human breast cancer, 
inverse correlation could be found between Nm23 expression and metastatic 
potential (Steeg et al., 1988b; Su et al., 1993; Honoki et al., 1993; Bevilacqua 
etal., 1989). In colorectal cancer, correlation has been noted between nm23 
mutations and metastasis (Cohn et al., 1991; Wang et al., 1993) in addition to 
inverse association of nm23 mRNA expression and liver metastasis (Yamaguchi 
etal., 1993). However, further studies in other models and tumour types have not 
found the same correlation (Sastre-Garau etal., 1992; Haut et al., 1991; Myeroff & 
Markowitz, 1993). Controversy therefore exists about the role of the nm23 gene in 
tumour metastasis.
The Drosophila gene abnormal wing discs (awd), encodes for a developmentally 
regulated protein which shares 78% identity of the predicted amino acid sequence 
with Nm23 (Rosengard et al., 1989; Biggs et al., 1990). Mutations or decreased 
expression of awd causes abnormal morphology, aberrant differentiation and cell 
necrosis during metamorphic stages of Drosophila development (Dearolf et al., 
1988a, 1988b). It has since been realised that Gip 17, a protein purified from 
Dictyostelium discoidium, identified as a nucleoside diphosphate (NDP) kinase, 
has 77% similarity to the human Nm23 protein and 75% similarity with Awd from 
Drosophila (Wallet et al., 1990). Furthermore, two nm23 genes have been 
identified, nm23-Hl and nm23-H2, which share 88% amino acid identity (Stahl 
etal., 1991) and these have been identified to be the A and B polypeptide chains 
respectively, of the human erythrocyte NDP kinase (Gilles et al., 1991). The
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human erythrocyte NDP kinase is a hexameric enzyme which can form several 
isoforms through permutations of the A and B polypeptide chains (Gilles et al.,
1991).
Phosphorylation studies of NDP kinase have identified the catalytic intermediate 
which is phosphorylated on histidine residue 118 during the "ping-pong" 
mechanism of nucleoside diphosphate phosphorylation (Gilles et al., 1991). Also, 
an acid-stable auto-phosphorylation product of NDP kinase at residue serine 44 has 
been identified (MacDonald et al., 1993). This serine 44 residue is conserved in 
mouse, human, rat and Drosophila Nm23 / NDP kinase sequences and 
conservatively substituted for threonine in Dictyostelium and Escherichia coli 
(MacDonald et al., 1993). Nm23 / NDP kinase activity has not been consistently 
correlated with metastatic potentials (Sastre-Garau et al., 1992) and one recent 
publication suggests that the acid-resistant auto-phosphorylated Nm23 at serine 44 
exhibits correlation with the suppression of lung colonization potential as assayed 
by tail vein injection (MacDonald et al., 1993). Transfection experiments with a 
mutated histidine 118 residue which abrogates the NDP kinase activity, did not 
produce viable colonies indicating that this kinase activity is absolutely required by 
the cell (MacDonald et al., 1993). Nucleotide binding to NDP kinase is within a 
cleft of each subunit (Dumas et al., 1992) and it is within this cleft that 
phosphorylated serine 44 also resides (Dumas et al., 1992, MacDonald et al.,
1993). In vitro evidence suggests that binding of nucleotides to the NDP kinase 
releases the serine phosphorylation (MacDonald et al., 1993), implying that 
serine 44 phosphorylation is separate from the kinase activity. This supports the 
observation that NDP kinase activity may not be the important parameter in 
metastasis, however this leaves open the question of what is the role of 
phosphorylated Nm23 in the cell and in metastasis.
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Microinjection of antibodies specific to Nm23 into rat embryo fibroblasts inhibited 
cell division (Sorscher et al., 1993). Expression of Nm23 has been detected on the 
cell surface as measured by flow cytometry, using specific antibodies to each of 
Nm23-Hl and Nm23-H2 (Urano, Furukawa & Shiku, 1993). Cell surface 
expression was of combinations Nm23-Hl+H2+, Nm23-Hl+H2- or Nm23-Hl-H2- 
but never Nm23-Hl-H2+ (Urano et al., 1993). Interestingly, Nm23-H2 has been 
discovered to be identical to the human c-myc purine-binding transcription factor 
PuF (Postel et al., 1993) and therefore it may not be surprising that Nm23-H2 is 
not cell surface expressed unless complexed with Nm23-Hl, since its normal 
localization may be nuclear in order to function as a transcription factor. 
Unfortunately, detailed cellular localization studies of each Nm23 protein have not 
been reported to date, which may resolve some of these observations.
II.3.2. Mts-1
This gene was reported by Lukanidin and colleagues to be expressed specifically 
in metastatic cells (Ebralidze et al., 1989). Mts-1 encodes for a protein with 55% 
amino acid identity within the calcium-binding domains of the SI00 family of 
calcium-binding proteins (Ebralidze et al., 1989) and is very similar to the rat 
proteins p9Ka (Barraclough et al., 1987) and 42A (Masiakowski & Shooter, 1988) 
which have also been identified to be related to the S100 family. Mts-1 is also 
apparently identical to a previously identified mouse calcium-binding protein, 
18A2 (Jackson-Grusby, Swiergiel & Linzer, 1987). However the reported 
expression patterns in normal tissues of Mts-1 and 18A2 appear to differ. 
Transfection studies with the rat homologue, p9Ka, has been reported to induce the 
metastatic phenotype in a benign rat mammary epithelial cell line, RAMA 37 
(Davies et al., 1993). However, transfection of p9Ka also dramatically reduces the 
tumour latency period suggesting that the primary effect may be tumorigenicity- 
related or a proliferative effect. Indeed, two of the transfected cell lines, KP1-LT2
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and KP1-LNT1, derived from metastases of primary tumours induced by pooled 
transfected cells, demonstrate no increased p9Ka mRNA levels or protein levels 
over the benign parental cell line but still exhibit similar (if not enhanced) 
metastatic abilities in comparison to another similarly metastasis-derived cell line 
containing elevated levels of p9Ka (Davies etal., 1993). Further evidence to 
suggest that mts-1 is not a directly related metastasis gene includes the rat 
equivalent, 42A, which differs from p9Ka by a single amino acid (Masiakowski & 
Shooter, 1988), and which was found to be induced in PC 12 cells induced to 
differentiate with nerve growth factor (NGF). It would seem more plausible that 
these calcium-binding proteins are important structurally as they are found in 
association with F-actin (Davies et al., 1993) and are induced under conditions 
which may involve cell shape change such as induced by growth factors and serum 
(Masiakowski & Shooter, 1988; Barraclough et al., 1987; Jackson-Grusby, 
Swiergiel & Linzer, 1987). Although this is important in invasion and metastasis, it 
appears that these proteins are not necessarily causative of the metastatic 
phenotype, rather they may be consequentially affected as a result of this 
phenotype.
II.3.3 CD44
As earlier described (section I.2.2.5), CD44 is a transmembrane, highly 
glycosylated protein which can be alternatively spliced (Screaton et al., 1992, 
1993; Tolg et al., 1993). Particular variant exons have been associated with the 
metastatic phenotype in a rat model system (Gunthert et al., 1991; Rudy et al., 
1993) and with some human cancers (Heider et al., 1993; Matsumura & Tarin, 
1992; Li et al., 1993), including colorectal cancer (Heider et al., 1993; Wielenga 
etal., 1993), although not in all human cancers (Chaudhry et al., 1994; Salmi 
etal., 1993). Notably, in early colorectal adenomas, CD44 is found to contain 
alternatively spliced exons including variant exon V5 which is not present in
42
normal mucosa, but not the metastatically-associated variant exons V6 or V7 
(Rudy et al., 1993; Wielenga et al., 1993). However, analysis of later stages of 
colorectal tumour progression correlate with the expression of variant exon V6 
(Weilenga et al., 1993). Clues to the function of CD44 alternative splicing come 
from the observation that these different CD44 isoforms are found transiently 
expressed on activated T cells (Arch et al., 1992; Haegel et al., 1993). Indeed it 
has been suggested that one role for these isoforms may be in homing of the T cells 
to the lymph nodes (Wu, Kincade & Shortman 1993; Arch et al., 1992). It can 
therefore be envisualized that a similar role may be employed by the metastatic 
cell with expression of these variant exons. Also proposed of some 
glycosaminoglycans such as CD44 is the ability to bind cytokines (Tanaka et al.,
1993). It may be that different variant isoforms can bind different cytokines, 
thereby influencing the interactions of these expressing cells with other cells 
responding to the cytokine. Alternatively, cytokines bound to CD44 may be 
internalized and mediate an intracellular effect. These possibilities have yet to be 
resolved or disregarded.
However, it is apparent that expression of particular CD44 isoforms are, in some 
instances, specifically associated with the metastatic phenotype, although in some 
systems, it may be the level of expression of the standard form of CD44 which is 
correlated with the metastatic process. As a prognostic marker, CD44 appears to be 
useful in certain human tumours to correlate the disease stage with expression of 
variant CD44, which can be detected in the blood of patients by the polymerase 
chain reaction (PCR) technique.
II.3.4 Cell Adhesion Molecules
E-cadherin, together with other cell adhesion molecules including the integrin 
a 4$\ (Qi^n, Vaux & Weissman, 1994), have been demonstrated to suppress the
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invasive capacities of tumour cell lines (Vleminckx et al., 1991; Frixen et al., 
1991). These genes are sometimes proposed as metastasis suppressor genes, but 
should be more accurately termed invasion suppressor genes. As already 
mentioned in section I.2.2.1, transfection of a cDNA encoding for E-cadherin both 
into \-ras transformed derivatives of Madin-Darby canine kidney (MDCK) cells 
which normally express very low levels of E-cadherin and into a subclone of the 
cell line NMuMG (normal murine mammary gland) which also lacked E-cadherin 
expression, resulted in the abrogation of their invasive phenotype as estimated in 
the invasion assays of chick embryo heart fragments and collagen matrices 
(Vleminckx et al., 1991). Studies on human cancers and cell lines derived from 
human cancers including breast, gastric, gynaecologic and squamous cell 
carcinoma of the head and neck (Mayer etal., 1993; Oka et al., 1993; Kinsella 
etal., 1993; Pignatelli et al., 1992; Schipper et al., 1991), often display altered 
expression of E-cadherin. Correlation is inverse with expression of E-cadherin 
protein in comparison with the status of tumour differentiation or lymph node 
involvement. One recent study of the E-cadherin gene on chromosome 16q22 
revealed in 3% of gynaecological carcinomas examined (n=135) somatic mutations 
which were either missense or nonsense (Risinger et al., 1994). In another study of 
cell lines derived from human gastric carcinomas, mRNA processing appeared to 
be disrupted in two cell lines; MKN45, a poorly differentiated adenocarcinoma and 
KATO-III, a signet ring cell carcinoma (Oda et al., 1994). Together, these results 
support the invasion-suppressor role of E-cadherin and it can be readily envisaged 
that breakdown of cell-cell contacts could increase the propensity of a tumour cell 
to detach from the primary mass and commence invasion into normal local stroma. 
Aberration of these cell-cell contacts can also arise from disruption of intracellular 
interactions with the cytoskeleton, such as cadherins with the catenins (described 
in section I.2.2.1). The human lung cancer cell line PC9, although E-cadherin 
positive, was not cell-cell adhesive and was found to have homologous deletion of
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part of the a-catenin gene (Shimoyama et al., 1992). Cell-cell adhesion was 
restored upon transfection of a functional a-catenin gene (Hirano et al., 1992). 
This would mean that immunohistochemical analysis of tumours for E-cadherin 
expression could be positive, but E-cadherin may still not be functional. Therefore 
the invasion suppressor role of E-cadherin can be extended to other components 
necessary for functional E-cadherin cell-cell adhesion.
A similar situation appears to exist for the a ^ j  integrin, recently described to be 
suppressive of invasion (Qian et al., 1994). Although many of the integrins are 
involved in cell-matrix interactions (see section I.2.2.2), some have also been 
implicated in cell-cell adhesion, including <x$>\ (Pulido et al., 1991; Campanero 
etal., 1990; Takada et al., 1989). A B16 melanoma variant cell line, B16a, was 
highly invasive and spontaneously metastasized from subcutaneous injection and 
did not express a 4 (Qian et al., 1994). Upon retroviral infection of this cell line 
with an a 4 cDNA, heterodimer Q.$>\ integrin expression was restored and these 
transfected cells were non-invasive when subcutaneously injected (Qian et al.,
1994). Furthermore, intravenous injection of transfected cells displayed similar 
colonization ability of the lung as mock-transfected cells, indicating that the 
functional integrin heterodimer was influencing the early invasive steps in 
metastasis and not the later events (Qian et al., 1994).
II.3.5 Conclusion
Evidently some genes are directly implicated in tumour invasion and metastasis, 
including some of those described above, and genes encoding for proteins such as 
the extracellular matrix degradation enzymes (section 1.2.3) and motility factors 
(section 1.2.4), but no single gene has truly been classified as a "metastasis gene". 
It may be that metastasis is indeed a collaboration of events within the cell, and 
certain genetic alterations can potentiate the ability for a cell to metastasize, but
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overall it may be the balance of the various factors which determines metastasis. 
This obviously presents significant difficulties in determining exactly what it is 
that makes a tumour cell metastatic and perhaps greater insight will result from 
research into cells such as lymphocytes which normally migrate throughout the 
body, but are obviously not tumorigenic and therefore do not form metastases.
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CHAPTER III MODEL SYSTEMS FOR THE ANALYSIS OF INVASION 
& METASTASIS
111.1 Introduction
To allow for the study of the complex processes of invasion and metastasis, many 
model systems have been developed which involve both in vivo and in vitro 
approaches (Evans, 1991). Because of the nature of metastasis, it is difficult to 
comprehensively represent the whole process in a single model, although there are 
advances in this field with in vivo model systems and orthotopic implantation 
techniques, as will be discussed later in this chapter (III.2). However, it is also 
advantageous to attempt to dissect the invasion and metastatic processes with 
in vitro analyses, which provides a favourable position for experimental 
manipulation. The major disadvantage of the "simplified" in vitro model systems is 
the physiological relevance, since these systems circumvent many of the complex 
parameters found in vivo, such as the extracellular matrix, appropriate tissue / cell 
types, host response, etc. However, without an ideal system which addresses all 
aspects of invasion and metastasis, many of the model systems viewed together 
should aid research into these multifaceted processes, bearing in mind the 
limitations of each model and therefore the interpretations of the results. The 
following sections give a brief overview of different model systems used to study 
invasion and metastasis.
111.2 In Vivo Model Systems
These model systems are largely dependent upon laboratory mice which are highly 
inbred strains, with largely known genetic backgrounds (Lyon & Searle, 1989). 
The two major systems for the initiation of primary tumours are 
chemically-induced, for example with the use of DMBA in multistage mouse skin 
carcinogenesis (reviewed by Bowden et al., 1994), or by direct injection of tumour
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cells, either of cell lines, for example in the CMT model (see section III.3.5) or 
ceils from a tumour. Initiation of a primary tumour and the formation of metastases 
at secondary distant sites is known as the spontaneous metastasis assay. The 
experimental assay, or the colonization assay, does not involve the initiation and 
formation of a primary tumour, but instead the tumour cells are injected directly 
into the blood circulation, for example via the tail vein. This latter metastasis assay 
does not represent the initial tumour formation and invasion stages of metastasis, 
but does reflect the later stages of metastasis, which is more accurately described 
as the colonization potential of circulating tumour cells. It should be noted here 
that some of the cell lines used in metastasis research display colonization 
potential as assayed by the experimental metastasis assay, but cannot form distant 
metastases spontaneously from subcutaneous injection, for example many of the 
B16 melanoma sublines (Evans, 1991), and therefore these cells lack a possibly 
fundamental property of metastasis and this should be taken into consideration 
when interpreting results.
Recently, it is becoming more widely recognized that the site of injection in the 
spontaneous assay can affect the subsequent behaviour of the tumour cells 
(reviewed by Manzotti, Andisio & Pratesi, 1993). Traditionally, the site of 
injection has been subcutaneous, however recent model systems are employing 
orthotopic implantation as opposed to ectopic injection (Furukawa et al., 
1993a & b; Stephenson et al., 1992). The orthotopic implantation models 
frequently utilize nude mice which are immunocompromised since they are 
athymic. When tumour cells are injected subcutaneously into nude mice, 
metastasis rarely occurs, but orthotopic implantation has been reported to mimic 
successfully the clinical disease with tumour spread to lymph nodes and organ- 
specific metastasis typical of the tumour cell origin (Furukawa et al., 1993a & b; 
Stephenson et al., 1992; Fidler, 1991). This therefore represents a more clinically
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relevant model system with which to analyse the metastatic phenotype and 
examine the potential of therapeutic agents.
A disadvantage of the in vivo model systems using immortalized tumour cell lines 
with known metastatic potentials is phenotypic drift consequent to long-term cell 
culture. The original parental tumours, from which many of the present cell lines 
were derived, are no longer available which could be used to determine the degree 
of phenotypic drift in the cell lines. However, this is a necessary sacrifice for 
having a stable model system with which repeated experimentation can be tested 
and allowing for the same model to be examined in different laboratories. 
Additionally, cell lines allow for substantial molecular and biochemical analyses 
since the cells can be grown to large numbers. The use of primary tumour material 
for orthotopic implantation overcomes the problems associated with in vitro tissue 
culture, however it too has a number of associated disadvantages. The primary 
disadvantage is the limited quantity of tumour sample which cannot be so readily 
analysed in great detail at the molecular and biochemical levels. In conjunction, 
due to tumour heterogenity, different sections of a tumour sample may exhibit 
different phenotypical charateristics (Heppner, 1984) and thus produce variablity 
into the assay. The obvious advantage to orthotopic implantation of tumour 
material is the mimicry of clinical metastasis.
The chick embryo is another in vivo model system for the study of colonization 
potential / experimental metastasis and spontaneous metastasis (Evans, 1991). 
However, although tumour cells seeded onto the chorioallantoic membrane (CAM) 
can invade and spread to organs of the developing chick, this event tends to take a 
considerable time. Since this is a xenogeneic system and the study of these 
processes are often preferred to be without immunological intervention, the tumour 
cells need to establish and exhibit their invasive and / or metastatic phenotype 
before the chick becomes immunocompetent at 18 days (Evans, 1991). A further
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constraint of this system is the CAM: the CAM is not suitable for seeding of 
primary tumour cells until it is sufficiently developed at 8 days. In addition, the 
status of the CAM can affect the experiment; slight damage to the CAM appears to 
enhance tumour growth (Armstrong, Quigley & Sidebottom, 1982). The 
mechanism by which this operates is unclear. It may be postulated that the damage 
induces the normal repair processes which results in the stimulation of growth 
factor secretion and possibly of angiogenic factors which can in turn be utilized by 
the tumour cells.
As a result of the disadvantages of this model system (the short time window of 
8-18 days within which the chick embryo and the CAM are compatible for 
experimentation, and the poor correlation with other model systems, e.g. syngeneic 
animals, of the invasive phenotypes) the chick embryo is not a preferentially used 
model system.
III.3 In Vitro Model Systems
A number of in vitro model systems have been developed and all study aspects of 
invasion (Evans, 1991). Due to the complex process of metastasis, it has not been 
possible to design a system which could operate in vitro and represent the whole 
process of metastasis. However, although the in vitro model systems are limited in 
their applicability to later events of the metastatic process, they may provide some 
valuable insight into the initial stages of invasion. Unfortunately, due to the 
simplified nature of these models - an advantage in itself for the greater control of 
experimental parameters than in vivo - it is poorly representative of the 
physiological situation and therefore caution needs to be taken in the interpretation 
of results.
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II1.3.1 Confrontation Assays
Explants are taken from tissues such as the chick embryo heart in this assay, and 
placed in culture ~lmm distant to a tumour explant. From these explants, cells can 
migrate and grow out to "confront" cells from the opposing explant. This assay is 
meant to be representative of the invasion characteristics of tumour cells, however 
"invasion" can often be seen equally from both sources (Stephenson & Stephenson, 
1978), thus questioning the validity of this experimental approach.
111.3.2 Collagen Gels / Matrigels
These assays provide a 3-dimensional invasion assay as opposed to the essentially 
2-dimensional confrontation assay (III.3.1). The use of native collagen to form a 
gel or reconstituted basement membrane gel prepared from EHS tumours 
(matrigel) (Kleinman et al., 1986), allows for the examination of tumour cells 
penetrating the gel and tumour cell migration through the gel. With the use of 
fluorescent stains or tagged antibodies, invading cells can be visualized with a 
confocal microscope. This assay system allows for the addition of chemoattractant 
factors and specific inhibitors to experimentally manipulate the invasion process 
and therefore attempt to dissect the process. However, as with all in vitro invasion 
assays, the system is highly simplified in comparison to the in vivo situation and 
caution must be maintained in extrapolating results.
111.3.3 Invasion Of Tissue Fragments
Different types of normal tissue fragments have been employed to assess invasive 
potentials of tumour cells. These include chick embryo heart, chick embryo CAM, 
amnion and blood vessels (Evans, 1991). Invasion of the chick embryo heart has 
been tested in both stationary and gyratory coculture with tumour cells (Evans, 
1991). Generally, tumour cells are incubated with whole or fragments of chick
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embryo heart and invasion is assessed by sectioning of the tissue and examination 
for invading cells. This is a rather laborious method for analysis and the 
implications from the results of these experiments are questionable for their 
validity since the heart is rarely a site for metastasis.
Invasion of the amnion is essentially performed in a chemotactic chamber with the 
amnion clamped over a millipore filter and the tumour cells are seeded upon the 
upper surface (Thorgeirsson et al., 1982). At various time intervals, the amnion can 
be removed and analysed for cells which have successfully invaded. Cells which 
have succeeded in invading the amnion completely can be collected and identified 
from the filter. Since the upper amnion surface is epithelium and is generally a 
poor substrate for adhesion, it is usually removed by treatment with 
0.1M ammonium hydroxide. It would appear that in this assay system the vital 
criterion for invasion is the expression of matrix metalloproteases, since 
uninhibited expression of these enzymes correlate with invasion of the amnion 
(Thorgeirsson et al., 1982). However, as already noted with other in vitro model 
systems, some tumours do not exhibit the same invasive phenotype in this in vitro 
assay as characteristic of their tumours in in vivo models, for example MCF-7 cells 
form highly invasive tumours, but only display a limited basement membrane 
degradation ability in this assay.
Poste et al. (1980) developed an in vitro assay system examining the invasion of 
blood vessels by tumour cells. Excised blood vessels were inserted with a porous 
cylinder capable of allowing the passage of single cells. The blood vessel itself 
could be orientated with the endothelium facing either inwards or outwards after 
eversion. This was then linked with a flow through system which could maintain 
an internal circulation and the external surface of the blood vessel was bathed in 
non-circulating medium. Tumour cells were inoculated into the surrounding 
medium and the cells which successfully traversed the blood vessel were recovered
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from the internal circulating system. Although this is an ingenious system for the 
study of blood vessel traversion by tumour cells, there are certain physiological 
deviations: the blood vessel which is used is usually a vein which is different from 
the capillary bed normally associated with the extravasation of metastasizing 
tumour cells. Also, a modification of the system would have allowed for the 
incorporation of blood flow and shear stress to be examined by the inoculation of 
the tumour cells into the circulating system and the recovery of cells from the 
surrounding medium.
ni.3.4 Summary
To reiterate, in vitro model systems focus on particular aspects of the metastatic 
process, most notably invasion. Consequently, the effects of many of the normal 
physiological conditions are omitted from these studies, such as interactions with 
host cells, immune reactions, circulation and the extracellular matrix. However, 
due to the vastly complex nature of metastasis, dissection of this process may be 
advantageous and in vitro model systems will prove advantageous if viewed in 
perspective.
The in vivo model systems are presently in two main categories for the study of 
metastasis: "spontaneous" and "experimental" assays. The experimental assay 
system essentially reflects colonization potential, but not metastatic ability. The 
spontaneous metastasis assay, although more analogous than other systems to the 
complete metastatic process, generally does not allow for detailed investigations of 
the individual steps necessary for metastasis.
Overall, until superior assay systems for the analysis of the metastatic process are 
developed, if possible, then metastasis research is limited to the aforementioned 
assay systems. However, these should prove worthwhile and provide valuable 
insight when the limitations of the systems are taken into consideration. The model
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which does provide the greatest representation of metastasis is the spontaneous 
metastasis assay. These systems are also valuable for the evaluation of possible 
therapeutic trials since complete understanding of the biology of metastasis need 
not be fully comprehended before such experimentation can be attempted. For this 
thesis, a murine model representative of the spontaneous metastasis phenotype was 
employed and further details of this model are described in the following section 
(m.3.5).
m.3.5 CMT Model
This mouse model system for the investigation of the metastatic phenotype was 
first described in 1976 (Franks et al.) and characterized for stable metastatic 
variants in 1984 (Layton & Franks). The basis of this model is a series of epithelial 
cell lines which were originally derived from a spontaneous alveologenic 
carcinoma of a female C57B/T mouse (Franks et al., 1976). The derivation of the 
cell lines is illustrated in Figure 3. Briefly, a heterogeneous cell line (CMT 64) was 
first established from explant cultures of fourth transplant generation tumour tissue 
(Franks et al., 1976). Subsequent heterogeneous sub-lines of this parent cell line 
were then derived by means of subcutaneous injection of CMT 64, the resultant 
lung metastases were pooled and re-injected subcutaneously to form another 
primary tumour. From this tumour, explants were taken and cultured in vitro to 
generate the first sub-line CMT 167. This process was repeated with CMT 167 
cells being injected subcutaneously, resulting in the derivation of the sub-line 
CMT 170, which gave rise to other sub-lines following the same procedure. These 
sub-lines were cloned to produce a variety of cell lines which were then 
characterized for their metastatic abilities (Layton & Franks, 1984).
In the work described in this thesis, two sub-line clones were used for analysis: 
CMT 167/C6 (high metastatic capacity, as assayed by the spontaneous metastasis
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Figure 3
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Figure 3. Schematic Illustration Of The Derivation Of The CMT Cell Lines
The CMT cell lines were derived from the same spontaneous lung carcinoma of a 
female C57B/T animal through the sequential selection of cell lines established in 
cell culture (Layton & Franks, 1984). The cell lines CMT 167/C6 and 
CMT 170/E9 which, among many other cell lines, were characterized for their 
metastatic potential (Layton & Franks, 1984). These CMT cell lines were 
subsequently chosen as the basis of the CMT model of metastasis through their 
differing metastatic phenotypes (CMT 167/C6: high metastatic potential; 
CMT 170/E9: low metastatic potential).
Spontaneous papillary aveologenic lung carcinoma of C57B/T
Tumour transplanted for four generations in vivo
Tumour explanted to in vitro culture
v
Passage 8: cells mostly epithelial; cell line CMT 64
Passage 22: s.c. injection of 5x10s cells
At 3 weeks, primary tumour formed: lung metastases pooled and 
s.c. transplanted in vivo
Primary tumour formed and explanted to in vitro culture
Epithelial outgrowth established as CMT 167 subline
Passage 4: s.c. injection of 5xl05cells
At 3 weeks, primary tumour formed: lung metastases pooled and 
s.c. transplanted in vivo
Primary tumour formed and explanted to in vitro culture
Passage 10: single cell 
cloning to establish cell lines 
including CMT 167/C6
Epithelial outgrowth established as CMT 170 subline
■i
I
Passage 5: single cell 
cloning to establish cell lines 
including CMT 170/E9
Further sublines CMT 175 and CMT 181 selected as above
Derivation of Cell Lines from a Spontaneous Lung Tumour
assay) and CMT 170/E9 (low metastatic capacity). It was reasoned that these two 
cell lines with their markedly differing metastatic potentials would be the most 
informative for analysing the metastatic phenotype.
To date, this model system has not been extensively characterized. Initial studies 
have determined the effects of cell fusion upon the metastatic phenotype with the 
general conclusion that fusion of metastatic cells (CMT 167) with non-metastatic 
L cells or EJ bladder carcinoma cells results in a suppression of the metastatic 
phenotype (Layton & Franks, 1986). However, other studies have indicated that 
fusion studies and chromosome transfer mediated by microcells, resulted in an 
instability of the metastatic phenotype (Pickford, 1987). Indeed, the procedure of 
single cell cloning could in some instances result in an apparent destabilization of 
the metastatic potential of CMT 167/C6 cells. There have been no reported studies 
on the biological and molecular characteristics of both CMT 167/C6 and 
CMT 170/E9 cell lines which could identify the cause of their differing metastatic 
abilities. Therefore, the major aim of this research was to attempt to define the 
determining factors involved in the metastatic phenotype of this system. An 
advantage of this system is the ability of the cell lines to metastasize spontaneously 
and therefore these cells are representative of the complete metastatic process. 
Also, since both cell lines are derived from the same spontaneous primary tumour, 
the basic genetic background of these cells are essentially identical with hopefully 
only the key differences which are pertinent to the metastatic phenotype present. In 
addition, unlike many other models of metastasis based upon cell lines, these cells 
have not been in in vitro cell culture for many decades, thereby minimizing 
phenotypic drift which may be a significant factor in other systems.
56
MATERIALS
AND
METHODS
CHAPTER IV MATERIALS
IV .l ANTISERUM
The rat monoclonal against E-cadherin (ECCD-2) (Shirayoshi et al., 1986) and rat 
monoclonal against P-cadherin (PCD-1) (Nose & Takeichi, 1986) were gifts from 
Prof. M. Takeichi and Dr. D. Prowse.
Supplier: 1CN Biomedicals Inc., California, USA
-anti-pl integrin, mouse monoclonal; clone DF5 
-anti-p3 integrin, mouse monoclonal; clone BB10 
-anti-allb integrin, mouse monoclonal; clone CA3
Supplier: Novocastra Laboratories Ltd., Newcastle upon Tyne, England 
-CM1; anti-p53, rabbit polyclonal
Supplier: Sigma Immunochemicals, Poole, Dorset, England 
-anti-NCAM, mouse monoclonal; clone NCAM-OB11 
-anti-N-cadherin, mouse monoclonal: clone GC-4 
-goat anti-mouse IgG (Fab specific) - peroxidase conjugate; 
product No. A-9917
-goat anti-mouse IgG (whole molecule) - alkaline phosphatase 
conjugate; product No. A-3688
-goat anti-mouse IgG (whole molecule) - FITC conjugate; 
product No. F-2012
-goat anti-rat IgG (whole molecule) - FITC conjugate; 
product No. F6258
IV.2 CELL UNES, MEDIA & TISSUE CULTURE SUPPUES 
Murine cell lines CMT 167/C6 and CMT 170/E9 were obtained either from 
laboratory stocks or from stocks held at Glasgow Royal Infirmary Department of 
Surgery. All other cell lines used in this thesis were from laboratory stocks.
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Supplier: Beatson Institute Central Services 
-sterile dE^O 
-sterile PBS 
-sterile CT buffer
-sterile glassware and glass pipettes
Supplier: Becton Dickinson Labware, Plymouth, England
-60mm and 100mm diameter tissue culture dishes
Supplier: Costar, 1 Alewife Ctr, Cambridge, MA 02140, USA
-6 well cluster and 24 well cluster tissue culture dishes 
-sterile disposable cell scrapers
Supplier: Fisons Scientific Equipment, Loughborough, Leics., England 
-dimethylsulphoxide (DMSO)
Supplier: Gibco Europe Life Technologies Ltd., Paisley, Scotland 
-lOx DMEM concentrate 
-methionine-free DMEM 
-Newborn calf serum 
-200mM glutamine 
-lOOmM sodium pyruvate 
-7.5% (w/v) sodium bicarbonate 
-1MHEPES 
-2.5% (w/v) trypsin 
-lOOx non-essential amino acids
Supplier: A/S Nunc, Roskilde, Denmark 
-Tissue culture flasks 
-Nunc tubes
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IV.3 CHEMICALS
Supplier: Amersham International pic, Amersham, Bucks, England 
-[a-32P] dCTP ~3000Ci/mmol 
-[y-32P] ATP ~5000Ci/mmol 
-[a-35S] dATP ~600Ci/mmol 
-32P-<9rr/zophosphate, carrier-free
Supplier: BDH Chemicals Ltd., Poole, Dorset, England
Unless otherwise stated, all chemicals were obtained from BDH and were of
AnalaR grade or better.
Supplier: Boehringer Mannheim UK Ltd., Lewes, East Sussex, England 
-cesium chloride
Supplier: Bethesda Research Laboratories, Life Technologies, Inc.,USA 
-agarose, ultrapure electrophoresis grade 
-LMP agarose, ultrapure electrophoresis grade
Supplier: James Burrough Ltd., Witham, Essex, England 
-ethanol
Supplier: Cinna/Biotecx Laboratories Inc., Houston, Texas, USA 
-RNAzolB
Supplier: Difco Laboratories, Detroit, Michigan, USA 
-Bactoagar
Supplier: Fisons Scientific Equipment, Loughborough, England 
-38% (w/v) formaldehyde
Supplier: Fluka Chemika-Biochemika AG, Buchs, Switzerland 
-formamide
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Supplier: Koch-Light Ltd., Haverhill, Suffolk, England 
- isoamyl alcohol
Supplier: Merck, Darmstadt, Germany 
-ninhydrin
Supplier: Millipore UK Ltd., Watford, Herts., England 
-all reagents for 2D-gel electrophoresis
Supplier: National Diagnostics, Manville, New Jersey, USA 
-Ecoscint A
Supplier: New England Nuclear, DuPont UK Ltd., Stevenage, Herts, England 
-35S-methionine
Supplier: Pharmacia Ltd., Milton Keynes, Bucks., England 
-dextran sulphate 
-50mM dNTPs 
-poly (dl-dC)
Supplier: Rathburn Chemicals Ltd., Walkerburn, Scotland 
-phenol (water-saturated)
Supplier: Sigma Chemical Co. Ltd., Poole, Dorset, England 
-ampicillin -MOPS
-bromophenol blue -phosphoserine
-BSA (fraction V) -phosphothreonine
-coomassie brilliant blue R -phosphotyrosine 
-dithiothreitol -polyvinylpyrrolidone
-ethidium bromide -salmon sperm DNA
-nitroblue tetrazolium -spermidine
-NP40 -TEMED
-methylene blue -triton X-100
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Supplier: Unipath Ltd., Basingstoke, Hants., England 
-PBS (Dulbecco A, tablet form)
IV.4 COLUMNS
Supplier: Pharmacia Ltd., Milton Keynes, Bucks., England 
-Nick columns
IV.5 ENZYMES & INHIBITORS
Supplier: Bethesda Research Laboratories, Gibco Ltd., Paisley, Scotland
All DNA modifying enzymes were obtained from BRL and supplied with the
appropiate buffer concentrates, with the following exceptions:-
Supplier: Boehringer Corporation (London) Lyd., Lewes, East Sussex, England 
-Klenow 
-Proteinase K 
-RNase T1
Supplier: Nothumbria Biologicals Ltd., Cramlington, Northumberland, England 
-AMV reverse transcriptase 
-RNase A
-T4 polynucleotide kinase
Supplier: Pharmacia Ltd., Milton Keynes, Bucks., England 
-Si nuclease 
-RNA Guard
Supplier: Sigma Chemical Co., Ltd., Poole, Dorset, England 
-aprotinin
-diethylpyrocarbonate (DEPC)
-leupeptin 
-lysozyme 
-pepstatin A
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IV.6 KITS
Supplier: Amersham International pic, Amersham, Bucks., England 
-ECL kit
Supplier: Bio 101 Inc., Stratatech Scientific, Luton, England 
-Geneclean kit
Supplier: Boehringer Mannheim UK, Lewes, East Sussex, England 
-DNA random priming labeling kit
Supplier: Perkin Elmer Cetus, Norwalk, CT 06859, USA 
-GeneAmp PCR reagent kit
Supplier: Pierce, Life Science Laboratories Ltd., Luton, England 
-MicroBCA protein assay kit
Supplier: United States Biochemical, Cleveland, Ohio, USA 
-Sequenase version 2.0 kit
Supplier: Vector Laboratories, Burlingame, California, USA 
-Vectastain ABC-AP kit
IV.7 MARKERS
Supplier: Amersham International pic., Amersham, Bucks., England 
-Prestained protein standards: Rainbow markers, 
range 14 300 - 200 OOODa
Supplier: Bethesda Laboratories Research, Gibco Ltd., Paisley, Scotland 
-<j)X174 RF DNA / Hae III fragments 
-X DNA /  Hind III Fragments 
-RNA ladder
Supplier: Sigma Chemical Co. Ltd., Poole, Dorset, England
-High molecular weight standard mixture (non pre-stained)
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-Standards for non-denaturing electrophoresis: BSA dimer (132kD), 
BSA monomer (66kD), chick egg albumin (45kD), carbonic 
anhydrase (29kD)
IV.8 MEMBRANES, PAPER, TLC PLATES & X-RAY FILM
Supplier: Amersham International pic, Amersham, Bucks., England 
-Hybond N+
Supplier: Eastman Kodak Co., Rochester, New York, USA 
-Duplicating film (DUP-1)
-X-ray film (XAR)
Supplier: Fuji Photo Film Co., Ltd., Japan 
-X-ray film (RX)
Supplier: Presentation Technology Ltd., Clydebank, Scotland
-AGFA Rapitone photographic paper (black & white)
Supplier: Phase Separations Ltd., Deeside, Clywd, Wales
-20x20cm cellulose TLC plates (w/o fluorescent indicator)
Supplier: Sartorius Ltd., Epsom, Surrey, England 
-dialysis bags 
-nitrocellulose membranes
Supplier: Whatman International Ltd., Maidstone, Kent, England 
-GF-C filters
-3MM chromatography paper
IY.9 WATER
Distilled water for buffers and all general solutions was purified through a
Millipore MilliRO 15 system. Water for protein or recombinant DNA procedures
which required further purifcation was obtained from a Millipore MilliQ system at
18MQ cm.
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CHAPTER V METHODS
V.l CELL CULTURE
V.1.1 Cell Maintenance
CMT cell lines were maintained in Dulbecco's modified Eagles medium (DMEM) 
(see below), supplemented with 10% new bom calf semm, in conditions of a 
humidified atmosphere with 10% (v/v) CO2 at 37°C. Cells were subcultured every 
4-5 days as follows:- growth medium was aspirated from the monolayer of cells, 
the cells were briefly rinsed with sterile phosphate buffered saline (PBS) then 
incubated with a minimum volume of 0.25% (v/v) trypsin in CT buffer (146mM 
sodium chloride, 14mM tri-sodium citrate, 14mM tricine, 0.5% (w/v) phenol red, 
pH 7.8) at 37°C for 3-5mins. Cells were detached with gentle agitation, 
resuspended in fresh growth medium and replated at the appropriate density.
lOx DMEM 50mls
200mM glutamine 5mis
lOOmM sodium pyruvate 5ms
7.5% sodium bicarbonate 22mls
sterile ch^O 418mls
pH 6.8 - 7.2 with sterile IN NaOH
V.1.2 Mycoplasma Testing Of Cell Lines
All cell lines used throughout this thesis were routinely checked for mycoplasma 
contamination. Conditioned medium was collected from cells which had been 
cultured for at least 2-3 days by centrifugation at 1300rpm for 8-10 mins. ~2mls of 
this conditioned medium was co-incubated with 2 x 10^ NRK49 fibroblasts in 
2mls fresh medium. NRK49 fibroblasts are known to be mycoplasma free, 
although a negative control was always set up in parallel: NRK49 cells without
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conditioned medium. After incubation at 37°C in a humidified atmosphere with 
5% (v/v) CC>2 for 3 days, cells were fixed by the addition of fixative (1 volume 
glacial acetic acid : 3 volumes methanol) for 5mins. This was followed with a 
further two incubations with fresh fixative for 5mins and the cells allowed to air - 
dry. Hoechst 33258 is a fluorescent stain which detects DNA and was prepared 
from a 1 mg/ml stock by diluting 1:20 000 in PBS. This solution was added to the 
fixed cells and incubated at room temperature for lOmins. After staining, excess 
stain was removed and cells washed 2x with dP^O, then viewed by fluorescent 
microscopy using a water immersion lens. Mycoplasma contamination was 
detected as fluorescence in the cytoplasm of NRK49 cells.
V.1.3 Treatment o f Culture Surfaces
In some experiments, tissue culture plastics were coated with either fibronectin or 
collagen. Lyophilized fibronectin was resuspended at 30pg/ml with sterile distilled 
water (dP^O). Under sterile conditions, fibronectin solution was added to the 
flasks / dishes in a volume sufficient to cover the surface area and incubated at 
room temperature for 2 hours. Excess solution was then aspirated off and the flasks 
/ dishes rinsed with sterile PBS.
Concentrated rat tail type 1 collagen was diluted with 0.02M NaOH to 100pg/ml. 
As above, the collagen solution was incubated on the required plastics, except 
incubation was for 20mins at room temperature before excess solution was 
removed. The plastics were then rinsed with sterile PBS.
Stock solutions were stored at 4°C ; flasks / dishes were either air - dried and 
stored at 4°C until required, or used immediately for the culture of cells.
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V.1.4 Cell Storage
Cells were frequently stored in order to maintain stocks of cells at early passage. 
Trypsinised cells were resuspended as a single cell suspension in storage medium 
(DMEM supplemented with 10% (v/v) dimethylsulphoxide [DMSO]) at -5x10^ - 
10? cells / ml. Cell suspensions were aliquoted into 1ml Nunc cryotubes and 
allowed to slowly cool to -70°C overnight in a well-insulated container before 
transferring to storage in liquid nitrogen.
V. 1.5 Soft Agar Assays
Soft agar assays were performed to assess anchorage-independent cell growth. In a 
200ml Duran bottle, lg of Difco bacto-agar in 40mls sterile d l^O  was melted 
using a microwave oven and cooled to 44°C. Added to this was 40mls of 2x 
DMEM (see below), 20mls newborn calf serum and lOOmls lxDMEM. This 0.5% 
(w/v) agar solution was maintained at 44°C for pouring, -5mls / 60mm dish, and 
these base plates allowed to set at room temperature or 4°C. 0.5mls of CMT cells 
or control cells, at a concentration of 2x10^ cells / ml in normal growth medium, 
were mixed with 1ml of cooled (-37°C) base agar in a sterile plastic universal, 
resulting in a 0.3% soft agar / cell mix. Each base plate was carefully overlaid with 
this mix and allowed to set at room temperature. Plates were subsequently 
incubated at 37°C, in a 10% (v/v) CO2 humidified incubator. Each assay was 
typically performed in at least triplicate and colony formation was assessed 
following 2 weeks incubation.
2x DMEM: lOx DMEM 20mls
200mM glutamine 2mls
lOOmM Na pyruvate 2mls
7.5% sodium bicarbonate lOmls 
1M HEPES 4mls
sterile d t^O  58mls
66
V.1.6 MTT Assay
The MTT assay is a rapid colorimetric assay for cell growth and the estimation of 
viable cell numbers. Its advantages over other biological assays include a time 
saving factor, allowing for numerous samples to be assayed simultaneously and the 
eliminated use of radioactive material. Enzymatic cleavage of the tetrazolium ring 
present in the compound MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl 
tetrazolium bromide; also named thiazol blue), by mitochondrial dehydrogenases 
produces a formazan precipitate around the mitochondria of respiring cells. This 
blue crystallized salt can be dissolved with DMSO and the resulting colour 
measured; the degree of absorbance at wavelength 595nm relates to viable cell 
number.
Cells were seeded in flat-bottomed 96-well tissue culture plates at the appropriate 
concentration in a volume of lOOpl per well. Replica plates were set up for each 
time point. Plates were incubated in a humidified atmosphere with 10% (v/v) CC>2 
at 37°C. At each time point, lOpl of MTT (5mg/ml in PBS) was added to each 
well and incubation of the cells continued for a further 4 hours. The excess 
medium was carefully pipetted out, leaving the adherent cells and precipitate in the 
wells. lOOpl of DMSO was then added per well, dissolving the precipitate and the 
plates read in a 96-well plate scanner at 595nm.
Absorbance values were converted to equivalent viable cell numbers using a 
standard curve of known cell numbers plotted against their absorbance values as 
measured by the MTT assay.
V.2 SPONTANEOUS METASTASIS ASSAY
A  single cell suspension of 5x10^ cells in O.lmls DMEM was injected 
subcutaneously (s.c.) into the right flank of mice, without anaesthesia. Tumour
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growth was monitored regularly and once growth was of palpable size, 
measurements were taken of both the largest diameter and smallest diameter of the 
primary tumour. These measurements were computed in the equation:-
V = jt.D.d2/6, where V = volume (mm^); jt = 3.14; D = largest diameter;
d = smallest diameter (Ferguson, Carmichael & Smith, 1986).
Animals were sacrificed at 3-5 weeks, or when tumour diameter reached 2cm or if 
animals became moribund.
In order to examine for metastatic spread, animals were killed in a euthanasia 
chamber. Using standard dissection techniques, internal organs were examined for 
lesions, these organs were dissected out, preserved in Fekete's solution (lOOmls 
70% ethanol, lOmls 38% formaldehyde solution, 5mls glacial acetic acid) for later 
histological examination. To quantify metastatic deposits in the lung, the thoracic 
cavity was opened and the trachea exposed. Ligatures were placed around the 
trachea both proximal and distal, an incision made between ligatures and a blunt 
ended hypodermic needle inserted which was then secured by the proximal 
ligature. The lungs were subsequently inflated with ~1.5mls Indian ink solution 
(15% (v/v) Indian ink, 0.5% (v/v) ammonia solution), the distal ligature tied, 
needle withdrawn and proximal ligature tied. The lungs were then dissected out, 
rinsed briefly in dK^O, Fekete's solution and then stored in Fekete's solution. 
Lungs were stored for a minimum of 24 hours for bleaching and fixation before the 
lobes of the lungs were dissected under 70% ethanol, and metastatic deposits 
counted using a microscope. The metastatic deposits on the surface of the lung are 
visualised as white lesions against a black background of normal lung tissue.
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V.3 DNA METHODOLOGIES
V.3.1 Genomic DNA Extraction & Purification
Cells were rinsed with sterile PBS before lysing in lOmls lysis buffer / 10^ cells 
(lysis buffer:- lOmM NaCl, lOmM EDTA, lOmM tris-HCl, pH8.0) containing 4% 
(v/v) sarcosine and lOOpg/ml proteinase K. This viscous solution was incubated 
overnight at 37°C, tumbling gently in 50ml Falcon tubes. One volume of TE- 
(lOmM tris, ImM EDTA, pH8.0) equilibrated phenol / chloroform was added to 
extract proteins and tumbled gently for 10-30mins. Centrifugation was carried out 
at 1500rpm for 30mins at room temperature. The aqueous phase was transferred to 
a fresh tube using wide bore pipettes and precipitated with one tenth volume 3M 
sodium acetate and 2.5 volumes ethanol. High molecular weight nucleic acids were 
spooled out using a hooked pasteur pipette (fashioned using a Bunsen flame), 
sequentially dehydrated in 70% ethanol, 95% ethanol and chloroform, then 
resuspended in O.lx SSC (20x SSC:- 0.3M sodium chloride, 0.03M tri-sodium 
citrate, pH 7.0) at twice the original volume of lysis. The suspension was further 
incubated with 50pg/ml heat-treated RNase A, lpg/ml RNase T1 for 3 hours at 
37°C, tumbling gently, followed by another 3 hour incubation at 37°C with one 
tenth volume 0.1M EDTA, 4% (v/v) sarcosine and 50|ig/ml proteinase K. Phenol / 
chloroform extraction was repeated twice as before, followed with precipitation 
and spooling out of high molecular weight DNA. The dehydrated DNA was 
resuspended in TE buffer to a concentration of 0.1 - 0.5mg/ml.
V.3.2 Spectrophotometric Quantitation Of DNA
The concentration of aqueous solutions of DNA was measured 
spectrophotometrically. Absorbance readings at 260nm and 280nm were taken of 
samples diluted in TE buffer using a quartz curvette with a 1cm pathlength. The 
spectrophotometer was calibrated with a TE blank. An absorbance value of 1 at
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260nm was taken to be equivalent to 50pg/ml and an A250 I ^280 rat*° °f 1*8 
indicative of an essentially pure preparation of DNA.
V.3.3 Restriction Enzyme Digestion Of DNA
Restriction enzyme digestion of —lpig plasmid DNA was typically carried out in a 
total volume of 10pl using 1-10 units of the appropriate enzyme with the 
manufacturer's supplied reaction buffer at 37°C for 1-2 hours. Digestion of 
genomic DNA (usually 50pg in reaction volume of 500pl), was essentially the 
same, except 3mM spermidine was added to the reaction and incubation was 
overnight. For digestion with more than one enzyme, manufacturer's information 
was consulted for choice of optimal reaction buffer. Reactions were ceased with 
one tenth volume 0.1M EDTA (pH 7.0). Genomic DNA digests were purified by 
phenol / chloroform extraction, followed with chloroform washes and concentrated 
by ethanol precipitation. Plasmid digests did not undergo purification and 
precipitation but were instead directly electrophoresed with the addition of lx 
loading buffer (lOx loading buffer: 50% (v/v) glycerol, 0.4% (w/v) bromophenol 
blue in TE buffer).
V.3.4 Agarose Gel Electrophoresis
DNA fragments were resolved according to apparent molecular weights on agarose 
gels. The percentage of agarose varied according to the size(s) of DNA of interest; 
generally, 1% (w/v) agarose dissolved in lx TAE buffer (40mM tris acetate, 
20mM sodium acetate, 2mM EDTA, pH 7.4) or lx TBE buffer (90mM tris-base, 
90mM boric acid, 2mM EDTA, pH 8.0) was used in preparation of Southern 
blotting procedures. For purification of DNA fragments, 1.5 - 2% (w/v) agarose 
gels were generally utilized. Once the agarose was dissolved in buffer by 
microwaving, the solution was allowed to cool to -45 - 50°C before the addition 
of ethidium bromide at final concentration of 0.5 pg/ml. Gels were cast in the
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appropriate gel former with appropriate well former and allowed to set at room 
temperature. Samples for electrophoresis were mixed with sample loading buffer, 
to a final concentration of lx (lOx loading buffer: 50% (v/v) glycerol, 0.4% (w/v) 
bromophenol blue in TE buffer), loaded into sample wells and electrophoresed in 
either lx TAE or lx  TBE buffer as appropriate. Molecular weight markers were 
run in parallel, usually Hind III digested bacteriophage X DNA and Hae III 
digested <j>X174. After electrophoresis, resolved DNA was visualised by UV 
transillumination and a permanent record kept as either a Polaroid photograph or 
photoimage.
V.3.5 Southern Transfer & Hybridization
Following electrophoresis of 15-20pg digested genomic DNA, as outlined above 
(II.3.4), the gel was washed for 2x 20mins in 1.5M sodium chloride, 0.5M sodium 
hydroxide at room temperature with slow shaking in order to denature the DNA. 
The gel then neutralized with washes in 1M ammonium acetate, 0.02M sodium 
hydroxide for 2x 30mins, at room temperature with slow shaking. Transfer to 
Hybond N+ was by capillary action and proceeded for a minimum of 16 hours 
using 1M ammonium acetate, 0.02M sodium hydroxide as transfer buffer. After 
transfer, the Hybond N+ membrane was briefly rinsed with 2x SSC (20x SSC: 3M 
sodium chloride, 0.3M sodium tri-citrate, pH 7.0), air dried, then UV crosslinked 
to fix the DNA to the membrane.
For hybridization, the membrane was pre-hybridized for a minimum of 4 hours 
with continuous shaking, at 42°C in formamide hybridization buffer (50% (v/v) 
formamide, 4x SSPE [20x SSPE: 3.6M sodium chloride, 0.2M sodium phosphate, 
0.02M EDTA, pH 8.3], 0.5% (w/v) Marvel, 10% (w/v) dextran sulphate, 1% (w/v) 
SDS) supplemented with 500pg/ml sonicated salmon sperm ssDNA, boiled just 
prior to use. After pre-hybridization, radioisotopically labelled probe was heated to
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100°C and chilled on ice for 5mins before addition to the hybridization buffer. The 
membrane was subsequently hybridized for a minimum of 16 hours at 42°C with 
continuous shaking. Following hybridization, the membrane was washed under 
increasingly high stringency conditions with the following washes:-
2x 15mins at room temperature with 2x SSC, 0.1% (w/v) SDS
2x 30mins at 65°C with 0.5x SSC, 0.1% (w/v) SDS
lx 30-45mins at 65°C with O.lx SSC, 0.1% (w/v) SDS.
The membrane was then exposed to X-ray film at -70°C for the appropriate times. 
V.3.6 Plasmid DNA Minipreparations
Single bacterial colonies were picked from agar plates and grown overnight in 
5mls L-broth supplemented with the appropriate antibiotic. 1.5mls of the overnight 
culture was pelleted in a benchtop microfuge at 14K for lOsecs. The supernatant 
was discarded and the pellet resuspended in lOOpl GTE (50mM glucose, 25mM 
tris-HCL, lOmM EDTA, pH 8.0) containing 4mg/ml lysozyme with vortexing and 
incubating at room temperature for 5mins. For alkaline lysis, 200pl of 0.2M 
sodium hydroxide, 1% (w/v) SDS was added, mixed gently and chilled on ice for 
5mins. 150pl of 5M potassium acetate was added to precipitate proteins and 
detergent, mixed by inversion and chilled on ice for a further 5mins. 
Centrifugation was carried out for 5mins at 14K and 380pl of supernatant removed 
and further purified by phenol / chloroform extraction using equal volumes. The 
aqueous phase containing nucleic acids was then precipitated with 0.6 volumes 
iso-propanol, incubated at room temperature for 2mins, pelleted by centrifugation 
for 15mins at room temperature and the pellet allowed to air-dry. This pellet was 
finally resuspended in 50pl TE buffer and treated with lpg heat-treated RNase A.
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V.3.7 Large Scale Plasmid DNA Preparations
Large overnight cultures (500-1000mls) were extracted on the same principle as 
the method for small scale preparations (see II.3.6), but with some modifications. 
Cultures were pelleted in 500ml polypropylene bottles by centrifugation in a 
Sorvall GS3 rotor at 5K for lOmins at 4°C. The pellet was resuspended in 20mls 
GTE plus 5mg/ml lysozyme by pipetting and vortexing, then allowed to stand on 
ice for 30mins. 40mls of pre-chilled 0.2M sodium hydroxide, 1% (w/v) SDS was 
added, mixed gently by inversion and incubated on ice for 5mins. Precipitation of 
proteins and detergent was facilitated by the addition of 30mls 5M potassium 
acetate and incubation on ice for a further 15mins. Cellular debris and precipitate 
were pelleted by centrifugation at 8K for lOmins at 4°C. The supernatant was then 
filtered through a double layer of gauze and precipitated with 0.6 volumes of iso- 
propanol at room temperature for 15mins. Precipitate was collected by 
centrifugation for lOmins at 8K, 4°C, the pellet drained thoroughly before 
resuspension in 8.5mls TE buffer. Precisely 8mls of this crude plasmid DNA 
preparation was then added to 8g of caesium chloride in a plastic universal, 
transferred to a screw cap polycarbonate ultracentrifuge tube and balanced to 
within 0.05g of other tubes with paraffin oil. 0.5mls of lOmg/ml ethidium bromide 
was finally added and centrifugation carried out in a Sorvall T1270 rotor at 40K 
for 40-48 hours at 20°C. Plasmid DNA was carefully removed from the caesium 
chloride gradient and repeatedly extracted with caesium chloride-saturated iso- 
propanol to remove ethidium bromide before dialysis against TE buffer which was 
continued for 24 hours at 4°C, with 3-4 changes of buffer. Dialysed plasmid DNA 
was subsequently ethanol precipitated and resuspended in 1ml TE buffer. DNA 
concentration was estimated spectrophotometrically as described in V.3.2.
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V.3.8 Purification Of DNA Fragments From Agarose Gels
DNA fragments were recovered from agarose by the methods of "Genecleaning" 
or centrifugation. The procedure of "Genecleaning" was according to the 
manufacturer's instructions. The method of centrifugation involved the excision of 
the appropriate band from the gel with the aid of UV illumination. This gel slice 
was then cut into smaller fragments and placed on top of a glass wool plug 
contained in a 0.5ml eppendorf tube. This 0.5ml tube was previously pierced at the 
base using a syringe. The plugged tube with the gel slice was then placed in a 
1.5ml eppendorf tube and centrifuged for 5-10mins at 5K, room temperature in a 
benchtop microfuge. This resulted in the DNA being eluted from the agarose in the 
gel buffer and collected in the 1.5ml eppendorf. The agarose remained in the glass 
wool plug. The DNA was further purified by phenol / chloroform extraction and 
ethanol precipitated when necessary.
V.3.9 Preparation & Quantitation Of Oligonucleotides
Oligonucleotides were synthesized on an Applied Biosystems model 381A DNA 
synthesizer. 5' trityl groups were removed on the synthesizer before the 
oligonucleotide was eluted from the column in concentrated (29%) ammonia 
solution for 1.5 hours at room temperature. Oligonucleotides were deprotected by 
incubation of the oligonucleotides in ammonia contained in a sealed glass vial 
overnight at 55°C. This was followed by ethanol precipitation with extensive 
washing of the pellet with 70% ethanol to remove salt. Oligonucleotides were 
resuspended in TE buffer and quantified spectrophotometrically. An A250 value of 
1 was taken to equal 33pg/ml of oligonucleotide. A ratio of A2601 ^280 was 
when sufficiently purified.
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V.3.10 Chain-Termination Sequencing
Single strand sequencing was carried out using a commercially available kit 
"Sequenase version 2.0" marketed by United States Biochemical Corporation. This 
kit contains a genetic variant of bacteriophage T7 DNA polymerase which has had 
its 3'-5' exonuclease activity removed by genetic manipulation. The protocol 
followed was as manufacturer's instructions using the universal primer supplied 
(-40) which was suitable for sequencing the pUC19-based vector containing the 
insert of interest.
V.4 RNA METHODOLOGIES
V.4.1 RNA Extraction, Purification & Quantitation
In preparations of RNA and handling of RNA, some precautionary steps were 
taken in order to avoid degradation by contaminating RNases. All manipulations 
were carried out wearing gloves, tubes and solutions were pre - cooled on ice and 
centrifugations carried out at 4°C. All tubes were also pre - treated with 
diethylpyrocarbonate (DEPC), an irreversible inhibitor of RNases. The tubes were 
immersed in a solution of 0.1% (v/v) DEPC for a minimum of 2 hours in a fume 
hood, the solution decanted off and the tubes autoclaved followed by drying in an 
oven at 80°C. These tubes were subsequently stored in sealed DEPC - treated 
containers. Distilled water was also DEPC - treated: a 0.1% (v/v) solution was 
prepared, incubated overnight and autoclaved.
RNA extraction using RNAzol™B and purification was carried out according to 
the manufacturer's instructions. Quantitation was determined 
spectrophotometrically essentially as for DNA (see V.3.2), except calibration 
blank was DEPC treated dE^O, A250 value of 1 was taken to be equivalent to 
40pg/ml RNA and A260 / 280 rat °^ ^-0 represented essentially pure RNA.
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V.4.2 RNA Electrophoresis
RNA samples, typically 15-20pg for Northern analysis, were freeze-dried and 
resuspended in 3pl DEPC-treated dH20. Freshly prepared sample buffer (0.70mls 
formamide, 0.15mls lOx MOPS buffer [lOx MOPS buffer: 200mM MOPS, 50mM 
sodium acetate, lOmM EDTA, pH7.0], 0.24mls formaldehyde, 0.1 mis DEPC- 
treated dH20, 0.1 mis glycerol, 0.05% (w/v) bromophenol blue), was added to the 
resuspended RNAs at 5x sample volume. RNA samples were denatured at 65°C 
for 15mins, chilled on ice for lOmins, followed with a brief microfuge and the 
addition of lpl of 1 mg/ml ethidium bromide. Electrophoresis was performed in a 
formaldehyde gel, typically of 1 - 1.5% (w/v) agarose concentration (1 - 1.5g 
agarose, lOmls lOx MOPS buffer, 87mls DEPC-treated dt^O , heated in a 
microwave oven, cooled to ~50-55°C before the addition of 5.1mls formaldehyde). 
Electrophoresis running buffer was lx MOPS buffer with recirculation using a 
peristaltic pump.
V.4.3 Northern Transfer & Hybridization
Following electrophoresis, Northern gels were washed 2x 30mins with d l^O  
before capillary action transfer to Hybond N+. Transfer buffer was 20x SSC, and 
transfer was allowed to proceed for a minimum of 16 hours. After transfer, the 
membrane was UV crosslinked then briefly rinsed with 2x SSC before pre- 
hybridization. Molecular weight markers were run in parallel, usually 
commercially available RNA ladders.
Hybridization buffer (5x SSPE [20x SSPE: 3.6M sodium chloride, 0.2M sodium 
phosphate, 0.02M EDTA, pH8.3], 5x Denhardts [50x Denhardts: 1% (w/v) ficoll, 
1% (w/v) polyvinylpyrrolidone, 1% (w/v) bovine serum albumin (BSA)], 50% 
(v/v) formamide, 0.5% (w/v) SDS), was supplemented with 250pg/ml sonicated 
salmon sperm ssDNA, boiled just prior to addition, and incubated with the
76
membrane at 42°C for a minimum of 4 hours. Following pre-hybridization, 
radioisotopically labelled probe was heated to 100°C for lOmins then chilled on 
ice for 5 mins before addition to the hybridization buffer. The membrane was 
subsequently hybridized for a minimum of 16 hours at 42°C with continuous 
shaking. After hybridization, the membrane was washed under increasingly 
stringent conditions with the following washes: -
2x 20mins at room temperature with 2x SSC, 0.1% (w/v) SDS
lx 30-45mins at 65°C with O.lx SSC, 0.1% (w/v) SDS
The membrane was then exposed to X-ray film at -70°C for the required times.
V.4.4 cDNA Synthesis & Polymerase Chain Reaction (RT-PCR)
cDNA synthesis was carried out as follows: lO i^g of RNA was freeze-dried and 
resuspended in 20pl of annealing buffer (400mM potassium chloride, lOmM 
PIPES, 0.25 units/pl RNA GuardR [an RNase inhibitor], pH 6.4). lOOng of the 
appropriate 3' primer was added, then incubated at 85°C for 5mins, followed with 
immediate incubation at 65°C for a further 15mins. The annealed product was then 
diluted in 200pl of extension buffer (50mM tris-HCL, lOmM dithiothreitol [DTT], 
6mM magnesium chloride, 0.5mM dNTPs, 0.25 units/pl RNA GuardR, pH 8.2) and 
divided into two aliquots: one aliquot for reverse transcription, the other a control 
without reverse transcription. For reverse transcription, 10 units of avian 
myeloblastosis virus (AMV) reverse transcriptase was added, both aliquots were 
then incubated at 42°C for 1 hour. Products and control were ethanol precipitated 
and resuspended in lOpl TE buffer. These were then ready for PCR.
Polymerase chain reaction (PCR) utilized the kit, GeneAmp PCR reagent kit, 
supplied by Perkin Elmer Cetus. The protocol followed the manufacturer's 
instructions using the appropriate 5' and 3' primers. For most reactions, PCR cycle
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conditions were 25 cycles of:- denaturation at 94°C for lmin, annealing at 55°C 
for lmin, extension at 72°C for 3mins, followed by a final extension incubation at 
72°C for lOmins then maintained at 4°C until analysis. When necessary, annealing 
temperatures were modified to optimise the PCR reaction, taking into account the 
Tm of oligonucleotide primers. Analysis of PCR products by agarose gel 
electrophoresis was as previously described (II.3.4). Confirmation of the products 
to be those which the primers were designed to amplify was established by 
Southern blotting techniques (II.3.5) and probing with another specific internal 
oligonucleotide (different to the oligonucleotides previously used as 3' or 5' 
primers).
V.5 RADIOISOTOPIC LABELLING METHODS 
V.5.1 Random Priming
Random priming of probes for Northern and Southern analysis used the 
commercially available kit marketed by Boehringer Mannheim. The protocol 
followed was according to the manufacturer's instructions, incorporating the 
radioisotope [a-^P ] dCTP. Probes were separated from unincorporated 
radioisotope using Pharmacia Nick columns. An aliquot of probe was counted on a 
liquid scintillation counter to estimate specific activity and the probe heated to 
100°C for lOmins and chilled on ice for 5mins before incubation with pre­
hybridized membranes.
V.5.2 Replacement Synthesis
This method of labelling was employed for the technique of in-gel renaturation 
(see V.7.1). The properties of bacteriophage T4 DNA polymerase allowed for the 
retention of the original size of the DNA fragment, which is one criteria of 
absolute requirement for the success of in-gel renaturation. Limited 3' exonuclease
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digestion of -100 nucleotides of DNA fragments was achieved by the addition of 
0.5pg of restriction digested DNA to 2pl of 5x react buffer (165mM tris-acetate 
[pH 7.9], 330mM sodium acetate, 50mM magnesium acetate, 2.5mM DTT, 0.5mM 
BSA), in a total volume of 9pl. 0.625 units of T4 DNA polymerase was added to 
the reaction, mixed and briefly microfuged, then incubated at 37°C for exactly 
5mins. Immediately after incubation, reaction tubes were chilled on ice and 1 pi of 
dNTPs (dATP, dTTP, dGTP, each at 2mM) and 30pCi [a-32P] dCTP were added, 
mixed and briefly microfuged, then incubated at 37°C for 60mins. Following this 
resynthesis reaction, lpl of cold 0.2mM dCTP was added in order to ensure 
complete resynthesis, incubation continued at 37°C for 20mins. Reactions were 
terminated by incubation at 70°C for 5mins. Separation of unincorporated 
radioisotope from labelled DNA was achieved with Nick columns and specific 
activity was estimated by counting an aliquot in a liquid scintillation counter.
V.5.3 Klenow Labelling Of Double - Stranded Blunt Ends
This method of labelling replaced the 3' hydroxyl group with [a-32F] dNTP. The 
DNA to be labelled was diluted to 17.5pl in TE buffer; 2.5pl of lOx reaction buffer 
(any common restriction enzyme buffer sufficed ), 50pCi [ a 32?] dCTP and 1 unit 
of Klenow enzyme were added to the reaction mixture and incubated at room 
temperature for 15mins. This was followed with lpl of dNTP mix (dGTP, dCTP, 
dATP, dTTP; each of 2mM concentration) to fill in nicked ends; incubation at 
room temperature for 5mins. The reaction was terminated by heating to 70°C for 
5mins. DNA was separated form unincorporated nucleotides by ethanol 
precipitation with one tenth volume 3M sodium acetate and 2.5 volumes ethanol. 
Centrifugation was carried out in a bench top microfuge for 45mins at 14K, the 
pellet washed with 70% ethanol, and air-dried before resuspension in TE buffer 
and an aliquot read in a scintillation counter.
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V.5.4 End Labelling Of Oligonucleotides
In a reaction volume of 50pl, 300ng of oligonucleotide, lx T4 polynucleotide 
kinase buffer, (final concentration) (lOx T4 PNK buffer: 0.5M tris-HCL [pH 7.6], 
0.1M magnesium chloride, 50mM dithiothreitol [DTT], ImM spermidine, ImM 
EDTA), 50pCi [y-^P] ATP and 20 units of T4 polynucleotide kinase enzyme 
were mixed. Incubation was carried out at 37°C for 1 hour. The reaction was 
terminated with 2.5pl of 0.25M EDTA. Unincorporated nucleotides were removed 
from the oligonucleotide by ethanol precipitation as detailed above (II.5.3), and 
32p incorporation estimated using the scintillation counter.
V.6 PROTEIN METHODOLOGIES
V.6.1 Whole Cell Protein Extraction
Unless otherwise stated, whole cell protein extraction was carried out as follows:- 
Cells were grown to sub-confluence or to just confluence, in 10cm tissue culture 
dishes, using pre-chilled sterile PBS, cells were rinsed twice and the excess PBS 
aspirated off. Plates were immediately transferred onto ice and 0.5mls of 
SDS-PAGE sample buffer pipetted onto each plate (lx sample buffer: 20% (v/v) 
glycerol, 2% (w/v) SDS, lOOmM tris pH6.8); and added fresh, 5% (v/v) (3- 
mercaptoethanol). Cells were scraped using a disposable cell scraper and lysed 
cells transferred to pre-chilled screw cap eppendorf tubes. Samples were boiled for 
5mins, chilled on ice and followed with sonication in order to shear high molecular 
weight DNA. After centrifugation at 14K for 2mins at 4°C, supernatants were 
transferred in aliquots to fresh eppendorf tubes and stored at -70°C until required.
V.6.2 Nuclear Protein Extraction
This procedure was essentially carried out as described by Andrews & Faller, 
1991, utilizing hypotonic lysis of cells followed by a high salt extraction of the
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nuclei. Adherent cells (~106 - 107) were washed once with cold PBS before the 
cells were scraped off with 1.5mls cold PBS and transferred to a pre-chilled 
screw-cap eppendorf tube. Cells were pelleted in a benchtop microfuge for 10s at 
14K and resuspended in 400(0.1 buffer A (lOmM HEPES-KOH, pH7.9 at 4°C, 
1.5mM magnesium chloride, lOmM potassium chloride and added fresh: 0.5mM 
dithiothreitol [DTT], 0.2mM phenylmethylsulphonyl fluoride [PMSF], l|iM 
leupeptin, 0.3(iM aprotinin, l(iM pepstatin A). Cells were allowed to swell on ice 
for lOmins then vortexed for 10s. Samples were then centrifuged for 10s at 14K 
and the supernatant discarded. The residual pellet was resuspended in lOOjol 
pre-chilled buffer B (20mM HEPES-KOH, pH7.9, 25% glycerol, 420mM sodium 
chloride, 1.5mM magnesium chloride, 0.2mM EDTA and added fresh: 0.5mM 
DTT, 0.2mM PMSF, l|iM  leupeptin, 0.3p.M aprotinin, lpM pepstatin A) with 
gentle flicking of the tube and incubated in ice for 20mins for high salt extraction. 
Cellular debris was removed by centrifugation for 2mins at 14K at 4°C. The 
supernatant containing crude nuclear protein extract was aliquoted and stored at 
-70°C until required.
V.6.3 Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis (SDS-PAGE)
Proteins were resolved on SDS-polyacrylamide gels by electrophoresis according 
to their apparent molecular weights. Resolving gels were typically between 7 - 
10% with respect to the aciylamide concentration (30% stock acrylamide solution : 
29.6% [w/v] acrylamide, 0.4% [w/v] to-acrylamide) and stacking gels ranged 
between 4 - 5 %  acrylamide. Acrylamide solutions of the required concentration 
were mixed with the appropriate gel buffer to a final concentration of lx with 
dH20.
4x resolving gel bujfer: 1.5M tris (pH 8.9), 0.4% (w/v) SDS
4x stacking gel buffer: 0.5M tris (pH 6.7), 0.4% (w/v) SDS
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Prior to pouring of either resolving or stacking gels, lOOpl of a 10% (w/v) 
ammonium persulphate solution and 1 Opil of TEMED were added per lOmls of 
resolving or stacking gel solution, briefly mixed by gentle swirling then poured 
between clamped vertical plates. For most SDS-PAGE procedures in this thesis, 
ATTO mini-gel apparatus was used which utilized plates giving gels of ~0.5mm 
thickness.
Resolving gels were overlaid with l-2mls of butan-2-ol and allowed to polymerize 
at room temperature for 20 - 45 mins. Once polymerized, excess butan-2-ol was 
removed with 3MM Whatman filter paper and the appropriate comb inserted. The 
stacking gel was subsequently poured and allowed to polymerize for 15 - 20 mins. 
After polymerization, clamps and the sealing gasket were removed and the plates 
assembled in the gel tank. Both reservoirs were filled with lx SDS-PAGE running 
buffer (lOx SDS-PAGE running buffer: 522mM tris, 4% (w/v) glycine, 1% (w/v) 
SDS), the bubbles removed from the base of gels and the comb carefully removed. 
Using a needle and syringe, unpolymerized acrylamide was rinsed from the wells 
with running buffer before the samples were loaded.
Samples were denatured prior to loading by heating to ~100°C for 3-5mins in 
sample buffer with |3-mercaptoethanol and -0.1% (w/v) bromophenol blue. Equal 
amounts of sample protein were added to each lane as calculated using a protein 
determination kit marketed by Pierce and as confirmed by visualization of a 
Coomassie brilliant blue stained back gel when gels were electrophoresed in 
duplicate.
Following electrophoresis, the front gel was used for Western transfer (see below, 
V.6.4) and the duplicate back gel was stained with Coomassie brilliant blue stain 
as follows: the gel was carefully removed from the plates and incubated at room 
temperature in staining solution (0.1% (w/v) coomassie brilliant blue in 45: 45: 10
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(v/v) methanol: dl^O: acetic acid) for 45-60mins with gentle shaking. 
Subsequently, the gel was destained in 45: 45: 10 (v/v) methanol: dt^O : acetic 
acid with several changes of destain. Alternatively, gels were stained overnight in 
a weaker solution of 0.5% (v/v) coomassie brilliant blue in 45: 45: 10 (v/v) 
methanol: dF^O: acetic acid, and destained the following day as above.
V.6.4 Western Transfer & Blotting
Protein extracts were resolved together with the appropriate molecular weight 
standards on SDS polyacrylamide gels. Western transfer to nitrocellulose 
membranes was carried out using one of two methods: semi-dry transfer (~1 hour) 
or wet transfer (overnight).
Semi-dry transfer was carried using a Sartorius semi-dry blotting apparatus 
according to the manufacturer's instructions. Twelve pieces of Whatman 3MM 
paper and a single piece of nitrocellulose were cut to the size of the gel and 
equilibrated in lx transfer buffer (lOx transfer buffer: 600mM tris, 500mM 
glycine, 16mM SDS) with 20% (v/v) methanol. The gel was rinsed in lx transfer 
buffer and placed upon six pieces of pre-soaked Whatman 3MM, laid on top was 
the nitrocellulose and finally the remaining six pieces of 3MM. Air bubbles were 
carefully removed and transfer effected towards the anode at full power for 30- 
40mins. Transfer could be monitored if pre-stained markers were used; once the 
markers were transferred completely, the nitrocellulose could be either used 
immediately for blotting or alternatively, air-dried and stored at 4°C until required.
Wet transfer was usually undertaken as transfer quality was consistently higher 
than semi-dry transfer. Bio-Rad transfer apparatus was used in this procedure. Four 
pieces of Whatman 3MM paper and one piece of nitrocellulose were cut to the size 
of the gel and equilibrated in Towbin (12.1 lg tris, 57.6g glycine, 800mls methanol, 
1.2mls conc. HC1; volume made to 41). The gel was rinsed in Towbin briefly and
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placed upon two pieces of pre-soaked 3MM. Pre-soaked nitrocellulose was placed 
on top of the gel and then the remaining two pieces of pre-soaked 3MM. Air 
bubbles were removed carefully and this whole "sandwich" placed between the 
supplied sponges and sandwich plate of the wet transfer apparatus. This was then 
inserted into the tank filled with Towbin and transfer effected towards the anode 
overnight at 30 volts at 4°C. Following transfer, the nitrocellulose was either 
blotted immediately or air-dried and stored at 4°C until required.
Efficiency of transfer was checked and location of non - pre-stained markers was 
determined by staining the nitrocellulose with lx Ponceau S stain (lOx: 2g 
Ponceau S, 30g trichloroacetic acid, 30g sulphosalicyclic acid, made to lOOmls 
with dF^O). 5 - lOmls of lx stain was added to the nitrocellulose for ~3 - 5mins 
before rinsing with d t^O  until the protein bands became visible. Marker sizes 
were marked with a ballpoint pen and blotting continued as protocol. Ponceau S 
staining is temporary and is washed off during blotting washes.
Blotting of nitrocellulose membranes followed a standard protocol using the 
appropriate antibodies. First stage was blocking of the membrane for 1 hour in 
blotto (5% (w/v) non-fat milk powder [Marvel], 0.05% (v/v) Tween 20 in PBS) at 
4°C with continuous shaking. Primary antibodies were diluted in blotto at optimal 
concentrations as recommended by the suppliers (ECCD-2 — 1:100, PCD-1 — 
1:50, D. Prowse, personal communication) and incubated with the membrane for 4 
hours at 4°C with continuous shaking. The membrane was subsequently washed 
lx 15mins and 2x 5mins with blotto at room temperature, before incubation with 
the appropriate secondary horseradish peroxidase (HRP) conjugated antibody 
diluted in blotto at 1:2000. Incubation continued at 4°C for 1 hour, again with 
continuous shaking. The membrane was finally washed extensively with at least 
two rinses and washes of lx 15mins and 4x 5mins in PBS / 0.05% Tween 20. 
Detection used the enhanced chemiluminescence (ECL) kit as marketed by
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Amersham International pic. Equal volumes of solution A and solution B were 
mixed and incubated on the membrane for -1 min before briefly drying the 
membrane, covering with SaranWrap™ and exposing to X-ray film for 30s - 
15mins.
V.6.5 SDSSubstrate Gel Analysis Of Proteinoses - Zymography
The production of secreted proteinases by cells can be analysed by the method of 
zymography. Non-denaturing SDS-polyacrylamide gels are impregnated with 
substrate (such as gelatin or casein) and samples which may contain active 
enzymes are subjected to electrophoresis. After incubation to allow for enzymatic 
activity, the gel is stained and enzymatic activity is visualized as zones of clear 
areas against a stained background where the impregnated substrate has undergone 
degradation. The active enzyme can be identified according to the substrate used 
and its apparent molecular weight following electrophoresis.
Cells were plated in 6 well tissue culture plastic plates for 24-48 hours in normal 
medium (see V.1.1), and incubated at 37°C in 10% (v/v) CO 2 Medium was then 
replaced with serum-free DMEM supplemented with 0.5% BSA after 2 washes of 
cultured cells with sterile PBS; serum was removed from cultures since it was 
found to contain high amounts of the proteinases assayed for in this technique and 
produced too high a background level. Incubation continued for 24 hours, 
conditioned medium was then harvested and cleared by centrifugation at lOOOrpm 
for lOmins at room temperature. Aliquots of conditioned medium could be stored 
at -70°C.
Metalloproteinases can be activated from their pro-enzyme form by treatment with 
4-aminophenylmercuric acetate (APMA). APMA was kept as a stock solution of 
0.02M in 0.5% sodium hydroxide. At a final concentration of ImM, APMA was 
incubated with conditioned medium at 37°C for 1 hour. Non-denaturing sample
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buffer was added to a final concentration of lx  (5x sample buffer: 10% (w/v) SDS, 
50% (v/v) glycerol, 0.312M tris-HCL (pH 6.8), 0.05% (w/v) bromophenol blue), 
and a further incubation at 37°C for lOmins before electrophoresis. Molecular 
weight markers for non-denaturing SDS-PAGE were electrophoresed in parallel.
Substrate SDS-polyacrylamide gels were as described in II.7.4, except substrate 
was added to gels prior to pouring and polymerization at a final concentration of 
1 mg/ml. Stacking gels were 5% and resolving gels were 10%.
Following electrophoresis, the gel was incubated in 2% (v/v) triton X-100 for 30 
mins at 37°C with gentle shaking to remove SDS. Incubation continued at 37°C 
for 18-24 hours with gentle shaking in substrate buffer (50mM tris-HCL [pH 8.0], 
5mM calcium chloride) allowing for enzyme activity. The gel was finally stained 
at room temperature with gentle shaking for 45-60mins in coomassie blue stain 
(0.1% (w/v) coomassie blue R250 in 45: 45: 10 (v/v) methanol: d ^ O : acetic acid) 
and destained in 45: 45: 10 (v/v) methanol: d ^ O : acetic acid. Proteolytic activity 
indicated as clear zones.
V.6.6 lmmunocytochemistry
Vectastain kits were used for the immunocytochemistry procedures in this thesis. 
Cells were grown to near confluence in plastic, 8 well chamber slides. Cells were 
washed in pre-chilled PBS, dipped once into ice-cold methanol (chilled in -20°C 
freezer overnight) then immediately tranferred to fresh, ice-cold methanol. Cells 
were allowed to fix for 20mins. After fixing, the cells were allowed to air-dry for 
~20mins before blocking with the vectastain supplied blocking serum (1 drop 
serum per ml of 0.1% (w/v) BSA in PBS). Incubation was carried out at room 
temperature for 30mins in a moist chamber. Blocking solution was then drained off 
and the primary antibody added at the appropriate concentration in 0.1% (w/v) 
BSA in PBS to the cells. Incubation continued for 1 hour in a humidified
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atmosphere at room temperature. Cells were subsequently washed 3x lOmins in 
wash buffer (0.05% (v/v) Tween 20, 0.15M sodium chloride in PBS, pH 7.6), and 
the cells incubated with the secondary peroxidase-conjugated antibody (1 drop of 
antibody supplied in the kit per lOmls blocking solution) for 1 hour in a moist 
chamber at room temperature. The washes were repeated as before, followed with 
incubation with the ABC reagent: 1 drop of solution A and 1 drop of solution B in 
5mls blocking solution. Incubation continued for 1 hour in a moist chamber at 
room temperature. Washes were again repeated as before and stain developed with 
peroxidase substrate (1 tablet (lOmg) of 3,3'-diaminobenzidine hydrochloride 
(DAB), dissolved in 16.7 mis of distilled water with 10pl hydrogen peroxide added 
just prior to use). Incubation continued in complete darkness for 7.5mins. The 
reaction was terminated by washing the slides in distilled water and the slides 
mounted using an aqueous mountant. Negative controls were as above with the 
omission of the primary antibody: incubation was with blocking solution only.
V.6.7 Immunofluorescence
Cells were grown on plastic, 8 well chamber slides to near confluence. The 
medium was removed and the cells were washed twice with PBS. The cells were 
then fixed in ice-cold acetone for 30mins and allowed to briefly air-dry before 
incubation with blocking solution (1.5% (w/v) BSA in PBS) for 5-10mins at room 
temperature. Using the appropriate concentrations, the primary antibody was 
incubated on the cells for 1 hour in a moist chamber at room temperature (ECCD-2 
used at 1:500, NCAM-OB11 used at 1:100). Following incubation with the 
primary antibody, cells were washed three times in blocking solution before 
incubation with the secondary FITC-conjugated antibody diluted in blocking 
solution at the manufacturer's recommended dilution, for 1 hour at room 
temperature in a moist chamber. Finally cells were washed with PBS and a 
coverslip mounted with aqueous mountant. Staining was visualized with a UV
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microscope. Negative controls followed the same procedure in parallel, with the 
omission of the primary antibody; incubation was with blocking solution only.
V.6.8 Phosphoamino Acid Analysis Of Whole Cell Lysates
Phosphoamino acid analysis was carried out according to the method described by 
Cooper, Sefton & Hunter, 1983, as follows:- cultures of exponentially growing, 
sub-confluent CMT 167/C6 and CMT 170/E9 cell lines were rinsed twice with 
pre-warmed phosphate-free DMEM supplemented with 10% (v/v) newborn calf 
serum and 2mM glutamine. To each culture in T25 flasks, 2mls of fresh 
phosphate-free medium was added and incubation continued at 37°C for 1 hour. 
After phosphate starving of the cells, lmCi/ml of carrier-free ^P-ort/zophosphate 
was added to cultures and labelling of the cells continued for 18-20 hours at 37°C. 
Cultures were then transferred to ice and washed twice with pre-chilled PBS before 
lysis in 1ml of modified lysis buffer (lOmM tris-HCl (pH 7.0), 150mM sodium 
chloride, 1% (v/v) NP40, 1% (w/v) sodium deoxycholate, 0.1% (w/v) SDS, 2mM 
EDTA, lOmM sodium pyrophosphate, lOmM (3-glcerophosphate, lOpM sodium 
orthovanadate, 2mM PMSF, ~lpg/ml aprotinin). Cells were incubated on ice for 
lOmins then scraped using disposable cell scrapers and the cells incubated for a 
further lOmins on ice to allow for complete solubilization of adherent structures. 
Lysed cells were subsequently transferred to pre-chilled screw-cap eppendorfs and 
lysates centrifuged at 4°C at 14K for 20mins in a Sorvall SS34 rotor. From the 
supernatant, 300pl was carefully pipetted off and transferred to a fresh eppendorf 
containing 400pl NTE (lOmM tris-HCl (pH 7.5), lOOmM sodium chloride, ImM 
EDTA) and 400pl NTE-saturated phenol at room temperature. Tubes were capped 
tightly and vortexed for 30 secs before centrifugation for lmin in a bench top 
microfuge at 14K at room temperature. The aqueous phase was discarded and the 
phenol phase extracted with a further 800pl NTE. The phenol phase and interface 
material was then transferred to a 30ml Corex tube, to which 13mls d ^ O  and
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2mls 100% TCA were carefully added. After careful thorough mixing, the tubes 
were placed on ice for 1 hour to allow for precipitation. The precipitated material 
was collected by centrifugation at 8K for lOmins at 4°C in a Sorvall SS34 rotor. 
The supernatant was decanted off and the pellet extracted with 5mls chloroform / 
methanol (2:1) at room temperature with vortexing. Centrifugation was repeated as 
above but at room temperature. Supernatant was decanted off and the pellets 
allowed to air-dry before being dissolved in 200pl 6M HC1, then transferred to 
Wheaton vials with 2x lOOpl 6M HC1 washes. Vials were sealed and hydrolysis 
carried out for 2 hours at 110°C. Samples were allowed to cool to room 
temperature before all the liquid was collected at the bottom of the vials. The vials 
were then broken open and the hydrolysate diluted with an equal volume of 
distilled w'ater and transferred to screw-cap eppendorfs before drying overnight 
under vacuum in a desiccator over solid sodium hydroxide and phosphorus 
pentoxide. Dried residues were washed twice by redissolving in 200pl df^O  and 
drying under vacuum. Dried residues were finally redissolved in 30pl pH 1.9 
buffer (98-100% formic acid: glacial acetic acid: d ^ O , at ratios 45: 156: 1799) 
and stored at -20°C.
Thin layer separation of phosphoamino acids was carried out as follows:- 
approximately 30-50% of hydrolysates were spotted onto the origin of single 
20 x 20cm cellulose thin layer plates (Kodak, 100pm) together with 0.5 pg of each 
unlabelled standards (phosphoserine, phosphothreonine, phosphotyrosine) in 0.3 - 
0.5pl aliquots. Hydrolysates were resolved by electrophoresis at pH 1.9 towards 
the anode at a constant 700volts for 2 hours. After thorough drying, the plates were 
rotated 90° and electrophoresis carried out at pH 3.5 (pH 3.5 buffer:- pyridine: 
glacial acetic acid: d ^ O , at ratios 10: 100: 1890) towards the anode at a constant 
600volts for 1 hour 40mins. The thin layer plate was maintained below 10°C 
during electrophoresis using a block cooled with tap water circulating at
89
approximately 1 litre / min. Following electrophoresis, the plate was dried 
thoroughly before the standards were visualized using ninhydrin (0.2% in ethanol, 
developed at 80°C). Dried plates were subsequently exposed to X-ray film.
A quantitative estimate of the relative abundance of the individual phosphoamino 
acids was taken after separation of total cell hydrolysates. Following radiography, 
the areas of cellulose containing the ninhydrin stained standards, together with the 
appropriate background areas were scraped and collected using a glass wool- 
plugged 1ml pipette tip attached to a vacuum line and the collected material 
transferred to a scintillation vial containing lOmls Ecoscint and vortexed 
vigorously before counting for lOmins. Abundance was expressed as a percentage 
of total radioactivity incorporated into the three phosphohydroxyamino acids.
V.6.9 2-D Gel Analysis
Cells were grown to sub-confluence in 6 well tissue culture plastic plates. The 
medium was aspirated off and the cells rinsed twice with sterile PBS before 
incubation of the cells with methionine-free DMEM containing 200pCi / ml [^S] 
methionine for four hours at 37°C in a humidified atmosphere. Following 
methionine labelling, cells were lysed in 150pl sample buffer (9.9M urea, 
4% (v/v) NP-40, 2.2% (v/v) ampholytes pH 3-10 / 2D, lOOmM DTT) and the acid 
insoluble counts determined. The 2-D gel analysis was expertly performed by 
L. McGarry as follows:- first dimension gels contained: 9.5M urea, 2% (v/v) 
NP-40, 4.1% (v/v) acrylamide (from stock acrylamide solution containing 
30.8% (w/v) acrylamide, 2.6% (w/v) bis-acrylamide), 2% (v/v) ampholytes 
pH 3-10 / 2D and polymerized with 0.67% (w/v) ammonium persulphate. These 
gels were overlayed with: 0.5M urea, 0.2% (v/v) NP-40, 0.1% (v/v) ampholytes 
pH 3-10 / 2D, 5mM DTT, 0.7M |3-mercaptoethanol, then prefocused to 2000V 
using a constant current of 11 Op A per gel. Samples were then applied beneath the
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overlay buffer; each sample contained 380 OOOcpm in 50jil sample buffer. 
Focusing was carried out for 18000volts-hours (17.5 hours at lOOOvolts then 
30mins at 2000volts), after which the gels were extruded into gel equilibriation 
buffer (0.3M tris-base, 75mM tris-HCl, 3% (w/v) SDS, 50mM DTT, 0.001% (w/v) 
bromophenol blue) and allowed to equilibriate for 2mins before being placed 
horizontally on the upper surface of a vertical SDS polyacrylamide gel (10% (v/v) 
acrylamide/bis-acrylamide (stock: 30.8% / 2.6%), 0.37M tris pH 8.8, 0.1% (w/v) 
SDS and polymerized with 0.05% (v/v) TEMED and 0.025% (w/v) ammonium 
persulphate). Electrophoresis continued for ~4 hours at a constant power of 16W 
per gel. All 2-D gel chemicals were supplied by Millipore (UK) Ltd.
V.7 OTHER TECHNIQUES
V.7.1 In-Gel Renaturation Analysis Of Gene Amplification
Analysis of gene amplification was carried out without the prior specification of 
particular genes to be analysed (such as would be detected by Southern blotting 
techniques, see V.4.5), but instead utilized methods by which DNA sequences 
were detected as a consequence of being reiterated. The method of in-gel 
renaturation was essentially followed as originally described by I.B. Roninson 
(1987). A diagrammatic illustration of this technique is given in Figure 25.
Solution A: 2.5M sodium hydroxide, 3M sodium chloride
Solution B: 1M sodium phosphate (pH7.0), 3.6M sodium chloride, 2mM
EDTA
Solution C: deionized formamide
Solution D : 0.5M sodium acetate, 2M sodium chloride, lOmM zinc
sulphate, (pH4.6)
Solution E: 10% (w/v) SDS
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Genomic DNA of interest was digested with restriction enzymes as described 
previously (V.3.3) and 0.5pg of this digested DNA was subsequently 
radioisotopically labelled with ^ P  by replacement synthesis (described in section 
V.5.2) using T4 DNA polymerase. This tracer DNA had to be of high specific 
activity (~2x 10^ cpm/pg, or greater) for efficient in-gel renaturation. Equal 
amounts of tracer DNA was mixed with excess (15pg) cold driver DNA (the same 
restriction digested DNA but unlabelled), and loading buffer added to lx (lOx 
loading buffer: 0.4% bromophenol blue, 50% glycerol in TE buffer). Samples were 
thoroughly mixed and briefly microfuged before loading onto gel. The gel was 1% 
agarose in lx electrophoresis buffer (80x electrophoresis buffer: 1.8M tris-base, 
0.8M sodium acetate, 0.08M EDTA, adjusted to pH 8.3 with acetic acid) with 
0.5pg/ml ethiudium bromide, final concentration. Specific dimensions of the gel 
were required: 390mm x 190mm x 4mm. Electrophoresis was carried out for 
-30 mins at 120volts then continued for 18-20 hours at 75volts with the 
electrophoresis buffer continuously recirculated using a peristaltic pump.
Following electrophoresis, resolved DNA was visualized by UV transillumination 
and a permanent record kept as either a Polaroid photograph or a photoimage. The 
gel was then placed into an air-tight perspex box and incubation commenced with 
350mls of pre-warmed (45°C) denaturation buffer (solution A: d ^ O , at ratios 
1:4) in a rotor incubator rotating gently at -30-40 rotations per minute and at a 
temperature of 45°C for 35mins. This incubation was repeated once with fresh 
denaturation buffer before being replaced with 350mls of pre-warmed renaturation 
buffer (solution B: formamide: d ^ O , at ratios 1:2: 1) and incubation continued 
for 20mins. These renaturation washes were repeated 5 times and the pH of the gel 
measured using a pH stick. The gel required to be less than pH 8 before incubation 
of the gel overnight in fresh renaturation buffer. The following day, the incubation 
temperature was lowered to 37°C and the gel then incubated with 5 x 15min
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washes with 350mls of pre-warmed SI nuclease buffer (solution D: df^O , at 
ratios 1:9). Once the gel was equilibriated in SI nuclease buffer, single stranded 
DNA was digested within the gel with 14000 units SI nuclease in 250 mis buffer. 
Incubation continued at 37°C with gentle shaking for 2 hours. The second round of 
in-gel renaturation was then started; the incubation temperature was raised to 45 °C 
and the gel incubated with denaturation buffer as before. Again, the renaturation 
steps were repeated and the SI nuclease digestion as before. Following the second 
SI nuclease digestion, the gel was incubated at 37°C with 500mls of pre-warmed 
elution buffer (solution B: solution E: dl^O , at ratios 15: 1: 84) to elute digested 
single stranded DNA. Incubation continued for 50mins followed with a further 
wash in elution buffer for 1 hour 45mins. Finally the gel was removed from the 
sealed box and dried down on 3MM Whatman paper and the dried gel exposed to 
X-ray film for the appropriate times at -70°C.
V.7.2 Electrophoretic Mobility Shift Analysis (EMSA)
Double-stranded probes were prepared as follows:- lOpg of complementary 
oligonucleotides were mixed in lOOpl of TE buffer and heated to 90°C before 
allowing to slowly cool to room temperature, thus allowing for oligonucleotide 
annealing. Double-stranded oligonucleotides were radiolabelled as described 
previously (V.5.4) and purified over a Nick column followed by PAGE. The 
labelled oligonucleotide was visualized by autoradiography and the appropriate 
band excised and eluted into 1ml of TE buffer by incubation at 37°C overnight.
The DNA:protein binding reaction was carried out as follows:- the appropriate 
volume of nuclear extract (typically containing lOpg protein, see section V.6.2) 
was incubated with 6pg poly (dl.dC).(dl.dC), 5pi gel shift buffer (final 
concentration lOmM Hepes, pH 8.0, 0.5M EDTA, lOOmM sodium chloride, 
lOmM magnesium chloride, ImM dithiothreitol, 10% (v/v) glycerol, O.lmg BSA),
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approximately 500pg labelled oligonucleotide probe and d l^O  to a total volume 
of 25pl. Reactions were incubated at room temperature for 20mins before loading 
onto a pre-run (lhr at 25mA) 6% acrylamide gel with 0.5% TBE. Running buffer 
was 0.5% TBE. Electrophoresis continued for approximately 3 hours at 25mA then 
the gel dried down and exposed to X-ray film.
V.7.3 Dye Transfer Assessment Of Gap-Junctional Communication
Efficiency of gap-junctional communication was assessed in cultured cells by the 
method of microinjection of a fluorescent dye. Cells were cultured to sub­
confluence in 60mm dishes using standard techniques (see V.1.1). The culture 
medium was subsequently replaced with medium buffered with 25mM HEPES, 
and the dish placed onto a 37°C temperature controlled microscope stage in 
preparation for microinjection. Individual cells were selected and iontophoretically 
injected with 4% lucifer yellow CH dye using microelectrodes made from "Kwik- 
fill" thin wall glass capillaries. Injection continued for 2 mins with a current of 
lOnA at 0.5sec pulses at 1Hz and was monitored on a Leitz Diavert inverted 
microscope with UV (epillumination) or visible (phase-contrast) light sources. The 
extent of dye spread to adjacent cells was photographically recorded.
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RESULTS
CHAPTER VI BIOLOGICAL CHARACTERIZATION
VI.1 In Vivo Confirmation Of Metastatic Phenotypes Of The CMT Model
As described earlier (see section III.3.5), this model system for the analysis of the 
metastatic phenotype was founded upon two clonal murine cell lines which 
significantly differed in their metastatic potentials. The cell line CMT 167/C6 had 
a high metastatic potential and CMT 170/E9 had a low metastatic potential as 
assayed by the spontaneous metastasis assay (Layton & Franks, 1984). Since one 
of the crucial parameters of this model system was the differing metastatic 
potentials, the cell lines were periodically tested in vivo for the assessment of their 
metastatic abilities. In addition, to minimize phenotypic drift due to prolonged 
in vitro culture, cell lines were not maintained beyond passage 25.
Initially, the facilities at the Beatson Institute did not routinely house C57B/T 
animals, the original syngeneic mouse strain which is maintained at the Imperial 
Cancer Research Fund (ICRF) laboratories. Due to the different "in-house" viruses, 
simple importing of these animals to our facilities as a long term arrangement was 
problematic. It was concluded that alternative mouse strains may suffice for the 
analysis of the metastatic abilities of the cell lines and this idea was tested.
A closely related in-bred mouse strain C57B/6J and athymic nude mice were 
chosen for comparison, and these were already routinely housed and bred at the 
Beatson Institute. Thirty C57B/T animals were obtained from the ICRF and kept 
isolated in containment units throughout the initial experiment. The spontaneous 
metastasis assay was performed as described in materials and methods 
(section V.2). For each cell line, fifteen animals of each of the three mouse strains 
were subcutaneously (s.c.) injected in the right flank with 5 x 105 cells. The 
formation of primary tumours was closely monitored and the animals sacrificed 
between 3 - 5 weeks post - injection. Measurements of the primary tumour were
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recorded and plotted against time (see Figure 4) and the number of metastatic 
deposits counted on the surface of the lungs (see Figure 5), which were prepared as 
described in materials and methods (section V.2).
It became clear that the tumorigenic potentials, as measured by the rate of tumour 
growth, and metastatic potentials of these two cell lines in the different strains of 
mice varied substantially. The high tumorigenicity and relatively low metastatic 
potentials exhibited in nude mice has been documented before by many different 
workers using numerous cell lines (Gioranella & Fogh, 1985; and references 
therein), it should therefore not have been particularly surprising that this was also 
the finding here (see Figures 4C and 5C). The greater metastatic potential of the 
CMT 167/C6 cell line was clearly evident in C57B/6J animals (see Figure 5B). 
However, the tumorigenic potentials of the two cell lines clearly diverged: 
CMT 170/E9 primary tumours largely remained below 1000mm3 in volume 
whereas CMT 167/C6 primary tumours ranged in sizes between 1000 - 3000mm3 
(see Figure 4B). Injection into syngeneic animals, C57B/T, revealed a CMT 
167/C6 cells exhibiting at least a ten-fold increase in the number of metastatic 
deposits found in the lungs when compared to CMT 170/E9 cells at equivalent 
tumour burdens (see Figure 5A) and between 4 - 5  weeks, tumour burdens were 
approaching equivalence (see Figure 4A).
As it was considered that for a valid comparison of these two cell lines for their 
metastatic abilities, the tumorigenic potentials should be comparable such that the 
results obtained from differing metastatic abilities reflects metastatic potential and 
not tumorigenic potential. With this consideration, it was decided that C57B/T 
animals should be used for all future experiments and consequently this mouse 
strain was caesarian - derived and established at the Beatson Institute. This would 
have been a particularly vital consideration if this work had extended to the 
manipulation of the cell lines in an attempt to alter their metastatic abilities.
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Figure 4
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Figure 4. Comparison Of CMT 167/C6 And CMT 170IE9 Primary Tumours In 
Different Mouse Strains
Scatter graphs o f  primary tumour volume are plotted against time. Each point 
represents an individual animal sacrificed at the indicated time follow ing  
subcutaneous injection o f  5x10s cells in 0.5mls. Graphs A, B and C represent 
different mouse strains as indicated. For comparison, average tumour volum es for 
each cell line are indicated, at the appropriate time point, as line graphs.
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Figure 5. Comparison Of Metastatic Potentials OfCMT 167IC6 And CMT1701E9 
Cell Lines In Different Mouse Strains
Scatter graphs o f the number o f  metastatic deposits counted on the surface o f  
excised lungs plotted against the primary tumour volum e at the time o f  sacrifice. 
Graphs A , B and C represent different mouse strains as indicated. Each point 
represents an individual animal.
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However, the research detailed in this thesis served to characterize the cell lines in 
an attempt to explore and gain further insight into the metastatic phenotype as 
exhibited in this particular model system. The in vivo metastasis analyses of these 
cell lines confirmed previous findings about their respective phenotypes and 
further studies were therefore undertaken with the confidence that this model 
system would be effective for the analysis of the metastatic phenotype and one 
which would hopefully provide a unique insight.
VI.2 In Vitro Characteristics Of The CMT Model
The CMT cell lines CMT 167/C6 (high metastatic potential) and CMT 170/E9 
(low metastatic potential) of this metastasis model system have not been 
previously characterized extensively, particularly with respect to the various 
biological characteristics associated with the metastatic phenotype (see Chapter I), 
such as cell adhesion, nor of genetic alterations such as inappropriate expression of 
particular putative metastasis-associated genes (see Chapter n). Since this is a 
relatively novel system, it was important to establish which factors that have been 
previously reported to correlate with the metastatic phenotype in other metastasis 
model systems, which may be contributory to the differing metastatic phenotypes 
of this model, and also to attempt to identify further deciding factors necessary for 
the metastatic phenotype. This characterization therefore serves as a foundation for 
future research into metastasis using this model system.
The biological characterization of the CMT murine model will be detailed in this 
chapter, and the following chapter (Chapter VII) will present the results from the 
molecular genetics analyses.
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VI.2.1 Anchorage-Independent Growth
For many years now, it has been a recognized phenomenon that malignantly 
transformed cells have greater anchorage-independence than most normal cells 
(Folkman & Moscona, 1978). The underlying reason for this phenomenon has not 
been elucidated, however a recent hypothesis has evolved from evidence which 
suggests that anchorage-dependent cells are susceptible to apoptosis when induced 
to detach from matrix substrate by disruption of integrin-mediated cell adhesion 
with RGD peptides or by maintaining cells in suspension thereby preventing cell 
attachment (Meredith et al., 1993; Frisch & Francis, 1994). Therefore the 
transformed cell may overcome the apoptotic pathway by alleviating the 
requirement for cell adhesion to the substratum, thus conferring anchorage- 
independence and initiating the malignant transformation of the cell (Ruoslahti & 
Reed, 1994).
Since anchorage-independent growth can be readily tested in soft agar assays (see 
Methods V.1.5), and is a classical test of the transformed phenotype, both 
CMT 167/C6 and CMT 170/E9 cell lines were assayed, together with a positive 
control of Swiss 3T3 cells transfected with a temperature sensitive src mutant, 
LA29 (a kind gift from M. Unlu, Beatson Institute). Following incubation at the 
appropriate temperatures, both CMT cell lines were seen to form tight colonies 
within the soft agar (see Figure 6). It was noted that both CMT cell lines took 
longer to establish as colonies than the control cell line, this most probably 
reflected the differing doubling times of the different cell lines (M. Unlu, personal 
communication). As expected, both cell lines exhibited anchorage-independent 
growth in soft agar.
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Figure 6. Soft Agar Assays For Anchorage-Independent Growth
2xl05 cells were plated in soft agar (0.3%(w/v) final concentration) as described in 
section V.1.5, and incubated for two weeks at the appropriate temperatures: CMT 
cell lines were incubated at 37°C, and positive control cells, Swiss 3T3 f29 cells 
were incubated at 35°C. Swiss 3T3 f29 cells have been transfected with a 
temperature sensitive src which is permissive at 35°C (a kind gift from M. Unlu, 
Beatson Institute).
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VI.2.2 In Vitro Growth Curves Of The CMT Cell Lines
In order to address the question of whether a contributory factor to the cell lines 
differing in their in vivo characteristics was directly related to their growth 
characteristics in vitro, the cell lines were examined for their growth patterns and 
doubling times by MTT assay.
Standard growth curves were established for each cell line over a period of seven 
days using the MTT assay which estimates viable cell number, as described in 
section V.1.6. Replica plates for each time point were seeded simultaneously and 
incubated as described. Assays were performed in triplicate. Figure 7 illustrates 
typical growth curves of both CMT 167/C6 and CMT 170/E9 cell lines seeded at 
103 cells /  ml. From these assays, it is apparent that both cell lines have similar 
growth curves, although the CMT 167/C6 cell line had a slight increase in cell 
numbers during logarithmic growth over the CMT 170/E9 cell line. From these 
studies, it would appear that the minimum of a ten-fold difference in metastatic 
abilities observed of these cell lines in vivo (see section VI. 1) cannot be solely 
attributed to any differing growth rates of the cell lines in vitro. This therefore 
substantiates the proposal that these two cell lines possess other intrinsic 
differences which are related to the metastatic phenotypes.
VI.2.3 Morphology Of CMT Cell Lines Plated On Matrix Components
During the course of this research, both CMT cell lines were observed to exhibit 
altered morphology when cultured on different matrix components. Previous 
published literature concerning these cell lines describe routine culturing of the 
CMT cell lines directly on tissue culture grade plastic; this was therefore a new 
observation. Both CMT 167/C6 and CMT 170/E9 cell lines display similar 
morphology on both untreated tissue culture plastic and on fibronectin-coated 
tissue culture plastic (see section V.1.3) with cells generally tightly packed (see
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Figure 7. Growth Curves Of CMT Cell Lines In Vitro
CMT 167/C6 and CMT 170/E9 cell lines were seeded at 105 cells/m l in 96 w ell 
plates and incubated at 37°C  in a humidified atmosphere for 1 - 7 days before 
viable cell numbers were estimated by MTT assay. A ssays were performed in 
triplicate and the average values plotted on a line graph o f viable cell numbers 
against time.
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Figure 8. Morphology Of CMT Cell Lines Plated Onto Matrix Components 
In Vitro
Culture surfaces o f  plastic 6 w ell plates were treated with PBS alone (control), 
fibronectin (30p.g/ml) or collagen (100|LLg/ml), as described in section V .1.3. CM T  
cell lines were subsequently seeded into the w ells and cultured in normal growth  
medium. Photographs were taken 3 - 5 days later.
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Figure 8). However, cells plated onto collagen-treated tissue culture plastic 
displayed subtle shape changes to a more flattened and classical epithelial 
morphology. Both CMT cell lines reacted in a similar fashion, and it could be 
speculated that these subtle shape changes upon culturing on collagen may be 
related to the cells expression of integrin receptors for collagen. Unfortunately, as 
will be discussed later (see section VI.3.3), at the time of this work, there were no 
suitable mouse-specific antibodies available which could be used to determine if 
the cells expressed either fibronectin or collagen integrin receptors.
VI.2.4 P53 Status
One of the most frequent genetic alterations found in human cancers is the deletion 
or mutation of the TP53 gene (Nigro et al., 1989). Indeed, in colorectal cancer, 
TP53 is mutated in at least 50% of cases (Rodrigues et al., 1990) and reported in 
some instances to be mutated in over 75% of colorectal cancers (Baker et al., 
1989). A characteristic of missense mutated TP53 is an increase in the stability of 
the protein (Reich, Oren & Levine, 1983; Martinez et al., 1990). Consequently, 
mutant p53 is found in higher concentrations in transformed cells. In order to 
examine the status of p53 expression in the CMT cell lines, immunocytochemistry 
was performed using a polyclonal antibody (CM1) capable of recognizing both 
wild type and mutant forms of p53. Intense cellular staining of p53 was observed 
in both cell lines (see Figure 9) and not of the negative controls which were 
identically treated cells but without incubation with the primary p53-specific 
antibody (see section V.6.6). Interestingly, unlike most cell lines, p53 staining was 
observed to be strongly cytoplasmic and not, as more commonly found, nuclear. 
The underlying reasons for this have not been further investigated and it could be 
postulated to be due to alterations in the nuclear localization signals of p53 or due 
to interactions with other cellular proteins. However, gross changes such as large 
deletions are not anticipated since polymerase chain reaction (PCR) products of
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Figure 9. p53 Immunocytochemical Analysis Of CMT 167IC6 And CMT 170/E9 
Cell Lines
CMT cell lines were cultured in 8 well chamber slides until -90%  confluency  
before fixing and staining as described in section V.6.6. Negative controls received  
identical treatment with the om ission o f the primary antibody which was 
substituted with blocking solution alone. The secondary antibody (CM 1), was 
horseradish peroxidase (HRP)-conjugated and the substrate used was 
3,3'-diaminobenzidine (DAB) hydrochloride. Positive staining is coloured brown.
As can be seen in Figures A  and C, intense staining is present in the cytoplasm  o f  
the cells with scattered, granular staining in the nucleus. No background staining is 
detected in the negative controls (Figures B and D).
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TP53 from both CMT 167/C6 and CMT 170/E9 cell lines amplified and correlated 
with normal control sizes, as estimated on an agarose gel (data not shown).
VI.2.5 Gap-Junctional Communication
As already mentioned (see section I.2.2.6), in some instances, the reduction or loss 
of normal cell-cell communication via gap junctions has been associated with the 
metastatic phenotype. Since the two CMT cell lines exhibit markedly different 
metastatic potentials, their ability to communicate through homologous coupling 
of the cells was investigated. Each cell line was grown to confluency to ensure 
close cell-cell contact and a single cell within the monolayer selected and 
microinjected with lucifer yellow dye as described in section V.7.3. Examination 
under ultraviolet light of the monolayer reveals the extent of dye spread to adjacent 
cells. As can be seen in Figure 10, neither cell line exhibited dye transfer, 
indicating that normal gap-junctional intercellular communication has been 
disrupted in these cell lines.
Further investigations (in collaboration with I. Foulkes, Beatson Institute) of both 
CMT cell lines for their expression of connexin 43, a component implicated in gap 
junction formation, have revealed that although both cell lines express connexin 43 
mRNA, only CMT 170/E9 (the low metastatic potential cell line) expresses the 
protein (I. Foulkes personal communication and unpublished data). However, this 
expression does not appear to represent functional gap junctions since it is not 
detected at regions of cell-cell contact which would indicate functional expression 
(I. Foulkes, personal communication & unpublished data). These results confirm 
the finding that both cell lines are unable to communicate via gap junctions as 
assayed by dye transfer. In addition to homologous coupling, neither cell line 
appears to form heterologous coupling with normal cells since both CMT cell lines 
are able to form foci when seeded upon a confluent fibroblast monolayer of either
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Figure 10. Gap-Junction Intercellular Coupling (GJIC) Of CMT Cell Lines
Cells were cultured to subconfluence in 60m m  dishes using standard techniques. 
Using a Leitz Diavert inverted microscope, single cells were selected for injection  
with luciferase yellow  CH fluorescent dye, as described in section V .7.3. The 
extent o f dye spread, and therefore the indication o f functional gap-junction  
intercellular com munication, was visualised by epillumination. Phase contrast 
photographs indicate the same field o f vision with the selected cell for dye 
injection in the confluent monolayer marked with a black dot.
M agnification x 1000
CM T 167/C6 - Lucifer Yellow Dye Transfer
CM I I 70/RD - Lucifer Yellow Dye Transfer
Ph;»sc* Contrast I h im e s i /c n c e
Swiss 3T3 cells or IOTV2 cells (I. Foulkes, personal communication). If the cell 
lines formed functional, heterologous coupling of gap junctions, it would be 
expected that the cells would have been growth inhibited and unable to form foci.
These results indicate that loss of gap-junctional intercellular communication has 
occurred in these cell lines. However, it does appear that loss cannot be correlated 
directly with metastatic potentials, since both CMT cell lines have lost intercellular 
communication via gap junctions and these two cell lines have markedly differing 
metastatic potentials. However, because both cell lines do possess varying degrees 
of metastatic potential, it may be that the loss of gap-junctional communication is 
reflective of the capacity to metastasize rather than extent of high or low metastatic 
potential and perhaps the metastatic potential of CMT 170/E9 cells, although low, 
still requires the loss of gap-junctional communication. Experiments are presently 
being undertaken to establish whether or not transfection of connexin 43 is 
sufficient to restore functional gap-junction intercellular communication and 
abrogate the metastatic potential and / or affect the tumorigenic potentials of these 
cell lines in vivo (I. Foulkes, personal communication).
VI.2.6 Matrix Metalloproteinase Expression
A characteristic feature of invasive carcinomas is their association with the 
expression of matrix metalloproteinases (see section 1.2.3). Therefore, it can be 
suggested that differing expressions of these enzymes may be correlated with the 
metastatic potentials, and upon this speculation, the expression and secretion of the 
type IV collagenases was investigated of these cell lines. Early zymography 
experiments, which assay for enzymatic degradation of substrate impregnated 
within the gel by enzymes separated according to molecular weight by non­
denaturing gel electrophoresis (see section V.6.5), did not reveal any type IV 
collagenase activities in conditioned medium collected from either cell line. The
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Figure 11. Zymography Of Gelatinase Activity In Conditioned Media Activated 
With APMA
Non-denaturing SDS-polyacrylamide gels can be impregnated with gelatin  
substrate to assay for the presence of enzymatic activity. CMT cell lines were 
cultured on untreated or fibronectin or collagen-coated surfaces as described in  
section V .6.5. Conditioned media were collected at 24 hours and treated w ith  
4-aminophenylmercuric acetate (APMA) to activate any latent enzym es present 
before analysis by zymography (section V.6.5).
Enzymatic activity is visualized as zones of clear areas against a Coom assie 
blue-stained background. The negative control was medium incubated without 
cells and the positive control was conditioned medium from a yds-transformed rat 
fibroblast cell line, FBR (a kind gift from B. Hennigan). As can be seen in  
Figure 11, no gelatinase activity can be detected in either cell line.
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absence of activity was not due to the enzyme being present in its inactive 
proenzyme form because samples were routinely treated with an organomercurial, 
4-aminophenylmercuric acetate (APMA), which activates the pro-collagenases. In 
addition, enzymes complexed with TIMPs are separated during electrophoresis, 
therefore only the active free enzyme should be present at the appropriate 
molecular weight position as separated by electrophoresis.
It was then considered that the expression and secretion of these enzymes may be 
dependent on the cells being cultured in the presence of components of the 
extracellular matrix, with the reasoning that the induction of the matrix 
metalloproteinase expression may be ligand dependent. However, even upon 
culturing of cells in the presence of either collagen or fibronectin (see section
V.1.3), type IV collagenases were not secreted into the medium (see Figure 11). It 
can be noted here that the three bands of 72kD type IV collagenase present in the 
control lane represent the two intermediate cleavage products of the proenzyme, in 
addition to the fully active enzyme product (Strongin et a l, 1993).
Since both 92kD and 72kD type IV collagenases can be detected using gelatin as 
the substrate in this assay, it can be concluded that neither cell line express either 
type IV collagenases. Similar experiments were attempted using casein as the 
substrate to assay for stromelysin enzyme expression, however these were 
unsuccessful.
VI.3 Cell Adhesion Analysis
As mentioned earlier, previous published literature concerning these two CMT cell 
lines of this metastasis model provide minimal information on their 
characterization in relation to their metastatic phenotypes. Since it is becoming 
increasingly apparent that cell adhesion can markedly influence the processes of 
invasion and metastasis (Vleminckx et al., 1991; Birchmeier & Behrens, 1994;
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Qian et al., 1994), potential alterations in quantitative or qualitative expressions of 
different cell adhesion molecules was investigated in these two cell lines.
VI.3.1 Cadherins
The cadherin superfamily of cell adhesion molecules (see section 1.2.2.1) is often 
affected in both squamous tumours and adenocarcinomas (reviewed in Birchmeier 
& Behrens, 1994), with the loss or down-regulation of E-cadherin expression 
frequently associated with poorly differentiated tumours and tumour progression to 
lymph node metastasis. Expression patterns of E, N and P-cadherins, at the protein 
level, were examined by western analysis of both cell lines. In agreement with the 
general correlation between loss of E-cadherin expression and tumour 
dissemination, the cell line CMT 167/C6, which exhibits high metastatic potential, 
was observed to have reduced E-cadherin expression relative to CMT 170/E9 (low 
metastatic potential cell line), see Figure 12.
Interestingly, expression levels in equivalent amounts of whole cell lysate proteins 
extracted both from in vitro cultured cell lines and from in vivo cell line-induced 
primary tumours, as estimated by coomassie blue staining of parallel gels, 
reproducibly differed. Expression levels consistently correlated inversely with 
metastatic potential, however overall expression levels appeared to be down- 
regulated in vivo (see Figure 12). This could be explained by at least two 
possibilities: (1) the proteins extracted from the primary tumours contained a high 
proportion of degraded material or (2) there is a selective suppression of 
E-cadherin in vivo. The former possibility can probably be discounted since the 
degradation products of E-cadherin are usually detected as lower molecular weight 
products on a western blot. Since these degradation products are not apparent, 
certainly not to any extent which could explain the reduction in signal of normal 
E-cadherin which migrates at 120-125kD size, it may be assumed that there is a
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Figure 12. ECL Western Analysis O f E-Cadherin Expression
Protein extracts from CMT cell lines cultured in vitro and from primary tumours 
were analysed by Western blotting and detected with ECL (kit marketed by 
Amersham Int. pic). Equal concentrations o f protein were loaded onto each lane 
(~15 |ig  using ATTO m ini-gel apparatus). Equal loading was confirmed by 
Coomassie blue staining o f a parallel gel (not shown). The primary antibody, 
ECCD-2, was used at 1:100 dilution.
Figure 12A. Specific detection o f E-cadherin can be seen in all lanes except the 
negative control (SD S-lysis buffer without protein extracts) at ~120-125kD . 
M olecular weight markers are shown to the left.
Figure 12B. Densitometric quantitation o f E-cadherin expression.
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Figure 13. Immunofluoresence Analysis Of E-Cadherin Expression
CMT cell lines were grown to subconfluence in 8 well chamber slides before 
fixing and staining for E-cadherin expression with the primary antibody ECCD-2 
(1:500 dilution), as described in section V.6.7.
Fluorescent staining can be seen at sites of cell-cell contact in both cell lines, thus 
indicating normal cellular localization and probably normal function. Slightly 
brighter staining is seen in CMT 170/E9 cells probably reflecting increased 
expression of E-cadherin in these cells as detected by Western analysis 
(Figure 12A). Phase contrast photographs depicts the area of cells visualized by 
epillumination.
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Figure 14. ECL Western Analysis O f N-Cadherin Expression
Protein extracts from CMT cell lines cultured in vitro were analysed by Western 
blotting and detected with ECL (kit marketed by Amersham Int. pic). Equal 
concentrations of protein were loaded onto each lane (~15mg using ATTO 
mini-gel apparatus). Equal loading was confirmed by Coomassie blue staining of a 
parallel gel (not shown). The primary antibody, GC-4, was used at 1:50 dilution, as 
manufacturer's recommended instructions (Sigma).
Specific detection of N-cadherin was only detected in the positive control (murine 
heart extract, a kind gift from D. Prowse). The lower molecular weight bands are 
non-specific bands which are detected by the primary antibody (D. Prowse, 
personal communication). Negative control was SDS buffer without protein 
extracts.
Figure 15
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Figure 15. ECL Western Analysis Of P-Cadherin Expression
Protein extracts from CMT cell lines cultured in vitro were analysed by Western 
blotting and detected with ECL (kit marketed by Amersham Int. pic). Equal 
concentrations of protein were loaded onto each lane (~15|ig using ATTO mini-gel 
apparatus). Equal loading was confirmed by Coomassie blue staining of a parallel 
gel (not shown). The primary antibody, PCD-1, was used at 1:50 dilution 
(D. Prowse, personal communication).
Specific detection of P-cadherin was only detected in the positive control (protein 
extract from the cell line BRL, buffalo rat liver, a kind gift from D. Prowse). 
The negative control was SDS-lysis buffer without protein extracts.
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suppression in vivo of E-cadherin expression, or alternatively, there is an 
up-regulation in vitro. Despite this in vivo / in vitro discrepancy, the relative 
expression levels of E-cadherin in both cell lines consistently correlate inversely 
with metastatic potential, although the in vivo relative difference appears to be 
marginally greater as measured by densitometric scanning analysis of the original 
autoradiograph (see Figure 12B).
Confirmation of the functional expression of E-cadherin resulted from 
immunofluorescence studies examining the cellular localization of E-cadherin. As 
shown in Figure 13, both cell lines express E-cadherin at points of cell-cell contact 
thus indicating that E-cadherin is functional in both cell lines. It may be therefore 
speculated that the relationship between metastatic potential and E-cadherin 
expression is, in part, dependent on the threshold levels of E-cadherin expression.
Examination of both cell lines for the expression of N-cadherin and P-cadherin 
were negative (see Figures 14 & 15), suggesting that E-cadherin is the principal 
member of the cadherins present on these two cell lines. The lower molecular 
weight bands seen in Figure 14 are non-specific bands detected by the primary 
antibody (D. Prowse, personal communication).
Vl.3.2 NCAM
In addition to the cadherin cell adhesion molecules, expression of the similarly 
Ci2+-dependent cell adhesion molecule NCAM was examined. NCAM, as already 
described in section I.2.2.4.1, mediates homophilic cell-cell adhesion and could 
therefore be a contributory factor in invasion of tumour cells when altered in its 
expression and/or function. Expression of NCAM in both CMT cell lines was 
examined by western analysis and the transmembrane isoform of NCAM was 
detected in both cell lines. CMT 167/C6 cells consistently exhibited reduced 
expression of NCAM relative to CMT 170/E9 cells. A representative western blot
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is shown in Figure 16A. Points to note about these results include the consistent 
relative reduction of NCAM expression in CMT 167/C6 (high metastatic potential) 
cells in comparison to CMT 170/E9 (low metastatic potential) cells. This is 
demonstrated both in cells cultured in vitro and in primary tumours formed from 
subcutaneous injection of both cell lines. However, it is noteworthy that the 
relative differences in quantitative expression appears to be dramatically affected 
between in vivo and in vitro cultures. As estimated by densitometiic scanning 
analysis, the relative difference in expression levels is greater than 30-fold in vitro, 
but less than 3-fold in vivo (see Figure 16B). Further still, overall expression levels 
are increased in vivo. From these results, it appears that expression levels of 
NCAM in vivo are high, but with the maintenance of a 3-fold difference between 
the low and high metastatic cell lines. This 3-fold quantitative difference may 
significantly affect the physiological strength of cell adhesion (Hoffman & 
Edelman, 1983) and in this model system it may be postulated that the reduction in 
NCAM expression in CMT 167/C6 cells enhances the cells ability to disseminate 
from the primary tumour.
Curiously though, the inverse relationship between NCAM expression and the 
metastatic potential observed in this CMT model is in contrast to the clinical 
correlations documented between NCAM expression and poor prognosis (see 
section I.2.2.4.1). It is possible that this clinical correlation is significant only in 
particular tumour types, and it appears that this correlation is indeed restricted to 
mostly small cell lung carcinomas according to present literature (Jaques et al., 
1993; Kibbelaar et al., 1991). It may be postulated that particular cell types 
respond differently to NCAM and it would therefore be conceivable that 
expression of NCAM may promote tumour outgrowth, comparable to the normal 
stimulation of neurite outgrowth stimulated by expression of the NCAM isoform
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Figure 16. ECL Western Analysis Of NCAM Expression
Protein extracts from CMT cedi lines cultured in vitro and from primary tumours 
were analysed by Western blotting and detected with ECL (kit marketed by 
Amersham Int. pic). Equal concentrations of protein were loaded onto each lane 
(~15|ig using ATTO mini-g;el apparatus). Equal loading was confirmed by 
Coomassie blue staining of m. parallel gel (not shown). The primary antibody, 
OB-11, was used at 1:100 dillution, as manufacturer's recommended instructions 
(Sigma).
Figure 16A. Specific detection of NCAM can be seen in all lanes except the 
negative control (SDS-lysis buffer without protein extracts) at ~140-160kD. The 
lower molecular weight bands, seen in extracts from primary tumours appear to be 
specific to samples with some normal blood cell infiltration; this is suggested from 
the cross reaction also seen ini the molecular weight standard, carbonic anhydrase 
extracted from bovine erythirocytes. Cross reaction is due to the secondary 
antibody.
Figure 16B. Densitometric quantitation of NCAM expression
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Figure 17. Immunofluorescence Analysis o f NCAM Expression
CMT cell lines were grown to subconfluence in 8 well chamber slides before 
fixing and staining for NCAM expression with the primary antibody OB-11 (1:50 
dilution), as described in section V.2.6.
Fluorescent staining can be seen at sites of cell-cell contacts in both cell lines, thus 
indicating functional expression of NCAM. Staining appears to be brighter in 
CMT 170/E9 cell lines which reflects the increased expression of NCAM detected 
by Western analysis (Figure 16). Phase contrast photographs depicts the area of 
cells visualized by epillumination.
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lacking the VASE exon (Saffell, Walsh & Doherty, 1994; Doherty et a l, 1992b). 
However, in other cell types such as epithelial cells, including the CMT cell lines, 
expression of NCAM may not stimulate outgrowth of these cells and functions 
solely as a cell adhesion molecule. Therefore increased expression of NCAM 
would be predicted to increase cell-cell adhesiveness and vice versa, and as such, 
in the tumour, decreased expression would be expected to be associated with 
increased invasive / metastatic potential.
The cellular localization of NCAM expression was examined in these two CMT 
cell lines by immunofluorescence (see Figure 17). In both cell lines, NCAM was 
found to be localized to the cell surface at points of cell-to-cell contact and thus, as 
predicted of E-cadherin, NCAM is expected to be functional in cell adhesion.
VI.3.3 Integrins
Attempts were made to examine the expression of different integrin subunits in the 
two CMT cell lines. However, the commercially available antibodies tested were 
not cross-reactive with murine samples, and therefore these expression studies did 
not yield results which could begin to assess the functional contribution of cell-to- 
matrix interactions in the phenotypes of these cell lines.
VI.4 Two-Dimensional Gel Analysis Of Total Cellular Proteins
Preliminary two-dimensional (2-D) analysis of whole cell protein extracts was 
tried in order to assess the possibility that the phenotypic differences exhibited by 
the CMT cell lines was due to one or more dramatic alterations of specific proteins 
within the cell. Large differences in protein turnover, or up-regulation /  down- 
regulation, or the presence / absence of proteins should be detected by 2-D gel
analysis was expertly carried out by 
of both cell lines were labelled with
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analysis. The technique of 2-D gel 
L. McGarry (Beatson Institute). Cells
i
35s methionine for four hours prior to protein extraction and 2-D gel analysis (see 
section V.6.9).
This preliminary work surprizingly revealed very few differences in the resolved 
proteins between the two cell lines. Altogether, nine quantitative differences were 
detected and no qualitative differences were found (see Figure 18). Interestingly, 
seven of the qualitative differences were increased in their expression levels in the 
low metastatic potential cell line, CMT 170/E9 and only two were increased in 
their relative expressions in the high metastatic potential cell line CMT 167/C6. 
Table 1 gives details of the estimated molecular weights and isoelectric points of 
these identified proteins.
Since this is only preliminary work, extrapolations should not be taken from these 
results inferring that the identified proteins which differ between the 2-D gels of 
each cell line are specifically metastasis-related. However, this result does lend 
evidence to the suggestion that metastasis may not be dependent on a single 
"metastasis-gene", but indeed may be the outcome of multiple subtle alterations 
within the cell, all of which require to attain a certain threshold level in order for 
metastasis to successfully occur. This would correlate the apparently low 
frequency with which tumour cells shed from the primary tumour actually proceed 
to form a metastatic deposit (Weiss, 1986; Glaves, 1983). However, it is also 
apparent that there must be key events which are important in metastasis which do 
occur, since many tumour types can be predicted to have metastasized at the time 
of diagnosis when the tumour has reached an advanced clinical stage, and as such, 
there must be events in particular cell types which predispose for the procurement 
of the metastatic phenotype.
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Figure 18. 2-D Gel Analysis Of Total Cellular Proteins
CMT cells were labelled with 35S for four hours prior to protein extraction and 
2-D gel analysis (see section V.6.9). Figure 18A is the 2-D gel analysis of 
CMT 167/C6 extracts and Figure 18B is the 2-D gel analysis of CMT 170/E9 cell 
extracts. From this preliminary analysis, a total of nine resolved proteins were 
detected which differed in intensity between the two CMT cell lines on the 
autoradiographs. These proteins, labelled A-I have been estimated for their 
approximate molecular weights and pi values (see Table 1).
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Table 1 Estimated isoelectric points and molecular weights o f proteins identified 
in 2-D gel analysis
Protein Apparent M.W. (kDa) Approximate pi
A 51 5.1
B 41 5.35
C 38 5.45
D 35 5.65
E 37 5.05
F 40 4.55
G 34 4.55
H 29 4.6
I 28.5 4.6
By comparison, proteins A and E are increased in CMT 167/C6 cells relative to 
CMT 170/E9 cells (see Figure 18, marked with short arrows). The other proteins 
noted are increased in CMT 170/E9 cells relative to CMT 167/C6 cells (see 
Figure 18, marked with long, thin arrows).
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VI.5 Phosphoamino Acid Analysis Of Total Cellular Protein
Many of the oncogenes associated with cellular transformation encode for proteins 
with intrinsic tyrosine kinase activity (reviewed by Hunter, 1989; and references 
therein). Consequently, these transformed cells have higher levels of 
phosphotyrosine-containing, proteins, reflecting the unregulated tyrosine kinase 
activity. This increase in activity can be measured by phosphoamino acid analysis 
of protein extracts from 32P-labelled cells (see section V.6.8). It was speculated 
that cells with differing metastatic phenotypes might be exhibiting altered signal 
transduction pathways affected by tyrosine kinases and their reciprocal partners, 
tyrosine phosphatases. Therefore, as a preliminary study, the relative 
phosphotyrosine content was examined in the two CMT cell lines by 
phosphoamino acid analysis of total cellular protein. As described in Methods 
V.6.8, cells were labelled with carrier-free 32P overnight before protein extraction, 
acid hydrolysis and thin layer separation by 2-D electrophoresis. The resulting 
autoradiographs are shown in Figure 19a & b. Relative abundances of 
phosphoserine, phosphothreonine and phosphotyrosine in each cell line was 
calculated by scraping the appropriate areas of cellulose from the plates, in 
addition to suitable background control areas, and recording the levels of 
radioactive incorporation. The relative abundance of each of the three 
phosphohydroxyamino acids is expressed as a percentage of the total radioactivity 
incorporated (see Figure 19d).
Early studies by Hunter & Sefton (1980) demonstrated that normal chick cells 
contain -0.03% phosphotyrosine and infection with Rous Sarcoma Virus (RSV) - 
the src gene product has tyrosine kinase activity - increased the cellular levels of 
phosphotyrosine 7-8 fold. Similar increases could be anticipated if the CMT cell 
lines exhibited altered constitutive tyrosine kinase activity correlating with the 
metastatic phenotypes. However, as can be seen in Figure 19d, the relative
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Figure 19
Figure 19. Phosphoamino Acid Analysis Of Total Cellular Protein
Phosphoamino acid analysis was performed as described (see section V .6.8). Cells 
were labelled with 32P for 18-20 hours before protein extraction, acid hydrolysis 
and thin layer separation by 2-D electrophoresis.
Figure 19a. Phosphoamino acid analysis o f CMT 167/C6 cells
Figure 19b. Phosphoamino acid analysis o f CMT 170/E9 cells
Figure 19c. Relative positions o f phosphoserine (PS), phosphothreonine (PT) and 
phosphotyrosine (PY)
Figure 19d. Relative abundance o f phosphoserine, phosphothreonine and 
phosphotyrosine content in each cell line expressed as a percentage o f  the total 
radioactivity incorporated.
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abundance of phosphotyrosine in both cell lines was 0.03% or less. It therefore 
appears that tyrosine kinase activity is not a significant parameter, in this model, of 
the metastatic phenotype, and tyrosine kinase activity is still apparently under the 
normal negative regulatory controlling mechanisms.
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CHAPTER VII MOLECULAR GENETICS ANALYSIS
Tumour progression has been associated with a number of genetic alterations, 
some of which were summarized in Chapter II. However, as already mentioned, 
few genetic alterations have been specifically associated with progression to the 
metastatic phenotype, although there are some genes which have been reported to 
be putatively metastasis-associated. Gene amplification has also, in some 
instances, been clinically associated with increased malignancy, for example 
amplification of N-myc in neuroblastomas (Brodeur et al., 1984).
The work described in this chapter details the analysis of the putatively metastasis- 
associated genes CD44 and mts-1. In addition, gene amplification was analysed, 
specifically of the N-myc gene and also non-specifically using the technique of 
in-gel renaturation (Roninson, 1987) to examine for reiterated DNA sequences 
with the aim of determining genes amplified in association with the metastatic 
phenotype.
VII. 1 Putative Metastasis-Associated Genes
In an attempt to understand die complicated process of metastasis, many 
researchers have attempted to identify specific "metastasis genes". Comparative 
studies between metastatic and non-metastatic tumorigenic cells have lead to the 
identification of candidate metastasis-specific genes. These candidate genes 
include CD44, mts-1 and nm23 (see section 13.3). The expression of both CD44 
and mts-1 were examined in this model system, and the results of these studies will 
be presented in the following sections (VII. 1.1 & VII.1.2).
VII.1.1 CD44
There is strong evidence substantiating the relationship of specific, alternatively 
spliced, variant isoforms of CD44 with metastatic potential in certain metastasis
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model systems and in particular tumour types (Gunthert et al., 1991; Rudy et al., 
1993; Weilenga et al., 1993 & see sections I.2.2.5 and II.3.3). To assess whether 
CD44 was also expressed in this CMT model, and to examine the possible 
correlation of variant isoform expression with metastatic potential, an analysis of 
both cell lines was carried out using a PCR-based approach.
At the time of this particular investigation, alternative splicing of murine CD44 
had not been reported. However, by comparison of the murine CD44 cDNA 
sequence (also referred to as Pgp-1) with human and rat CD44 cDNA sequences, it 
was possible to predict the potential site of alternative splicing within the 
extracellular domain (see Figure 20). Primers were designed for reverse 
transcription of extracted and purified RNA for cDNA synthesis (as described in 
section V.4.4), followed by PCR amplification (see Table 2 for oligonucleotide 
sequences & Figure 20 for a schematic representation of primer positions). The 
RNA samples were extracted from both cell lines cultured in vitro, in addition to 
RNAs extracted from CMT 167/C6 and CMT 170/E9 primary tumours in vivo. 
The PCR products were analysed by agarose gel electrophoresis and Southern blot 
hybridization (see sections V.3.4 and V.3.5). Hybridization of the nitrocellulose 
blot employed another oligonucleotide which was specific to a conserved region of 
CD44 (see Figure 20). The presence of alternatively spliced exons within the 
CD44 mRNAs should be detected as higher molecular weight products over the 
predicted molecular weight size of murine CD44, according to the positions of the 
oligonucleotide primers used to amplify by PCR. Since the oligonucleotide used to 
probe was specific to a conserved region of CD44, all variant isoforms should be 
detected in addition to the standard isoform which contains no alternatively spliced 
exons. As can be seen in Figure 21, a single CZ)44-specfic PCR product was 
detected in all samples. Furthermore, the estimated molecular weight of these 
products corresponds to the standard form of CD44, without any alternatively
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Figure 20. Schematic Diagram O f CD44, Alternative Splice Sites And Primer 
Positions
The proposed positions o f  alternative splicing within the murine C D 44 gene 
structure are indicated. Since this work was completed, these positions have been 
confirmed (Screaton et al, 1993). Variant exons v4-v7 have been found in a rat 
system  to confer metastatic potential (see text for details, section I.2.2.5). The 
standard form o f  CD44 has no alternatively spliced exons (also known as murine
p g p - iy
O ligonucleotide primers were designed to span the extracellular matrix domain to 
the cytoplasm ic domain, as represented in the diagram. An internal (EC) 
oligonucleotide was also designed to detect a conserved region o f  the extracellular 
domain by Southern hybridization. See Table 2 for oligonucleotide sequences.
Schematic Diagram Of CD44, Alternative Splice Sites And Primer Positions
Variant exons
v l v2 v3 v4 v 5 v 6 v 7 v8 v 9 v lO
3' primer
Insertion site
Extracellular domain__________________ ,,__ ,, Cytoplasmic
* domain
T ransmembrane 
domain
5' primerd i
Adapted from Screaton et a l, 1993
Table 2 Oligonucleotide sequences of PCR primers and probes for CD44 analysis
Oligonucleotide Sequence
5 'primer 5' TTG CCT CTT GCA GTT GAG CCT G 3'
3 'primer 5'GTC AGT AGC ACA TTG CAT CTG TG 3’
EC probe 5' GAC TGT ACA TCA GTC ACA GAC CTA
CCCAATTCC3’
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Figure 21. Southern Hybridization O f CD44 RT-PCR Products
R N A s were extracted from CMT cell lines cultured in vitro and from primary 
tumours. Follow ing RT-PCR, using the primers described in Table 2, the PCR  
products were electrophoresed on an agarose gel, Southern transferred and 
hybridized with an oligonucleotide (EC) specific to a conserved region o f  the 
extracellular domain (sequence detailed in Table 2). This EC oligonucleotide, due 
to its specificity to a conserved region, should detect all possible alternatively- 
spliced isoform s o f  CD44. A single CD44-specific PCR product was detected in all 
samples which corresponded in molecular weight to the predicted size o f  the 
standard form o f  murine CD44. N o other CD44 products were detected which  
could correspond with alternatively spliced variants o f CD44.
Southern Hybridization Of C D 44 RT-PCR Products
in vitro in vivo
sO O ' vO O '
U U £o o
sO sO*—•
E— H H H
s 2 2 s
u u U CJ
23.1kb
9.4kb
2.3kb
2.0kb
0.9kb
0.6kb
C D 44
spliced exons. It therefore appears that the variant CD44 isoforms are not 
significant in the metastatic phenotypes of this model system. Recent literature has 
provided evidence for the expression of CD44 variant exons in murine tissues 
(Screaton et al., 1993), therefore the lack of these variant isoforms in this model 
system is not due to inability of CD44 to undergo alternative splicing in the murine 
system, but is instead because CD44 in this CMT model is not subject to 
alternative splicing.
VII. 1.2 Mts-1
Another molecule reported most notably by Lukanidin and colleagues to be 
putatively metastasis-associated is mts-1 (Ebralidze et a l, 1989). As outlined in 
section II.3.2, Mts-1 appears to be related to the S I00 family of calcium-binding 
proteins. However, the relationship of mts-1 expression with the metastatic 
phenotype remains tentative, although it is presently regarded as a candidate 
metastasis-associated gene.
The mRNA expression of mts-1 was examined in both CMT cell lines. Northern 
analysis utilized as a probe the whole mts-1 insert from the pUC19-based 
construct, p271 (a kind gift of E. Lukanidin, Fibiger Institute, Copenhagen) 
excised with the restriction enzymes Kpnl and BamHl, see Figure 22. To confirm 
this insert encoded mts-1, the mts-1 insert was sequenced (data not shown) and was 
found to correspond to the published cDNA sequence.
Northern analysis of both CMT cell lines did not reveal any expression of mts-1 in 
either cell line (see Figure 23A). Since Ebralidze et a l  (1989) reported the 
association of mts-1 expression with metastatic potential in various cell lines, 
including a low metastatic potential B16 melanoma cell line exhibiting a 
corresponding low expression of mts-1, another pair of cell lines were analysed. 
Sublines B16 F10 (high colonization /  experimental metastasis potential) and
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Figure 22. Map O f Mts-1 Plasmid, p271 And Gel Purified Mts-1 Insert
Figure 22A. Plasmid map of p271 containing the mts-1 insert and ampicillin 
resistance gene. Restriction sites used to excise the mts-1 insert are shown.
Figure 22B. Ethidium bromide stained agarose gel containing purified mts-1 
insert.
Lane 1: Haelll digested 0X174 
Lane 2: lp.g of mts-1 insert 
Lane 3: 2p.g of mts-1 insert.
A.
Kpnl mts-1 BamYU
Ampr
(pUC 19 vector)
B. Lane: 1
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872bp 
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310bp _  
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Figure 23. Northern Analysis O f Mts-1 And Actin mRNA Expressions
Figure 23A. Northern analysis of mts-1 mRNA expression. 20|ig of purified total 
cellular RNAs were electrophoresed and transferred as described (see section 
V.4.1, V.4.2, V.4.3). Whole mts-1 insert (see Figure 22) was radiolabelled and 
used to hybridize the Northern blot, then washed under increasingly stringent 
conditions of:-
2x 20mins at room temperature with 2x SSC. 0.1% (w/v) SDS 
lx 30-45 mins at 65°C with O.lx SSC, 0.1% (w/v) SDS
Autoradiograph exposed for 2 weeks.
Figure 23B. Northern analysis of actin mRNA expression. The previous blot was 
stripped and re-hybridized with a murine-specific actin probe (a kind gift of 
R. Nibbs). Washes were repeated as above. Autoradiograph exposed for ~12 hours.
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B16 FI (low colonization potential) were examined for their mts-1 expression 
(RNAs a kind gift from P. Elvin, Zeneca Pharmaceuticals). Again, no expression 
of mts-1 was found in these Northern analyses (see Figure 23A). Furthermore, 
Northern analysis of lipopolysaccharide (LPS)-stimulated bone marrow-derived 
macrophages, which was reported to be modulated in response to LPS stimulation 
in an abstract by Grigorian et al. (1992), did not exhibit mts-1 expression (data not 
shown). To examine the possibility that these negative results were due to 
technical difficulties, and also to check for equal loading of samples, the Northern 
blots were stripped and reprobed for actin expression. As can be seen in 
Figure 23B, expression of actin was readily detectable and samples were 
approximately equal in RNA loading.
Since it was apparent that the methodology of Northern analysis was not failing, 
the mts-1 probe was checked for its ability to hybridize specifically to a 
nitrocellulose blot. Southern analysis of HindUl restriction digested genomic DNA 
using the same mts-1 insert to probe, hybridized to a single specific band identical 
in both CMT cell lines and corresponded with HindUl restriction digested genomic 
DNA extracted from normal kidney tissue of a syngeneic, C57B/T, animal 
(Figure 24).
Therefore, from these results it appears that the evidence presented here does not 
support the observations by Lukanidin and co-workers of the association between 
mts-1 expression and the metastatic phenotype. As already mentioned in section 
II.3.2, mts-1 may not have a direct role in the metastatic phenotype. However, 
since it is related to the calcium-binding proteins and may be inferred to be 
associated with cellular aspects such as shape change, it may therefore be seen, in 
certain circumstances, to be associated with the metastatic phenotype. However, it 
is apparent that further studies are necessary to clarify the role, if any, of mts-1 in 
metastasis.
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Figure 24. Southern Analysis Of Mts-1
Genomic DNAs were extracted from both CMT cell lines and normal C57B/T 
kidney tissue and subsequently restriction digested with HindUl. 10}ig of each 
restriction digested DNAs were electrophoresed on a l%(w/v) agarose gel and 
Southern transferred, as described in sections V.3.1, V.3.3, V.3.4, V.3.5. 
Hybridization was with radiolabelled, whole mts-1 insert (see Figure 22). Washes 
were under the following increasingly stringent conditions:-
2x 15mins at room temperature with 2x SSC, 0.1% (w/v) SDS 
2x 30mins at 65°C with 0.5x SSC, 0.1% (w/v) SDS 
lx 30-45mins at 65°C with 0.1% SSC, 0.1%(w/v) SDS
Autoradiograph was exposed for ~8 hours.
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VI 1.2 Gene Amplification
Gene amplification has been described in association with malignancy (see section 
II. 2) and may be involved in the acquisition of the metastatic phenotype. The 
search for amplified genes in association with the metastatic phenotype is 
hampered by the enormous task of examining individual candidate genes (often 
oncogenes) unless an alternative approach is attempted. Searching for the 
amplification of DNA sequences without the specific selection of genes has been 
made possible by the technique of in-gel renaturation (Roninson, 1987). Due to the 
potential of this technique to enable the identification of reiterated DNA sequences 
without the prior knowledge of the encoded DNA sequence, this technique could 
prove powerful in the discovery of previously unidentified amplified genes which 
may have significance in the metastatic phenotype. Both CMT cell lines of this 
metastasis model were examined and compared by the technique of in-gel 
renaturation.
VII.2.1 In-Gel Renaturation
The technique of in-gel renaturation, as already mentioned, allows for the detection 
of reiterated sequences without the prior knowledge of the DNA sequence 
(Roninson, 1987 & see Figure 25). Details of this technique are given in section 
V.7.1.1. Briefly, whole genomic DNA was extracted from each cell line and from 
tissue samples of C57B/T animals, subjected to restriction endonuclease digestion 
and a portion of these digested DNAs were radioactively labelled with 32P using 
the T4 DNA polymerase replacement synthesis method (see section V.5.2), which 
allows for the incorporation of radiolabelled nucleotides whilst retaining the 
original size of the restriction fragment, this being a critical factor of in-gel 
renaturation. A 30-fold minimum excess of unlabelled driver DNA and labelled 
tracer DNA were mixed together and electrophoresed on a large agarose gel. After
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Figure 25. Diagrammatic Representation Of The In-Gel Renaturation Procedure
The technique of in-gel renaturation for the detection of amplified sequences 
without the prior knowledge of the sequence was developed by Roninson (1987). 
The critical features of this technique require that amplified sequences must be of 
the same molecular weight, as separated by agarose gel electrophoresis, and are 
present at a high enough copy number to enable renaturation of DNA contained in 
the agarose gel following denaturation (see section VII.2.1 for details).
Double-stranded (ds) genomic DNA
Restriction enzyme digestion & 
radioisotope labeling 'with T4 DNA polymerase
P-labeled ds fragments
^  Agarose gel electrophoresis
single-copy 
fragments 
(all ss)
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DNA
Denature
DNA
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anded (ds) 
fragments
single-stranded (ss) 
fragments
double
SI nuclease digestion
Elution of ssDNA2nd cycle of in-gel renaturation 
and SI nuclease digestion
repeated segments
Autoradiography
Diagrammatic representation of in-gel renaturation 
(adapted from Roninson, 1987)
electrophoretic separation of fragments according to molecular weight size, the 
DNA whilst still retained in the gel, was subjected to two cycles of DNA 
denaturation, renaturation and SI nuclease hydrolysis. These treatments were 
carried out under stringent conditions whereby only restriction DNA fragments 
which are present in multiple copies would be retained in the gel after elution since 
the higher local concentration of repeated fragments results in their higher 
efficiency of reassociation as double-stranded DNA. The gel was then dried down 
and an autoradiograph exposed. The resulting autoradiograph reveals a series of 
bands corresponding to reiterated DNA sequences separated according to their 
varying molecular weights. By comparison of the two cell lines it was hoped that 
differences would be revealed between these cell lines which may then be 
subsequently isolated and cloned and hopefully identified to be associated with the 
metastatic phenotype.
The detection limit of in-gel renaturation for reiterated DNA sequences was 
estimated by Roninson to be 40 - 50 copies for the mouse genome (Roninson, 
1987). Estimation of in-gel renaturation sensitivity was determined by the 
minimum amount of //zVzdllTdigested X phage which could be detected in mixtures 
with mouse genomic DNA and expressed as the number of copies per haploid 
genome. Since the size of X DNA is 49 kb and the approximate size of the 
mammalian haploid genome is 2.9 x 106 kb, then a mixture of lOOpg of 
mammalian DNA and 170ng of X DNA would correspond to approximately 100 
copies of X per mammalian genome. Based on these calculations, the sensitivity of 
the in-gel renaturation technique was determined for the experiments presented in 
this thesis. At varying ratios from 500 X copies per mouse genome to 30 copies per 
mouse genome, this sensitivity experiment was repeated as described by Roninson 
(Roninson, 1983; Roninson, 1987). However, a number of experiments following 
the described protocol of radioactively labelling premixed X and CMT 167/C6 or
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CMT 170/E9 DNAs and running the in-gel renaturation experiment as standard, 
did not reveal any bands on the resulting autoradiograph which corresponded to the 
expected sizes of X fragments (see Figure 26 for an example).
Since it did not appear reasonable that the sensitivity of this experiment was less 
than 500 copies, another strategy was attempted to estimate the sensitivity of this 
technique. Instead of radioactively labelling premixed X DNA with either CMT 
cell line DNAs, X DNA was radioactively labelled separately and subsequently 
aliquoted to appropriate concentrations of "cold" X DNA and CMT DNA to give 
the relative ratios of X DNA to M/idIII-digested CMT DNA varying between 
100:1 to 20:1. Subsequent analysis of these samples by in-gel renaturation 
demonstrated that X DNA fragments could readily be detected at 20-fold 
reiteration for high molecular weight fragments and at least 30 - 40 fold for lower 
molecular weights, such as the 500bp X HindIII DNA fragment (see Figure 27). 
The reasons why the original experiments designed to test the sensitivity of in-gel 
renaturation were unsuccessful remain elusive. Perhaps in a large mixture of 
fragments there is preferential radioactive labelling by T4 DNA polymerase of 
particular fragments. This point should be noted for subsequent experiments, since 
the results may not be representative of total genomic DNA, but may have some 
preferential selection. However, this point cannot be readily proven. It can be 
concluded, however, that the sensitivity of in-gel renaturation here is at least as 
efficient as reported by Roninson (1987).
Comparative in-gel renaturation analysis of the two CMT cell lines, in addition to 
normal syngeneic DNA, was carried out using several different restriction 
endonucleases since these would yield different results according to their 
restriction site within potentially amplified sequences. An example of such an 
experiment is illustrated in Figure 28. This experiment used a double restriction 
digest of BamHl and EcoRL to increase the number of lower molecular weight
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Figure 26. In-Gel Renaturation Sensitivity Experiment (1)
Attempts to estimate the lim it o f in-gel renaturation for the detection o f known  
copy numbers o f  HindUl digested X DNA in CMT genomic D N A  digested with 
EcoRl and HindUl follow ing the protocol described by Roninson (see section
VII.2.1 for details) were unsuccessful. No bands corresponding to the sizes o f  
HindlU restriction digested X D N A  can be detected, only the bands corresponding 
with in-gel renaturation-treated CMT 170/E9 restriction digested D N A s are seen.
Autoradiograph was exposed for 18 hours.
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Figure 27. In-Gel Renaturation Sensitivity Experiment (2)
M odification o f  the technique to estimate the limit o f detection o f  amplified  
sequences by in-gel renaturation follow ed essentially the same protocol as 
described by Roninson, except only the HindUl X D N A  was radioactively labelled, 
which was then m ixed with restriction digested genomic D N A  extracted from  
CMT 167/C6 cells. Mixtures were at known copy numbers o f X D N A :genom ic  
D N A  ratios, ranging between 100:1 to 20:1 (see Figure 27A). Autoradiograph was 
exposed for 12 hours.
Figure 27B. Longer exposure o f  the 0.5kb fragment (5 days).
Figure 27C. Ethidium bromide stained gel following electrophoresis, but prior to 
in-gel renaturation demonstrating the presence o f equal quantities o f  restriction 
digested genom ic D N A .
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Figure 28. Example O f An In-Gel Renaturation Experiment Comparing Both 
CMT Cell Lines And Normal Syngeneic DNA
In-gel renaturation proceeded as protocol comparing BamHl/EcoRl double 
restriction digested genom ics D N A s extracted from in vitro cultured cell lines 
CMT 167/C6 and CMT 170/E9. Comparison was also with normal, syngeneic 
D N A  extracted from a C57B/T liver and similarly restriction digested.
X HindUl markers were also radiolabelled and electrophoresed in parallel to 
approximate molecular weights. Each lane contained radioactive tracer D N A s o f  
9 x 106 cpm. Comparison o f  these restriction digested D N A s by in-gel renaturation 
did not reveal any differences in bands corresponding with differences in reiterated 
sequences present in either o f  the cell lines, nor o f normal syngeneic D N A .
Autoradiograph was exposed for 18 hours.
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fragments which are resolved more efficiently in in-gel renaturation. However, this 
and other similar experiments did not yield qualitative differences in bands 
representative of different repeated DNA sequences between the cell lines.
Interestingly though, comparison of HindLII digested normal syngeneic DNA with 
both CMT DNAs revealed a quantitative difference in a single band which was 
consistently seen in repeat experiments (see Figure 29). This band is seen in both 
CMT cell line DNAs, and therefore does not appear to be a repeat fragment which 
has been entirely lost in both cell lines, however it does appear that there is a 
marked reduction when the relative intensities of the bands are compared. It may 
be postulated that this sequence has been altered as a consequence of the artificial 
maintenance of cells in tissue culture in vitro, or alternatively it may be possible 
that this sequence is tumorigenicity-related as opposed to metastatically-related. 
As the major aim of this project was to identify potentially metastasis-specific 
alterations causative of the phenotypes displayed by the CMT cell lines, and the 
possibility that the difference noted here between normal cellular DNA and the 
DNA of both cell lines may only be a tissue culture artefact, this finding was not 
followed through during this research.
It can be concluded from these results that at the level of detection of reiterated 
sequences by the technique of in-gel renaturation, gene amplification does not 
appear to have a significant role in the metastatic phenotype of this model system. 
However, this does not preclude the possibility that gene amplification is important 
in metastasis since the detection level of in-gel renaturation is not sensitive to 
detect small amplifications of 20-fold or less. As gene amplification may have a 
significant effect even if only as little as 2-3 fold, this remains a mechanism which 
may be contributory to metastasis, but obviously the technique of in-gel 
renaturation is not sensitive to detect such small amplifications.
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Figure 29. HindHI In-Gel Renaturation Experiment Comparing Both CMT Cell 
Lines And Normal Syngeneic DNA
In-gel renaturation proceeded as protocol comparing HindUl restriction digested 
genomic DNAs extracted from in vitro cultured cell lines CMT 167/C6 and 
CMT 170/E9. Comparison was also with normal syngeneic DNA extracted from a 
C57B/T liver and similarly HindUl restriction digested.
Comparison between the two cell lines did not reveal any differences in reiterated 
DNA sequences. However, a single band was noted to be consistently of greater 
intensity in normal syngeneic DNA, as compared with either CMT cell lines (band 
marked with an arrow in Figure 29). The band is not absent in the two cell lines, 
but is of lower intensity, suggesting fewer copies of this sequence(s). Alternatively 
this may be a polymorphism differing between the cell lines and C57B/T DNA.
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VII.2.2 N-myc
Consideration was given to the possibility that gene amplification of N-myc may 
have occurred in correlation with the altered expression of NCAM in this model 
system (sse section VI.3.2). Previous evidence has linked the down-regulation of 
NCAM expression with the transfection and expression of N-myc in a rat 
neuroblastoma cell line, which also correlated with increased metastatic capacity 
(Akeson & Bernards, 1990). N-myc is known to be frequently amplified in 
advanced stage neuroblastomas (Brodeur et al., 1984), therefore the suggestion 
that N-myc amplification may be in direct association with decreased NCAM 
expression exhibited in this model was examined.
Southern analysis of N-myc copy number was assessed of both CMT cell lines and 
compared with normal syngeneic DNA (see Figure 30). From densitometric 
analysis, N-myc appears to be present in both cell lines at twice the normal copy 
number (see Figure 30C). The differences in intensities of the upper and lower 
bands between the cell lines and the normal syngeneic DNA is due to partial 
retsrictioi digest. Amplification of N-myc does appear to be correlated with the 
altered NCAM expression observed in these cell lines (see section VI.3.2), 
however, it is possible that N-myc is differentially expressed in the two cell lines 
which nay correlate with NCAM expression, but this possibility was not 
examined.
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Figure 30. Southern Analysis OfN-Myc In Both CMT Cell Lines And Compared 
With Normal Syngeneic DNA
Figure 30A. Ethidium bromide staining of electrophoresed DNA samples. Each 
sample contained lOfig of restriction digested DNA.
Lane 1: HindWl X DNA markers
Lane 2: HaeIII <j)X174 DNA markers
Lane 3: Hindlll digested normal, C57B/T kidney DNA
Lane 4: HindUl digested CMT 167/C6 DNA
Lane 5: HindWl digested CMT 170/E9 DNA
Figure 30B. Southern hybridization with an N-myc specific probe (a kind gift from 
K. Ryan).
Lane 1: Normal kidney 
Lane 2: CMT 167/C6 
Lane 3: CMT 170/E9
Figure 30C. Densitometric analysis of cumulative values of N-myc specific band 
intensities for each sample.
f TT/p",
c.
CMT 170/E9 
7.317
CMT 167/C 6 C57B/T kidney^
Upper band 7.251 2.308
Lower band 0.842 0.877 1.308
Total Value 8.159 8.128 3.616
Interestingly, the promoter region of the NCAM gene has been characterized and 
found to contain a number of species-conserved regulatory elements including a 
homeodomain binding sequence, an SP-1 element and an AP-1 element (Colwell 
et a l , 1992). Preliminary studies of Hox gene expression in these two cell lines 
(M. Jackson, Beatson Institute, personal communication) prompted further 
investigation into transcription factor DNA binding activities present in these two 
CMT cell lines (see chapter VIII).
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CHAPTER VIII TRANSCRIPTION FACTORS IN THE CMT MODEL
Transcription is of key importance in the regulation of cell growth and 
differentiation through the control of gene expression. Various reports have 
suggested that particular DNA recognition sequence motifs (cis-acting elements), 
which are recognized and bound by corresponding transcription factors (trans­
acting factors), are important in the regulation of certain cell adhesion molecules 
and extracellular matrix degrading proteases. Therefore, the divergent metastatic 
phenotypes of the two CMT cell lines described in this work may be expected to 
display differential regulation of transcriptional activities which may account for 
the observed phenotypes.
As a preliminary and general analysis for DNA:protein interactions of different 
transcription factors with sequence-specific oligonucleotides, electrophoretic 
mobility shift assays (EMSAs) were performed with nuclear protein extracts from 
both CMT cell lines (see sections V.6.2. & V.7.2 for methods). EMSA double 
stranded DNA probes are typically 20-40 bp in length (see Table 3 for 
oligonucleotide sequences used in EMSAs described). These probes were 
radioactively labelled at the ends of both strands using T4 polynucleotide kinase 
(see section V.5.4). Following gel purification, the 5' end-labelled probes were 
incubated with crude nuclear extracts from each cell line in the presence of a large 
excess of non-specific competitor poly(dl.dC) .poly(dl.dC). Transcription factors 
bind specifically and with high affinity to the short recognition sequences of DNA. 
However, they can also weakly bind non-specifically to random DNA sequences, 
therefore the incorporation of large quantities of poly (dl.dC) .poly (dl.dC) in the 
incubation reaction will compete for any non-specific binding thus allowing for the 
specific, high affinity binding of transcription factors to the labelled probe. The 
presence of non-specific DNA binding proteins which do not readily bind 
poly (dl.dC) .poly(dl.dC) can be distinguished from specific binding by
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Table 3 Oligonucleotides for electrophoretic mobility shift assays (EMSAs)
Name
NFkB
E3-AP-1
AP-2
PEA3
ERG
CIEBP
c-myb
Sequence Reference
5' CAA CGG CAG GGG AAT TCC CCT CTT 3'
5' CCG AAG TTC AGA TGA CTA ACT 
CAGGG3'
5' CCG GCC CCA GGC GT 3’
5' GAT CCT CGA GCA GGA AGT TCG 
AGA C 3'
5' GAT CTC TAG CTG AAT AAC CGG 
AAG TAA CTC ATC CTA GGA TC 3’
5' GCT GCA GAT TGC GCA ATC TGC AGC 3'
5’ TTC GGC ATA ACG GTT CCG TAG CC 3'
Ballard et al., 1990 
Hurst etal., 1987
J. O'Prey, 
unpublished data
Wasylyk et al.,
1990
Reddy & Rao,
1991
Landschulz et al., 
1988
Guehmann et al.,
1992
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transcription factors through the inclusion in a competition EMSA assay of either 
an excess of unlabelled probe which should compete for binding, or competition 
with another unrelated DNA sequence which, if the DNA binding is specific, 
should not compete for binding with the labelled probe. The DNA:protein 
complexes are resolved by low ionic strength, non-denaturing PAGE according to 
their size, charge and conformation.
VIII.1 NF-xB
NF-xB is composed of two subunits designated p65 and p50. Specific inhibition of 
p65, using anti-sense phosphorothio oligonucleotides, correlates with inhibition of 
cell adhesion of murine embryonic stem cells (Narayanan et al., 1993). 
Furthermore, stable transfection of a murine fibrosarcoma cell line with antisense 
p65 resulted in a reduced capacity to form tumours in vivo (Higgins et al., 1993). 
Indeed, antisense p65 constructs caused the regression of established primary 
tumours following induction of antisense p65 expression (Higgins et al., 1993).
NF-xB sites have also been identified in the promoter regions of the cell adhesion 
molecules E-selectin and P-selectin (Smith et al., 1993; Shu et al., 1993; Pan & 
McEver, 1993). Furthermore, NF-xB has been demonstrated to be involved in the 
transcription of the serine protease, urokinase plasminogen activator (Hansen 
et al., 1992). Potentially, NF-xB may be differentially regulating the expression of 
genes directly involved with the metastatic phenotype, therefore, NF-xB was one 
of the candidate transcription factors examined by EMSA. As illustrated in 
Figure 31 A, nuclear extracts from both cell lines demonstrated similar banding 
patterns corresponding with radioactively labelled double-stranded oligonucleotide 
sequence (probe) incorporating the consensus NF-xB element complexed with 
NF-xB subunits. DNA binding was not competed out with non-specific probes to 
Myb binding sites or AP-2 sites but was competed with the same unlabelled
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Figure 31. EMSA Demonstrating The Presence OfNFKB Oligonucleotide Binding 
Activity In Nuclear Protein Extracts From Both CMT Cell Lines
Figure 31 A. Nuclear protein extracts were prepared from both CMT cell lines as 
described in section V.6.2. Double-stranded, end-labelled NFk5-specific 
oligonucleotides were incubated with 1, 2, 5 and lOjig of nuclear extracts of each 
CMT 167/C6 and CMT 170/E9 cell lines, as described in section V .1.2. Following 
non-denaturing polyacrylamide gel electrophoresis, the gel was dried down and 
exposed to X-ray film for ~ 12 hours. Two complexes can be seen in extracts from 
both cell lines, marked with arrows. Uncomplexed, free oligonucleotide is labelled 
as "free probe".
Figure 31B. NFkB competition EMSA. Cold competitor NFkB oligonucleotide 
was added to the binding reactions simultaneously with the labelled 
oligonucleotide at 50-fold excess (+) or 100-fold excess (++). Non-specific 
competitors were added to reactions at 100-fold excess (++). No competitor is 
labelled (-). Oligonucleotide sequences are as detailed in Table 3.
Specific complexes are indicated with arrows.
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NF-xB  probe (see Figure 3IB), thus indicating the protein interactions with the 
NF-xB oligonucleotide were specific. However, it is also apparent that no striking 
differences, qualitatively or quantitatively, exist between the nuclear extracts from 
the cell lines in this analysis.
VIII.2 PEA3&AP-1
The PEA3 DNA binding motif, first recognized in the polyomavirus enhancer, can 
complex with members of the Ets family of transcription factors in vitro, 
including: c-Ets-1, c-Ets-2, Elk-1 and the PEA3 protein (Wasylyk et al., 1990; Rao 
& Reddy, 1992; Xin et al., 1992). The AP-1 motif can complex with the 
transcription factor AP-1, is a composite factor consisting of heterodimers between 
the protein products of c-fos and c-jun gene family members (Curran & Franza, 
1988). Fos:jun heterodimers are stable complexes which bind strongly to AP-1 
sites and activate transcription (Smeal et al., 1989). Whereas jun can form 
homodimers which only weakly bind AP-1 sites, fos is unable to homodimerize 
and therefore does not activate transcription (Smeal et al., 1989).
Adjacent PEA3-\\ke and AP-1 motifs have been identified in the promoters of 
various genes including the extracellular degrading enzymes matrilysin, 
collagenase and urokinase (Gaire etal., 1994; Gutman & Wasylyk, 1990; Nerlov 
et al., 1992). Furthermore, an AP-1 site is also present in the promoter region of 
stromelysin, in addition to two c-Ets-1 binding sites, although these elements do 
not appear to act synergistically in stromelysin transcription (Wasylyk et al., 
1991). It is apparent that the transcription factors which complex with the PEA3 
and AP-1 motifs may significantly influence the metastatic phenotype through the 
control of the expression of extracellular matrix degradative enzymes which are 
characteristic of invasive and metastatic tumours (see section 1.2.3). PEA3 has also 
been found to be overexpressed in /zez/-induced mammary carcinomas which had
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metastasized to the lung in a mouse model (Trimble et al., 1993). Therefore, 
nuclear proteins prepared from both CMT cell lines were examined for their 
DNA:protein interactions with oligonucleotides encompassing the recognition 
sequences of PE A3 and AP-1 by EMSA.
Protein interactions with the PEA3 oligonucleotide of both CMT cell lines gave 
virtually identical band shifts (see Figure 32A). The three major bands which can 
be seen on the gel are competed out with increasing concentrations of non­
radioactive PEA3 oligonucleotide, indicating that these DNAiprotein interactions 
are specific (see Figure 32B). The lower complex, which is of greatest mobility, is 
relatively broad and may be indicative of more than one complex present in close 
proximity to each other. Alternatively, it may be possible that this broad band 
represents some degradation products. However, it appears that there are no major 
alterations in the presence or quantity of different Ets-related proteins which can 
bind with the PEA3 recognition sequence present in either CMT cell lines. This 
may be interpreted as a slightly surprising result since both cell lines possess 
dramatically different metastatic phenotypes and it is realised that PEA3, together 
with AP-1, contributes to the regulation of different extracellular matrix degrading 
enzymes. On the other hand, earlier experiments assaying for the production and 
secretion of collagenase matrix metalloproteinases by zymography (see section 
VI.2.6) revealed that neither cell line apparently secretes either inactive 
procollagenase or active collagenases. Therefore, the matrix degrading enzymes 
may not be a significant factor in the metastatic phenotype in this model system.
Examination of the DNA: protein interactions with an AP-1 -specific 
oligonucleotide revealed subtle differences between nuclear extracts prepared form 
CMT 167/C6 and CMT 170/E9 cell lines which was repeated in three different 
experiments. A predominant AP-1 band shift is seen in CMT 167/C6 extracts 
which is also seen in CMT 170/E9 band shifts, however, the intensity of the band
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Figure 32. EMSA Demonstrating The Presence Of PE A3 Oligonucleotide Binding 
Activity In Nuclear Extracts From Both CMT Cell Lines
Figure 32A. Nuclear protein extracts were prepared from both CMT cell lines as 
described in section V.6.2. Double-stranded, end-labelled PEA3-specific 
oligonucleotides were incubated with 1, 2, 5 and lOjug of nuclear extracts of each 
CMT 167/C6 and CMT 170/E9 cell lines, as described in section V.7.2. Following 
non-denaturing polyacrylamide gel electrophoresis, the gel was dried down and 
exposed to X-ray film for -12 hours. Two major complexes can be seen in extracts 
from both cell lines, marked with arrow. Uncomplexed, free oligonucleotide is 
labelled as "free probe". The PEA3 oligonucleotide sequence is detailed in Table 3.
Figure 32B. PEA3 competition EMSA. Cold competitor PEA3 oligonucleotide 
was added simultaneously with the labelled oligonucleoide at equal concentrations 
(+) or 10-fold excess (++). No competitor is labelled (-). Specific complexes are 
labelled with arrows.
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shift appears greater in CMT 167/C6 extracts in comparison with CMT 170/E9 
extracts (see Figure 33A). This result indicates increased AP-1 transcriptional 
activity in CMT 167/C6 cells in comparison with CMT 170/E9 cells. However, it 
should be taken into account that CMT 167/C6 cells grow marginally faster than 
CMT 170/E9 cells (see section VI.2.2), and the nuclear extracts were prepared 
from logarithmically growing cells in the presence of 10% serum. Therefore, this 
result may be a reflection of the slightly differing growth rates. A further 
experiment to examine this point would be to assay nuclear extracts prepared from 
cells cultured in low (0.5%) serum.
Another complex of higher mobility (labelled "X" in Figure 33A) is seen in 
extracts of CMT 170/E9 which is present to a much lesser extent in CMT 167/C6 
extracts. It is not clear whether this is a specific AP-1 complex or not, although it 
does seem to be competed with cold probe, but its presence appears to be variable 
between experiments. However, the strong AP-1 complex is specifically competed 
with the same, non-radioactively labelled oligonucleotide and is not competed in 
the presence of other unrelated oligonucleotides (see Figure 33B).
Vin.3 Erg
Another member of the Ets-superfamily of transcription factors is Erg (Reddy, Rao 
& Papas, 1987). Different Erg isoforms are encoded in a single erg gene through 
alternative sites of splicing and polyadenylation, together with alternative sites of 
translation initiation (Rao, Papas & Reddy, 1987; Duterque-Coquillaud etal., 
1993).
Analysis of the DNA:protein interactions with an Erg-specific oligonucleotide and 
nuclear protein extracts prepared from both CMT cell lines revealed a single 
predominant band shift in an EMSA (see Figure 34A). This band shift displays no 
quantitative difference between the two cell lines which could correlate with the
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Figure 33. EMSA Demonstrating The Presence Of AP-1 Oligonucleotide Binding
Activity In Nuclear Protein Extracts From Both CMT Cell Lines
Figure 33A. Nuclear protein extracts were prepared from both CMT cell lines as 
described in section V.6.2. Double-stranded, end-labelled E3-AP-1 -specific 
oligonucleotides were incubated with 1, 2, 5 and lOpg of nuclear extracts of each 
CMT 167/C6 and CMT 170/E9 cell lines, as described in section V.7.2. Following 
non-denaturing polyacrylamide gel electrophoresis, the gel was dried down and 
exposed to X-ray film for -12 hours. An intense complex can be seen in extracts 
from both cell lines, although more intense in CMT 167/C6 extracts (marked with 
an arrow). A higher mobility complex is also faintly seen, which is labelled "X". 
Uncomplexed, free oligonucleotide is labelled as "free probe".
Figure 33B. AP-1 competition EMSA. Cold competitor E3-AP-1 oligonucleotide 
was added to the binding reactions simultaneously with the labelled 
oligonucleotide at 50-fold excess(+) or 100-fold excess (++). Non-specific 
competitor oligonucleotides were added to 100-fold excess (++). No competitor is 
labelled (-). Oligonucleotide sequences are detailed in Table 3. Specific AP-1 
complex is indicated.
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Figure 34. EMSA Demonstrating The Presence Of Erg Oligonucleotide Binding
Activity In Nuclear Extracts From Both CMT Cell Lines
Figure 34A. Nuclear protein extracts were prepared from both CMT cell lines as 
described in section V.6.2. Double-stranded, end-labelled erg-specific 
oligonucleotides were incubated with 1, 2, 5 and lOfig of nuclear extracts from 
both CMT 167/C6 and CMT 170/E9 cell lines, as described in section V.7.2. 
Following non-denaturing polyacrylamide gel electrophoresis, the gel was dreid 
down and exposed to X-ray film for -12 hours. One major complex can be seen in 
extracts from both cell lines, marked with an arrow. Uncomplexed, free 
oligonucleotide is labelled as "free probe".
Figure 34B. Erg competition EMSA. Cold competitor erg oligonucleotide was 
added simultaneously to the binding reactions with labelled oligonucleotide at 
equal concentrations (+) or 10-fold excess (++). No competitor is labelled (-).
erg-specific oligonucleotide sequence is detailed in Table 3.
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different metastatic phenotypes. The specificity of this complex was confirmed 
through the competitive binding of the band shift with the same unlabelled 
oligonucleotide (see Figure 34B).
VIII.4 CIEBP
The family of C/EBP transcription factors, the term being derived from 
CCAAT/enhancer-kinding protein, has been associated with the cellular process of 
terminal differentiation (Birkenmeier et al., 1989; Friedman, Landschulz & 
McKnight, 1989; Christy et a l , 1989). Since malignancy is frequently associated 
with loss of differentiation, the presence or absence of C/EBP transcription factors 
was assayed by EMSA.
From repeat experiments with a CIEBP-specific oligonucleotide, four distinct 
complexes were found (see Figure 35A). Each of these complexes are present in 
both CMT cell line extracts, however, it appears that the complex termed a4 is less 
abundant in CMT 170/E9 nuclear extracts in comparison with CMT 167/C6 
nuclear extracts. The other complexes termed al, a2 and a3, appear to be at 
comparable levels in the two cell lines. Further analyses were not carried out to 
examine which components were present in the a4 complex since these 
experiments were only of a preliminary nature. However, it appears that complexes 
al-a4 are all specific since they are efficiently competed with cold probe and not 
affected by competition with unrelated oligonucleotides (see Figure 35B). The 
conflicting expectation of poorer differentiation to be associated with the high 
metastatic potential cell line, CMT 167/C6 and the result presented here with 
CMT 170/E9 displaying less apparent C/EBP abundance of complex a4 is 
addressed in the Discussion (see section DC3).
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Figure 35. EMSA Demonstrating The Presence O f CIEBP Oligonucleotide
Binding Activity In Nuclear Extracts From Both CMT Cell Lines
Figure 35A. Nuclear protein extracts were prepared from both CMT cell lines as 
described in section V.6.2. Double-stranded, end-labelled CIEBP specific 
oligonucleotides were incubated with 1, 2, 5 and 10p,g of nuclear extracts of each 
CMT 167/C6 and CMT 170/E9 cell lines, as described in section V.7.2. Following 
non-denaturing polyacrylamide gel electrophoresis, the gel was dried down and 
exposed to X-ray film for -12 hours. Four complexes can be seen in extracts from 
both cell lines, labelled al, a2, a3 and a4. Uncomplexed, free oligonucleotide is 
labelled as "free probe".
Figure 35B. C/EBP competition EMSA. Cold competitor CIEBP oligonucleotide 
was added to the binding reactions simultaneously with labelled oligonucleotide at 
50-fold excess (+) or 100-fold excess (++). Non-specific competitors were added 
to reactions at 100-fold excess (++). No competitor is labelled (-). Oligonucleotide 
sequences are detailed in Table 3.
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DISCUSSION
CHAPTER IX GENERAL DISCUSSION
Fundamental questions about metastasis can be expressed simply. For example, 
why are particular tumour cells metastatic and therefore what characterizes a 
metastatic cell? How does metastasis arise and which step(s) is(are) crucial to the 
metastatic process? Unfortunately, these questions, as to be expected, are not so 
simply answered.
Metastasis appears to be a highly complicated process with multiple stages through 
which the potentially metastatic cell must apparently progress successfully (see 
Chapter I). It can be envisaged that for primary tumour establishment there is loss 
of various regulatory mechanisms, such as loss of checkpoints in the cell cycle 
involving for example, pRb or p53 (reviewed by Hinds & Weinberg, 1994) which 
prevent inappropriate cell proliferation, or loss of the cell's ability to undergo 
programmed cell death or apoptosis (reviewed by Stewart, 1994). Metastasis could 
be envisaged to arise from further losses in normal cellular regulation. One such 
normally controlled regulation is the maintenance of the integrity of the organ 
tissue: once differentiated, cells are confined within the structured organ 
environment (an exception being the haematopoetic system), breakdown of this 
integrity would lead to cellular disorganization, as is essentially seen in invasion 
and metastasis. Further still, it may be also considered that metastasis is a transient 
or cyclical event since secondary tumours must re-establish in a distant organ and 
induce angiogenesis for example (see section 1.2.6), which is also necessary in the 
establishment of the primary tumour. Thus the metastatic phenotype may not be 
constitutively expressed, but induced under appropriate conditions. Additionally, 
metastasis may not be an entirely "programmed" event, but instead may contain a 
degree of randomness. This can arise from the chance events of certain tumour 
cells which are beginning to invade the normal surrounding stroma encountering a 
blood vessel or lymphatic channel thus allowing for these tumour cells to gain
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access to the circulation leading to their spread. Furthermore, tumour cells which 
gain access to the circulation require to survive such indiscriminate factors as shear 
stress and mechanical forces before depositing in a secondary site. Therefore, due 
to the complexity of metastasis and our limited understanding of the disease, 
clinical applications to the treatment of patients with cancer and metastasis remains 
poor. However, present research has led to some insight into the various steps of 
metastasis and a large proportion of this work has arisen through the use of 
models.
The study of the metastatic phenotype described in the previous sections (Chapters 
VI, VII & VIII) was founded upon a model system which was essentially two 
variant cell lines derived from the same spontaneous tumour and possessing 
different metastatic phenotypes. This CMT model of metastasis had not been 
previously studied to any great extent, therefore, a large proportion of this work 
examined the essential characteristics of the CMT cell lines, with some speculative 
research attempting to discover some possible clues to the nature of the metastatic 
phenotype in this model. By comparison of the two cell lines which differ in their 
metastatic capacities, it was hoped that some differences would be detected by the 
methods employed which may be implicated with the metastatic phenotype. These 
alterations, if found, would have been examined to determine their significance in 
metastasis using transfection experiments.
IX. 1 Biological Characterization Of The CMT Model
A vital consideration of the CMT model of metastasis was the maintenance of the 
phenotypes originally described by Layton & Franks (1984). Periodical assessment 
of the phenotypes of the cell lines CMT 167/C6 (high metastatic potential) and 
CMT 170/E9 (low metastatic potential) were routinely carried out using the
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spontaneous metastasis assay in immunocompetent syngeneic animals (see section 
VI. 1). Both cell lines were confirmed to have retained their respective differences 
in metastatic potential throughout the course of this work. This assurance was 
critical as phenotypic drift is recognized to occur as a consequence of the culture 
of cell lines under artificial conditions in vitro, which would therefore affect the 
outcome of any studies relating to the metastasis-associated characteristics (see 
chapters VI and VII).
Additionally, the possibility that the metastatic potentials of both cell lines merely 
correlated with proliferative capacity was also discounted following studies of 
in vitro growth rates. The two cell lines exhibited almost identical growth curves 
in vitro, in contrast to their substantially different metastatic potentials in vivo as 
assayed in the spontaneous metastasis assay in C57B/T animals. The average 
number of metastatic deposits from CMT 167/C6 tumours was 53 in comparison to 
CMT 170/E9 tumours which had an average of 2 metastatic deposits. However, to 
take into account differing growth rates of tumours in vivo, the number of 
metastatic deposits were counted and compared of tumours at equivalent tumour 
volumes and metastatic potentials were found to be a minimum of a ten-fold 
difference. Although an initial lag phase in tumour growth was noted of 
CMT 170/E9 cells in comparison with CMT 167/C6 cells in C57B/T animals (see 
Figure 4), at four weeks post-injection, tumour burdens were of equivalent sizes. 
The differing metastatic phenotypes of these two CMT cell lines does not appear to 
be simply a consequence of differing proliferation rates, but is indeed a result of 
some other fundamental difference between the two cell lines.
Expression studies of NCAM and E, N and P-cadherins in the CMT metastasis 
model (see section VI.3) have revealed that both E-cadherin and NCAM are 
expressed at quantitatively higher levels in the low metastatic potential cell line, 
CMT 170/E9, than in the related high metastatic potential cell line CMT 167/C6.
164
The inverse correlation between the expression of these cell adhesion molecules 
and the metastatic potentials agrees with the hypothesis that reduced intercellular 
adhesion contributes to the overall invasive and metastatic behaviour of 
tumorigenic cells by allowing cell detachment from the primary tumour mass. 
Appropriate studies to further examine this hypothesis in the CMT model would be 
transfection experiments examining the effect of increasing the expression levels 
of one or both cell adhesion molecules, E-cadherin and NCAM, in the cell line 
CMT 167/C6. Following stable transfection, the metastatic potential of the 
transfected CMT 167/C6 cell line could be compared with non-transfected 
CMT 167/C6 cells and mock-transfected CMT 170/E9 cells. The expected result, 
if decreased cell-cell adhesion confers an advantage for cell detachment from the 
primary tumour prior to tumour dissemination to secondary sites, would be a 
suppression in the observed metastatic capacity of transfected cells. Conversely, 
transfection of the low metastatic potential cell line CMT 170/E9 with anti-sense 
constructs to either cell adhesion molecule and comparison of metastatic potentials 
would be predicted to enhance metastatic potential. Similar experiments to these 
have successfully demonstrated transfection of each E-cadherin and the a4 integrin 
subunit to form functional a4pl integrin, suppress the invasive properties of 
tumorigenic cells which express low protein levels of these cell adhesion 
molecules (Vleminckx et ah, 1991; Qian et al., 1994). Therefore, these 
experiments substantiate the hypothesis that cell adhesion is a critical determinant 
in invasion of tumour cells in vivo and this conclusion would be expected to be 
supported from the above described experiments in this CMT metastasis model.
Unfortunately, the corresponding predicted increase in cell-matrix interactions, 
primarily through integrin-mediated adhesion, allowing for active dissemination 
into the extracellular matrix during invasion and extravasation processes of the 
different integrin protein subunits, could not be investigated with the materials
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available at the time of this work. Analysis of the mRNA expression levels of the 
different integrin subunits could have been examined; however, the ultimate 
criteria is the expression of a functional integrin receptor which influences the cells 
behaviour, and measurement of mRNA abundances is much less informative than 
that of cell surface protein levels.
Noteworthy of these cell adhesion studies (see section VI. 3) is the modulatory 
nature of the expression of the different cell adhesion molecules. There were no 
instances discovered of one cell line expressing a particular cell adhesion molecule 
and the other cell line without the expression of the same cell adhesion molecule. 
This indicates that metastasis may not be strictly dependent on an "all-or-nothing" 
expression of a single specific metastasis gene or inactivation of a metastasis- 
suppressor gene. Instead, metastasis may involve a number of modulatory changes 
of a quantitative nature.
Preliminary results which also suggest this conclusion arise from the 2-D gel 
analysis of total cellular proteins prepared from both cell lines (see section VI.4). 
Surprisingly, the two related CMT cell lines, although markedly different in their 
metastatic capacities, have apparently remarkably few differences in expressed 
proteins as resolved by 2-D gel analysis. Indeed, from the 2-D gel analysis, it 
appears that no qualitative differences can be readily associated with either the low 
or high metastatic properties. This suggests that metastatic potential may be 
consequence of a number of subtle alterations in the expression of normal cellular 
proteins. Another possibility is that metastasis may be a transient property which is 
induced only in responsive cells under appropriate conditions in vivo. Therefore, 
transient alterations which may occur within the cell concomitant with the onset of 
the metastatic process are unlikely to be detected either by 2-D gel analysis or, if 
signal transduction pathways involving the tyrosine kinases are affected, by
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phosphoamino acid analysis. Indeed, quantification of protein phosphotyrosine 
content by phosphoamino acid analysis revealed approximately equal 
phosphotyrosine content in both CMT cell lines.
The qualitative differences noted in the 2-D gel analysis, if found to be consistent 
in repeat experiments, could be very interesting to follow up. However, due to the 
present lack of a database for information regarding 2-D gel analyses of murine 
epithelial cells, which is available for rat fibroblasts and human keratinocytes 
(Celis et al., 1990), the identification of the protein(s) of interest would require 
microsequencing and / or possible screening of immunoblotted 2-D gels with 
antibodies specific to candidate proteins. These proteins would be chosen because 
of their similarity in estimated pH values and molecular weight sizes to the 
resolved proteins of interest. However, further experiments obviously require to be 
carried out before such experiments are attempted.
IX.2 Molecular Genetics Analyses Of The CMT Model
Associated with metastatic phenotype in some model systems are a few putatively 
metastasis-associated genes. These include CD44, mts-1 and nm23 (see 
section II.3). The expression of both CD44 and mts-1 were examined in this model 
system, however nm23 was not chosen to be studied for the following reasons: 
firstly, nm23 mRNA expression and its nucleoside diphosphate kinase activity 
have not been consistently correlated with the proposed metastasis suppressor 
activity in tumour samples (Myeroff & Markowitz 1993; Sastre-Garau et a l, 1992; 
Haut etal., 1991); secondly, in the experimental model system reported by Leone 
et al. (1991), transfection of nm23 into the TK cell lines did not, in my opinion, 
convincingly alter metastatic potential, but did appear to affect cell viability after 
transfection, in comparison with control transfections, and inhibit the in vivo 
tumour forming capacities and growth rates of the transfected cells. These results
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suggest that nm23 may not be directly causing altered metastatic potential, but 
instead may be affecting cell survival / proliferation. Since nm23 has not been 
convincingly demonstrated as a metastasis-specific gene and it would be 
impossible to analyse every candidate metastasis gene in this study, nm23 mRNA 
expression was not examined in this model.
IX.2.1 CD44 Expression
Expression of variant isoforms of CD44 has been associated with the activation of 
T cells (Arch et al., 1992; Haegel et a l, 1993) and has been postulated to be 
involved in homing of these T cells to lymph nodes (Wu et al., 1993, Arch et al., 
1992). Similarities can be suggested between homing of activated T cells and 
metastatic cells which spread through the lymphatic system. Therefore, expression 
of variant isoforms of CD44 could be expected to be involved in metastasis. This is 
also apparent from recent studies of a rat metastasis model in which expression of 
particular CD44 variant exons appear to be strongly correlated with metastatic 
capacity (Gunthert etal., 1991; Rudy et al., 1993). Expression of CD44 and 
possible variant isoforms was also examined in this model.
Examination of CD44 expression adopted an RT-PCR /  Southern hybridization 
approach (see section VII. 1.1). This method allowed for the detection of all 
possible alternatively spliced transcripts of CD44 expressed in either of the two 
CMT cell lines. Although at the time of this study, alternative splicing of murine 
CD44 had not been reported as had been reported of rat CD44 (Gunthert et al., 
1993; Rudy et al., 1993) and of human CD44 (Screaton et al., 1992; Screaton 
e ta l, 1993), it was predicted that murine CD44 would be similarly capable of 
undergoing alternative splicing as was later demonstrated to be the case (Screaton 
et al., 1993). However, as found in both CMT cell lines, no alternatively spliced 
isoforms of CD44 were discovered. Only the expected standard form, also known
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as pgp-1, was detected by Southern hybridization. This was found in both RNAs 
extracted from cells grown in culture and from RNAs extracted from primary 
tumours. Therefore, alternative splicing was not observed in cells growing under 
artificial conditions nor are other isoforms induced in vivo. Since alternative 
splicing of CD44 is still not understood, although it is recognised to occur 
transiently in such cells as T cells upon their activation (Arch et al., 1992; Haegel 
et al., 1993), the significance of the expression of alternative CD44 isoforms for 
example, in the rat metastatic model system, remains to be elucidated. Apparently 
it is not a significant factor in the CMT model system since it would be anticipated 
that with the sensitivity of PCR methodology, that the presence of any alternative 
transcripts of CD44 would be readily detected.
IX.2.2 Mts-1 Expression
Another gene reported to be metastasis-associated was mts-1 (Ebralidze et al.,
1989). However, although this gene has been reported to be expressed in 
association with various metastatic cell lines and in lipopolysaccharide (LPS)- 
stimulated macrophages, expression was not detectable in either CMT cell line, nor 
was it detected in putatively-positive controls of B16 melanoma cells or LPS- 
stimulated bone marrow-derived macrophages. Considerable effort was given to 
determine if the cause of this negative result was due to technical failure or due to 
other reasons. Northern analysis of actin expression was readily detectable, 
therefore the technique of northern analysis was not at fault. The mts-1 plasmid 
insert was sequenced and found to encode the correct sequence (Tulchinsky et al.,
1990) and therefore the appropriate probe was being used (mts-1 plasmid a kind 
gift from Lukanidin). In addition, this insert was successfully used to probe a 
Southern blot and therefore was fully capable of hybridizing to DNA on 
nitrocellulose in a specific manner. Together, these experiments appear to confirm 
that mts-1 expression is undetectable in either of the CMT cell lines. The link
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between mts-1 expression and metastasis still remains tenuous since no further 
evidence has been reported to further substantiate the putative association between 
mts-1 and metastasis. Since it appears to be related to the S100 family of 
calcium-binding proteins (reviewed by Kligman & Hilt, 1988), the association 
seen may be related to cytoskeletal reorganization associated with active migration 
seen in cells such as activated macrophages and invasive cells. Mts-1 expression 
may not therefore be causative of the metastatic phenotype, but is instead 
modulated in response to the invasive behaviour of metastatic cells.
IX.2.3 Gene Amplification
Earlier when this study was attempted, it was postulated that gene amplification 
may have a role in the acquisition of the metastatic phenotype. Amplification of 
N-myc, for example, has been recognised to occur in, and correlate with, advanced 
stage neuroblastomas (Brodeur et al., 1984). However, although the presence of 
cytogenetically identified elements of gene amplification (homogeneously staining 
regions and double minutes) are often recognised in association with malignant 
tumours, the genes contained in these elements often elude identification. In an 
attempt to screen for gene amplification present in the CMT cell lines which may 
be involved in the metastatic phenotypes, without prior selection of candidate 
genes which could be analysed by Southern hybridization techniques, the 
technique of in-gel renaturation was tested.
This technique as explained earlier (see section VII.2.1) can detect amplified 
sequences without previous knowledge of the encoded sequence. Roninson had 
estimated the limit of detection for the mouse genome of reiterated DNA 
sequences to be ~40 copies (Roninson, 1987). The experiment described by 
Roninson to determine this detection limit was repeated in order to confirm that the 
experiments carried out in this work was at least as sensitive as expected.
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Curiously, using the same protocol as described for the detection of known copy 
numbers of X DNA, up to 500 copies were "undetectable". This was obviously not 
an accurate result since the technique itself was operational and bands representing 
reiterated sequences contained in the murine genome were readily detectable and 
not all, if any, of these would be present at a greater than 500-fold copy number. 
Subsequent experiments using a modified protocol allowed for the determination 
of repeated sequences to be readily detected at 20 copies per murine genome (see 
section VII.2.1). The ensuing analysis of the two CMT cell lines for the presence 
of reiterated sequences in comparison with normal syngeneic DNA revealed no 
differences between the two CMT cell lines subsequent. Surprisingly, a consistent 
reiterated sequence was found to be present at a higher copy number in the normal 
syngeneic DNA as compared with both cell lines, as estimated by the relative 
intensities of the corresponding bands. This reiterated sequence may be related to 
the establishment and maintenance of the cell lines in vitro, possibly with relation 
to the tumorigenic nature of the cell lines, or alternatively this may represent a 
polymorphism which has occurred subsequent to the formation of the original 
tumour. This polymorphism would be retained in the CMT cell lines and would 
thus differ from normal syngeneic DNA. Since the difference identified was not 
between the two cell lines and therefore most likely not to be directly related with 
the metastatic phenotypes of these two CMT cell lines, this reiterated sequence 
was not pursued during this work. However, as already noted earlier, although no 
differences were detected between the two cell lines as analysed by in-gel 
renaturation, this does not preclude the possibility that gene amplification is an 
important phenomena in metastasis. Gene amplification may be of significance at 
less than 20-fold amplification of a particular gene and therefore the technique of 
in-gel renaturation would not be sensitive enough for their detection.
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The presence of amplified sequences in the conformation of inverted repeat 
duplications was also briefly analysed. The technique used was described by Ford 
& Fried (1986) and was a relatively simple procedure of intrastrand duplex 
formation and analysis (see Figure 36 for a simplified representation). Purified 
genomic DNA was subjected to denaturation followed by rapid renaturation and 
SI nuclease hydrolysis. The rapid renaturation step favours the annealing between 
only homologous sequences containing inverted duplications which are in direct 
proximity, thus forming intrastrand duplexes ("snap-backs") which are SI nuclease 
resistant. Purified intrastrand duplexes, after SI nuclease treatment, were either 
electrophoresed on an agarose gel and probed specifically for a candidate gene or 
non-specifically with restriction digested whole genomic DNA for a non-specific 
analysis following Southern transfer. Alternatively, purified intrastrand duplexes 
were used to probe a Southern blot of restriction digested genomic DNA. These 
analyses did not yield the specific detection of amplified sequences which were 
present in either cell line as inverted DNA sequences which may have been related 
with the metastatic phenotypes (data not shown).
The analysis of gene amplification by non-specific methods did not yield results 
pertaining to the metastatic phenotype, however, the specific analysis of one 
particular gene was examined. Consequent to the finding that NCAM had increased 
expression in the low metastatic cell line, CMT 170/E9, in comparison with the 
related cell line CMT 167/C6 (see section VI.3.2), and the realization that in 
another system, the transfection of N-myc into a rat neuroblastoma cell line caused 
down-regulation of NCAM expression and increased metastatic capacity (Akeson 
& Bernards, 1990), N-myc copy number was examined by Southern analysis. 
However, as estimated from the Southern blot, both cell lines possess equal copy 
numbers of N-myc. Therefore, in this model system of metastasis which does 
exhibit altered expression levels of NCAM correlating inversely with the
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Figure 36
173
Figure 36. Schematic Illustration Of Inverted Repeat DNA Analysis
This technique was described by Ford & Fried (1986) to detect the presence of 
repeated sequences which are in the inverted conformation. The rapid renaturation 
step favours the annealing between only homologous sequences which contain 
inverted duplications and are in direct proximity. These intrastrand duplexes can 
be specifically enriched by S1 nuclease hydrolysis of single-stranded DNA before 
analysis by Southern transfer techniques (details in section IX.2.3).
Inverted Repeat DNA Sequences
D enature and rapidly 
renature DNA
S tem -lo o p  s tru c tu re  
o f in v erted  d u p lic a te  D N A
SI nuclease hydrolysis 
o f single-stranded DNA
Purify and analyse by Southern hybridization
Diagram m atic illustration o f the technique for the detection of 
inverted repeat DNA sequences
metastatic phenotype (see section VI.3.2), no correlation was observed with N-myc 
copy number, unlike the report by Akeson & Bernards (1990). It may be that 
alterations of N-myc are present at the level of mRNA expression or the protein in 
this model system, but these possibilities were not examined due to time 
constraints. In addition, this model system is not neuroblastoma-derived unlike 
Akeson & Bernards', and therefore there may be tumour specificity in the effect of 
N-myc on NCAM expression. Indeed, the mechanism by which N-myc alters 
NCAM expression may not be a direct effect, but a secondary event. Therefore, in 
the CMT model, N-myc itself may not be targeted but instead a component 
downstream of N-myc is altered which in turn modulates NCAM expression.
IX.3 DNA Binding Activities Of Transcription Factors In The CMT Model
Interestingly, the promoter region of the NCAM gene has been characterized and 
found to contain a number of species-conserved regulatory elements including a 
homeodomain binding sequence, an SP-1 element and an AP-1 element (Colwell 
et al., 1992). Further still, in transfection studies using NIH 3T3 cells and Xenopus 
laevis Hox expression vectors, strong induction of NCAM expression by Hox-2.5 
was demonstrated, an effect which was abolished by Hox-2.4 in co-transfections 
(Jones et al., 1992). It is possible that these Hox genes, which can regulate the 
transcription of NCAM, may be involved in the differential expression of NCAM 
seen in the CMT model. Indeed, preliminary evidence has indicated the cell line 
CMT 170/E9 (low metastatic potential) which displays high NCAM expression in 
comparison with CMT 167/C6 (high metastatic potential), also exhibits expression 
of Hox-3.2 (M. Jackson, Beatson Institute, personal communication). Hox-3.2 is a 
paralogue of Hox-2.5 and it may be postulated that Hox-32  has a similar 
regulatory role of cell adhesion molecule expression as Hox-2.5, thus this gene 
could also influence the metastatic phenotype.
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Further to this finding, preliminary analysis was carried out to determine the 
transcription factor DNA binding activities of crude nuclear protein extracts 
prepared from both CMT cell lines. The transcription factors analysed have been 
previously shown to be important in the control of the expression of a number of 
genes important in metastasis. These include many of the matrix-degrading 
enzymes and cell adhesion molecules. Curiously though, differences in binding 
activity to an oligonucleotide specific for NFkB and related Rel proteins were not 
apparent between the cell lines. This was surprising since NFkB has been strongly 
implicated in the process of cell adhesion (Narayanan et al., 1993; Smith et al., 
1993; Pan & McEver, 1993; Shu et al., 1993). However, it may be that the cell 
adhesion molecules which are subject to regulation by NFkB are not the specific 
molecules which are altered in their expression in this CMT model of metastasis. 
Indeed the cell adhesion molecules known to contain NFkB recognition sequences 
in their promoter regions include E- and P-selectin and ELAM-1, which have not 
been examined in this model and it is unknown if their expressions are altered in 
either of the cell lines.
Again, no significant differences in DNA .-protein interactions were noted for a 
PEAi-specific oligonucleotide. PE A3 together with AP-1 have been shown to be 
adjacent motifs in the promoter regions of the matrix-degrading enzymes 
matrilysin, collagenase and urokinase (Gaire et al., 1994; Gutman & Wasylyk, 
1990; Nerlov et al., 1991). However, earlier experiments analysing the expression 
of Type IV collagenases by zymography (section VI.2.6) did not detect the 
expression in either cell line of active or inactive proenzymmatic forms, and 
therefore it may not be entirely surprising that differences in PE A3 DNA binding 
activity were not observed.
Subtle differences were noted in AP-1 DNA binding activity. Increased AP-1 
activity was apparent in CMT 167/C6 nuclear extracts. However, because these
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experiments were performed with crude nuclear extracts prepared from 
logarithmically growing cells, this slight quantitative change in DNA binding 
activity may be due to subtly different proliferation rates. To examine this 
question, further experiments need to be attempted with nuclear extracts prepared 
from cells maintained in 0.5% serum to eliminate the possible interference of 
serum stimulation in the interpretation of these results.
Another family of transcription factors subjected to preliminary analysis in this 
EMSA study was C/EBP (Umek, Friedman & McKnight, 1991). This large family 
of transcription factors is associated with terminal differentiation processes, 
therefore, it might be predicted that alterations may occur in the differentiation 
pathways corresponding with progression of tumorigenic cells towards a more 
aggressive state, i.e., the metastatic phenotype. From this hypothesis, it would be 
expected that the high metastatic potential cell line, CMT 167/C6, would exhibit a 
less differentiated phenotype in comparison with the low metastatic potential cell 
line CMT 170/E9. However, the result obtained from this EMSA experiment and 
repeat experiments gave the opposite result. Complexes al, a2 and a3 all appear to 
be equal between the two cell lines, but complex a4 appears to be weaker in 
CMT 170/E9 nuclear extracts. It is difficult to reconcile this conflicting result. 
However, since both cell lines were previously reported to form well differentiated 
tumours (Franks & Layton, 1984), it may be that the normal differentiation 
programme in these cells is retained to a certain degree thus the interpretation of an 
EMSA with a C/EBP differentiation-associated binding site is obscure. Further 
experiments are required to eliminate the possibility that this alteration is a 
consequence of the culture conditions of the cells thus relating to their growth 
status. In addition to these experiments examining DNA binding activities of 
nuclear protein extracts of cells maintained in 0.5% serum, experiments such as 
supershift assays, whereby specific antibodies are included in the assay to displace
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band shifts containing the recognized protein, could be tried. Alternatively, nuclear 
extracts can be pre-treated with antibodies to deplete the nuclear extract of specific 
proteins before incubation with the probe. Since the EMSA experiments described 
in this work were only of a preliminary nature, and through time constraints, these 
experiments have still to be attempted.
IX.4 Conclusions
Metastasis is a particularly complex process, of which the mechanisms involved at 
the various steps have still to be comprehended. The study of the metastatic 
phenotype described in this work utilized a murine model system which was based 
on two closely related cell lines, each of which were derived from the same 
spontaneous tumour. The CMT model of metastasis has not been used extensively 
before for the study of the metastatic phenotype and this work represents largely a 
characterization of the model with some studies aimed at hopefully providing an 
insight into the differing phenotypes. Unlike many other model systems, the CMT 
cell lines are assayed for their metastatic potential by a spontaneous metastasis 
assay which allows for the whole process of invasion through to secondary site 
colonization to be examined simultaneously. By these same criteria, dissection of 
the metastatic phenotype may be complicated due to the complex, multistep nature 
of metastasis which may hinder the isolation of particular traits associated with 
particular steps in the overall metastatic process. Unfortunately, it is widely 
accepted that at this stage in the research into metastasis, no ideal model system 
exists to date, and may not ever exist. As such, various approaches to the study of 
the metastatic phenotype have been adopted by different researchers with the hope 
that the next model will lead to a further understanding of metastasis. Since this 
model has not been in existence for any great length of time, particularly in 
comparison with some other models, it was hoped that various spurious traits, 
which were a consequence of prolonged culture under artificial conditions in vitro
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and which are irrelevant to the metastatic nature of the model, would not have been 
incorporated into this system.
An understanding of the metastatic phenotype has proved to be an extremely 
elusive goal. It would appear from many studies that the nature of metastasis is 
particularly intricate and multifaceted, as such it may well be proven that 
metastasis arises through a multitude of subtle alterations of normal cellular 
behaviour and the outcome will dependent on numerous qualities. How metastasis 
occurs may be an identifiable question with knowledge of the probable steps in the 
progression of a benign tumour to a fully disseminated malignant tumour. 
However, such questions as to why metastasis occurs may remain unanswered. 
Importantly, if we can understand how metastasis occurs and what characterizes a 
metastatic cell, then the treatment of patients with tumours, circulating tumour 
cells and metastatic disease can be given the most appropriate therapy to prevent 
metastasis or contain the disease and ultimately cause tumour regression.
IX.5 Future Prospects
Further strategies for the study of metastasis in this model system and in other 
suitable model systems include the techniques of differential mRNA display and 
cDNA subtractive hybridization analysis. The advent of more advanced and 
efficient procedures allows for these avenues of research to be ventured into, 
however, each have their own intrinsic difficulties and disadvantages but without a 
"more ideal" model to examine metastasis, these may provide the best insight into 
metastasis.
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